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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. The 
National Institute for Occupational Safety and Health has projected a 
formal system of research, with priorities determined on the basis of 
specified indices, to provide relevant data from which valid criteria for 
effective standards can be derived. Recommended standards for occupational 
exposure, which are the result of this work, are based on the health 
effects of exposure. The Secretary of Labor will weigh these 
recommendations along with other considerations such as feasibility and 
means of implementation in developing regulatory standards.
It is intended to present successive reports as research and 
epidemiologic studies are completed and as sampling and analytical methods 
are developed. Criteria and standards will be reviewed periodically to 
ensure continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on 
tungsten and cemented tungsten carbide by members of the NIOSH staff and 
the valuable constructive comments by the Review Consultants on tungsten 
and cemented tungsten carbide, by the ad hoc committees of the American 
Academy of Industrial Hygiene and the American Medical Association, and by
Robert B. O’Connor, M.D., NIOSH consultant in occupational medicine. The 
NIOSH recommendations for standards are not necessarily a consensus of all 
the consultants and professional societies that reviewed this criteria 
document on tungsten and cemented tungsten carbide. A list of Review 
Consultants appears on page vi.
sJohn F. Finklea, M.D.
Director, National Institute for 
Occupational Safety and Health
The Division of Criteria Documentation and Standards Development, National 
Institute for Occupational Safety and Health (NIOSH), had primary 
responsibility for development of the criteria and recommended standard for 
tungsten and cemented tungsten carbide. Sonia Berg of this Division served 
as criteria manager. Stanford Research Institute (SRI) developed the basic 
information for consideration by NIOSH staff and consultants under contract 
CDC-99-74-31.
The Division review of this document was provided by Richard A. Rhoden, 
Ph.D. (Chairman), J. Henry Wills, Ph.D., and Howard L. McMartin, M.D., 
with Gregory Ness (Division of Surveillance, Hazard Evaluations, and Field 
Studies), and Charles C. Hassett, Ph.D. John J. McFeters and Mary E. 
Cassinelli (Division of Physical Sciences and Engineering) submitted 
written comments.
The views expressed and conclusions reached in this document, together with 
the recommendations for a standard, are those of NIOSH. These views and 
conclusions are not necessarily those of the consultants, other federal 
agencies or professional societies that reviewed the document, or of the 
contractor.
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I. RECOMMENDATIONS FOR A STANDARD FOR TUNGSTEN
AND CEMENTED TUNGSTEN CARBIDE
The National Institute for Occupational Safety and Health recommends 
that employee exposure to elemental tungsten and its compounds and to 
cemented tungsten carbide dusts in the workplace be controlled by adherence 
to the following sections. The standard is designed to protect the health 
and provide for the safety of employees for up to a 10-hour work shift, 40- 
hour workweek, over a working lifetime. Compliance with all sections of 
the standard should prevent adverse effects (except sensitization) of these 
materials on the health and provide for the safety of employees. The 
recommended environmental limits for the standard are measurable by 
techniques that are reproducible and available to industry and government 
agencies. Sufficient technology exists to permit compliance with the 
recommended standard. Although NIOSH considers the workplace environmental 
limits to be safe levels based on current information, employers should 
regard them as the upper boundaries of exposure and make every effort to 
maintain exposures as low as is technically feasible. The criteria and 
standard will be subject to review and revision as necessary.
Approximately 70% of US tungsten production is eventually used in the 
manufacture of cemented tungsten carbide, where tungsten carbide is mixed 
with cobalt and/or other metals, including nickel, and their oxides or 
carbides to form a material valued for its hardness and wear resistance. 
The term "insoluble tungsten," used throughout this document, refers to 
elemental tungsten and all insoluble tungsten compounds (Table XII-1). The
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term "soluble tungsten" refers to those compounds of tungsten which are 
soluble in water and therefore readily translocated from the lungs, skin, 
or gastrointestinal tract to internal organs of experimental animals (Table 
XII-1). For the purpose of compliance with the recommended standards, 
insoluble tungsten compounds include all those for which water solubility 
is listed as "insoluble" or less than 0.01 g/100 cc. Soluble tungsten 
compounds are those listed as "very soluble," "soluble," "slightly 
soluble," equal to or greater than 0.01/100 cc or "decomposes." Those 
compounds for which no solubility information is listed should be 
considered soluble unless it can be demonstrated that they are insoluble in 
water. As a rough guide for control of airborne concentrations of tungsten 
compounds, the standard for insoluble tungsten should apply whenever 
processes within a building or independent structure involve only those 
stages which produce insoluble tungsten compounds from other insoluble 
tungsten compounds, eg, starting with ammonium-p-tungstate through tungsten 
carbide (Figure XII-1). Whenever soluble tungsten compounds are starting, 
intermediate, or final products, the standard for soluble compounds should 
apply throughout that building, unless it can be demonstrated through 
differential sampling and analysis that both limits are being met as 
appropriate.
The term "cemented tungsten carbide" or "hard metal" refers to a 
mixture of tungsten carbide (WC), cobalt, and sometimes other metals and 
metal oxides or carbides. The tungsten carbide content of hard metal is 
generally 80% or more, and the cobalt content is generally less than 10%, 
but it may be as high as 25%. When the cobalt content exceeds 2%, its 
contribution to the potential health hazard is judged to exceed that of
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tungsten carbide and all other components, and the recommended standard for 
such mixtures is based on the current US federal standard for occupational 
exposure to cobalt, 0.1 mg/cu m. If a future NIOSH recommendation for an 
occupational exposure limit for cobalt differs from the US federal standard 
for cobalt, this new recommendation should be considered to replace the 
current recommendation for an occupational exposure limit for dusts of 
cemented tungsten carbide containing more than 2% cobalt. If nickel is 
used as a binder rather than cobalt and the nickel content of the mixture 
exceeds 0.3%, then the NIOSH recommended occupational exposure limit for 
nickel of 15Atg/cu m shall apply. The recommended limits for airborne 
tungsten are different for "insoluble tungsten," "soluble tungsten," and 
"cemented tungsten carbide" because of their differing potential biologic 
effects and inherent toxicities. These criteria and the recommended 
standards shall apply to places of employment involved in the manufacture, 
use, storage, or handling of any of the defined materials.
The "action level" is defined as one-half the appropriate recommended 
time-weighted average (TWA) environmental limit. "Occupational exposure to 
cemented tungsten carbide, elemental tungsten, or its compounds" is defined 
as exposure at a concentration greater than the appropriate action level; 
ie, except for the case of cemented tungsten carbide products in which 
nickel is the binder, when the NIOSH definition of occupational exposure to 
nickel shall apply [1]. Exposures to airborne tungsten concentrations 
equal to or less than one half of the workplace environmental limits, as 
determined in accordance with Section 8, will not require adherence to the 
following sections, except for Sections 3(a), 4(b), 4(c), 5, 7, and 8. If 
exposure to other chemicals occurs, the employer shall also comply with the
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provisions of applicable standards for these other chemicals.
The recommended environmental limits are based on data which indicate 
that insoluble tungsten compounds and cemented tungsten carbide may cause 
transient or permanent lung damage and skin irritation, while soluble 
tungsten compounds have the potential to cause systemic effects involving 
the gastrointestinal tract and CNS. No carcinogenic, mutagenic, 
teratogenic, or reproductive effects in humans have been reported. 
Compliance with the appropriate recommended environmental limits should 
eliminate the hazards associated with tungsten compounds and cemented 
tungsten carbide, except for a few individuals who may become sensitized to 
cobalt or nickel and have adverse reactions upon exposure to extremely 
small amounts of cemented tungsten carbide.
Section 1 - Environmental (Workplace Air)
(a) Concentrations
(1) Occupational exposure to insoluble tungsten shall be
controlled so that employees are not exposed to insoluble tungsten at a
concentration greater than 5 milligrams, measured as tungsten, per cubic 
meter of air (mg/cu m), determined as a TWA concentration for up to a 10- 
hour work shift in a 40-hour workweek.
(2) Occupational exposure to soluble tungsten shall be
controlled so that employees are not exposed to soluble tungsten at a
concentration greater than 1 milligram, measured as tungsten, per cubic 
meter of air (mg/cu m), determined as a TWA concentration for up to a 10- 
hour work shift in a 40-hour workweek.
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(3) Occupational exposure to dust of cemented tungsten
carbide which contains more than 2% cobalt shall be controlled so that
employees are not exposed at a concentration greater than 0.1 milligram, 
measured as cobalt, per cubic meter of air (mg/cu m), determined as a TWA 
concentration for up to a 10-hour work shift in a 40-hour workweek.
(4) Occupational exposure to dust of cemented tungsten
carbide which contains more than 0.3% nickel shall be controlled so that 
employees are not exposed at a concentration greater than 15Mg of nickel 
per cu m air determined as a TWA concentration, for up to a 10-hour 
workshift in a 40-hour workweek as specified in NIOSH's Criteria for a 
Recommended Standard for Occupational Exposure to Inorganic Nickel.
(b) Sampling and Analysis
Environmental samples shall be collected and analyzed for tungsten as 
described in Appendices I and II, or for cobalt or nickel, as appropriate. 
Any methods shown to be at least equivalent in accuracy, precision, and 
sensitivity to the methods specified may also be used.
Section 2- Medical
Medical surveillance and counselling regarding its importance shall 
be made available to employees subject to occupational exposure to soluble 
tungsten, insoluble tungsten, or cemented tungsten carbide.
(a) Preplacement or initial examinations shall include:
(1) Medical and work histories.
(2) Physical examinations.
(3) Specific clinical tests including, but not limited to,
a 14- x 17-inch postero-anterior chest roentgenogram and pulmonary function
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tests including the forced vital capacity (FVC) and the forced expiratory 
volume in 1 second (FEV 1).
(4) A judgment of the employee's ability to use positive
pressure respirators.
(b) Periodic examinations shall be made available at least 
annually. These examinations shall include, but not be limited to:
(1) Interim medical and work histories.
(2) A physical examination and special tests as outlined in 
paragraph (a)(3) of this section.
(c) During or after examinations, applicants or employees having 
medical conditions which would be directly or indirectly aggravated by 
exposure to tungsten compounds or cemented tungsten carbide shall be 
counseled on the increased risk of impairment of their health from working 
with these materials.
(d) Initial medical examinations shall be made available as soon 
as practicable after the promulgation of a standard based on these 
recommendations.
(e) Employers shall ensure that pertinent medical records are kept 
for all employees exposed to tungsten compounds or cemented tungsten 
carbide in the workplace for at least 30 years after termination of 
employment. These records shall be made available upon request to the 
designated medical representatives of the Secretary of Health, Education, 
and Welfare, of the Secretary of Labor, of the employer, and of the 
employee or former employee.
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Section 3 - Labeling and Posting
All labels and warning signs shall be printed both in English and in 
the predominant language of non-English-reading workers. Illiterate 
workers and workers reading languages other than those used on labels and 
posted signs shall receive verbal information regarding hazardous areas and 
shall be informed of the instructions printed on labels and signs.
(a) Labeling
Containers of soluble tungsten compounds or cemented tungsten carbide 
shall carry labels which bear the trademarks of the products, the chemical 
name(s) of the compound(s) contained therein, and information on the 
effects of the particular product(s) on human health. The trademarks and 
pertinent information shall be arranged as in the following example:
TRADEMARK 
(CHEMICAL NAME)
MAY BE HARMFUL IF INHALED OR SWALLOWED 
MAY CAUSE SKIN AND RESPIRATORY TRACT IRRITATION
Avoid unnecessary contact with eyes, skin, and clothing.
Report any suspected skin irritation to your supervisor.
Avoid prolonged or repeated breathing of dust/vapor.
Use only with adequate ventilation.
Wash hands thoroughly after handling, before eating or smoking.
(b) Posting
In areas where soluble tungsten compounds or cemented tungsten
carbide are used, a sign containing information on the effects of the
specific compounds on human health shall be posted in readily visible
locations if employee exposures are above the action level. This
information shall be arranged as in the following example.
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TRADEMARK 
(CHEMICAL NAME)
MAY BE HARMFUL IF INHALED OR SWALLOWED
MAY CAUSE SKIN AND RESPIRATORY TRACT IRRITATION
Avoid prolonged or repeated breathing of dust/vapor.
Avoid unnecessary contact with skin, eyes, and clothing. 
Report any suspected skin irritation to your supervisor. 
Ventilation should be sufficient to carry away dust or vapor.
Section 4 - Personal Protective Clothing and Equipment
(a) Respiratory Protection
(1) Engineering controls shall be used when needed to keep 
concentrations of airborne tungsten products at or below the appropriate 
TWA exposure limits. The only conditions under which compliance with the 
permissible exposure limits may be achieved by the use of respirators are:
(A) During the time necessary to install or test the
required engineering controls.
(B) For operations such as nonroutine maintenance
and repair activities causing brief exposure at concentrations above the 
TWA exposure limits.
(C) During emergencies when concentrations of 
airborne tungsten products may exceed the TWA exposure limits.
(2) When a respirator is permitted by paragraph (a)(1) of 
this section, it shall be selected and used in accordance with the 
following requirements:
(A) The employer shall establish and enforce a
respiratory protective program meeting the requirements of 29 CFR 1910.134.
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(B) The employer shall provide respirators in 
accordance with Tables 1-1, 1-2, and 1-3 and shall ensure that employees 
use the respirators provided. The respiratory protective devices provided 
in conformance with Tables 1-1, 1-2, and 1-3 shall be those approved by 
NIOSH or the Minining Enforcement Administration. The standard is 
specified in 30 CFR 11.
TABLE 1-1
RESPIRATOR SELECTION GUIDE FOR INSOLUBLE TUNGSTEN COMPOUNDS*
Concentration Range 
(mg/cu m, as tungsten)
Respirator Type Approved under 
Provisions of 30 CFR 11
Less than or 
equal to 25**
(1) Single-use dust respirator
(2) Dust respirator with quarter-mask 
facepiece
Less than or 
equal to 50**
(1) Half-mask dust respirator
(2) Supplied-air respirator with half-mask 
facepiece
Greater than 50** (1) Full facepiece dust respirator
(2) Supplied-air respirator with full face­
piece, hood, or helmet
(3) Powered air-purifying respirator (posi­
tive pressure) with high efficiency filter***
(4) For abrasive-blasting with tungsten car­
bide, supplied-air respirator with hood or 
helmet operated in pressure-demand or other 
positive pressure mode or with continuous 
flow.
*In areas where ammonium-p-tungstate is used, a canister or cartridge which 
will remove ammonia is needed in addition to a particulate filter.
**When an employee informs the employer that eye irritation occurs while 
wearing a respirator, the employer shall provide an equivalent respirator 
with full facepiece, helmet, or hood and ensure that it is used.
***A high-efficiency filter is defined as one having a penetration of less than 
0.03% when tested against a 0.3-/am DOP aerosol.
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TABLE 1-2
RESPIRATOR SELECTION GUIDE FOR SOLUBLE TUNGSTEN COMPOUNDS*
Concentration Range 
(mg/cu m, as tungsten)
Respirator Type Approved under 
Provisions of 30 CFR 11
Less than or 
equal to 10**
(1) Half-mask dust and mist respirator
(2) Supplied-air respirator with half-mask 
facepiece
Less than or 
equal to 50**
(1) Full facepiece dust and mist respirator
(2) Supplied-air respirator with full 
facepiece
(3) Self-contained breathing apparatus with 
full facepiece
Greater than 50** (1) Powered air-purifying respirator (posi­
tive pressure) with high-efficiency filter***
(2) Supplied-air respirator with full face­
piece, hood, or helmet, continuous-flow or 
other positive-pressure type
(3) Self-contained breathing apparatus with 
full facepiece in pressure demand or other 
positive pressure mode
*Tungsten hexachloride in contact with water decomposes to tungsten and 
chlorine. Therefore, the dust and mist respirator is not satisfactory if 
the chlorine gas concentration exceeds the permissible level. When this 
occurs, the minimum acceptable respirator is a full facepiece respirator 
with a combination dust, mist, and chlorine canister.
**When an employee informs the employer that eye irritation occurs while 
wearing a respirator, the employer shall provide an equivalent respirator 
with full facepiece, helmet, or hood and ensure that it is used.
***A high-efficiency filter is defined as one having a penetration of less 
than 0.03% when tested against a 0.3-jum DOP aerosol.
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TABLE 1-3
RESPIRATOR SELECTION GUIDE FOR MIXTURES OF TUNGSTEN AND COBALT
Concentration Range 
(mg/cu m, as cobalt)
Respirator Type Approved under 
Provisions of 30 CFR 11
Less than or 
equal to 1.0*
(1) Any dust respirator, except single-use or 
quarter-mask respirator*
(2) Supplied-air respirator operated with 
a quarter-mask or half-mask facepiece
Less than or 
equal to 5.0
(1) Air-purifying respirator with full face­
piece and high-efficiency filter**
(2) Supplied-air respirator with full 
facepiece
(3) Self-contained breathing apparatus with 
full facepiece
Less than or 
equal to 100*
(1) Powered air-purifying respirator, posi­
tive pressure, with high efficiency filter**
(2) Type C supplied-air respirator contin- 
uous-flow type, with half-mask facepiece
Less than or 
equal to 200
(1) Type C supplied-air respirator, contin- 
uous-flow type, with full facepiece, hood, 
helmet, or suit
(2) Type C supplied-air respirator operated 
in pressure demand mode with full facepiece
Greater than 200 (1) Self-contained breathing apparatus with 
full facepiece operated in pressure demand or 
other positive pressure mode
(2) Combination Type C supplied-air respira­
tor with full facepiece operated in pressure 
demand mode with an auxiliary self-contained 
air supply
*When an employee informs the employer that eye irritation occurs while 
wearing a respirator, the employer shall provide an equivalent respirator 
with full facepiece, helmet, or hood and ensure that it is used.
**A high-efficiency filter is defined as one having a penetration of less 
than 0.03% when tested against a 0.3-;™ DOP aerosol.
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(C) Respirators specified for use in higher 
concentrations of tungsten compounds or cemented tungsten carbide may be 
used in atmospheres of lower concentrations.
(b) Eye Protection
Eye protection shall be provided in accordance with 29 CFR 1910.133 
for operations, such as grinding, which produce and scatter particulates 
into the air.
(c) Skin Protection
While most workers do not experience skin irritation as a result of 
exposure to tungsten compounds or cemented tungsten carbide, there are some 
who develop sensitivity. Fingerless gloves may be used during grinding of 
hard metal to protect the hands from abrasion. Protective sleeves of dust- 
proof material may be worn to prevent impact of hard-metal dust on the skin 
of the arms. In the absence of such gloves and sleeves, creams protective 
against abrasion may be applied liberally to the hands and arms to minimize 
contact of the skin with hard-metal dust. When skin irritation occurs, 
these workers should be referred to a physician for appropriate protective 
and therapeutic measures. When abrasive dust of tungsten carbide is likely 
to contact major parts of an employee's body, the employee should wear 
closely woven coveralls provided by the employer. The coveralls should be 
laundered frequently to minimize mechanical irritation from dust in the 
cloth.
Section 5 - Informing Employees of Hazards from Tungsten
(a) Each employee with potential for exposure to tungsten 
compounds or cemented tungsten carbide shall be informed at the beginning
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of employment or assignment to such work areas and periodically thereafter 
of the hazards, relevant symptoms, appropriate emergency procedures, and
proper conditions and precautions for the safe handling and use of these 
materials. Special mention should be made of possible sensitization to
cobalt or nickel. Employees engaged in maintenance and repair shall be 
included in these training programs.
(b) The employer shall institute a continuing education program, 
conducted by persons qualified by experience or training, to ensure that 
all employees have current knowledge of job hazards, proper maintenance and 
cleanup methods, and proper respirator usage. The instructional program 
shall include a description of the general nature of the medical 
surveillance procedures and of the advantages to the employee of 
participating in these programs. As a minimum, instruction shall include 
the information in Appendix III, which shall be kept on file, readily 
accessible to employees at all places of employment where exposure to
tungsten compounds and/or cemented tungsten carbide may occur.
(c) Required information shall be recorded on the "Material Safety 
Data Sheet" shown in Appendix III or on a similar form approved by the 
Occupational Safety and Health Administration, US Department of Labor.
Section 6 - Work Practices
(a) Control of Airborne Tungsten Compounds and Cemented
Tungsten Carbide
Engineering controls, such as process enclosure and/or local exhaust 
ventilation, shall be used to keep concentrations of airborne tungsten 
products within the recommended environmental limits. Ventilation systems
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shall be designed to prevent the accumulation or recirculation of these 
materials in the workplace environment and to effectively remove them from 
the breathing zones of employees. Wet process sharpening of cemented 
tungsten carbide material may not provide total control of dust, and local 
exhaust ventilation may also be required. Exhaust ventilation systems 
discharging to the outside air shall conform to applicable local, state, 
and federal air pollution regulations and shall not constitute a hazard to 
employees. Ventilation systems shall be subject to regular preventive 
maintenance and cleaning to ensure their continuing effectiveness. 
Continuous airflow indicators, such as water or oil manometers (marked to
indicate acceptable airflow), are recommended and should be checked
monthly. If such indicators are not used, the efficiency of the 
ventilation system shall be verified by airflow measurements taken at 
intervals determined by the documented maintenance history of the system.
(b) Control of Spills and Leaks
Only personnel properly trained in the procedures and adequately
protected against the attendant hazards shall be assigned to shut off
sources of tungsten, clean up spills, and repair leaks. Dry sweeping 
should be avoided.
(c) Handling and General Work Practices
(1) Care should be taken in pouring or scooping powdered 
materials to avoid excessive dust generation. If an employee experiences 
upper or lower respiratory tract irritation, special attention should be 
paid to work practices.
(2) Safety precautions are needed in the manufacture of 
filaments to protect against electrical hazards during high voltage
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smelting and against explosion hazards and lacerations from very finely 
drawn wire.
Section 7 - Sanitation
For insoluble tungsten compounds, appropriate provisions of 29 CFR 
1910.141 shall apply. In addition, the following precautions apply to all 
areas where a potential for exposure to soluble tungsten or cemented 
tungsten carbide exists:
(a) Eating and food preparation or dispensing (including vending 
machines) shall be prohibited in work areas containing soluble tungsten or 
cemented tungsten carbide.
(b) Employees who handle soluble tungsten, cemented tungsten 
carbide, or equipment contaminated with these materials shall be instructed 
to wash their hands thoroughly with soap or mild detergent and water before 
eating or smoking and shall be cautioned not to touch their faces or any 
other skin surfaces with contaminated fingers.
(c) Waste material contaminated with soluble tungsten or cemented 
tungsten carbide shall be disposed of in a manner which prevents harm to 
employees. The disposal method must conform with applicable local, state, 
and federal regulations and must not constitute a hazard to the surrounding 
population or environment.
Section 8 - Environmental Monitoring and Recordkeeping
As soon as practicable after the promulgation of a standard based on 
these recommendations, the employer shall conduct an industrial hygiene
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survey at each location where tungsten compounds or cemented tungsten 
carbide are released into the workplace air to determine whether exposure 
to airborne concentrations of tungsten products is above the respective 
action levels. The employer shall keep records of these surveys, including
the basis for concluding that air levels are at or below the appropriate
action levels. Surveys shall be repeated at least once every 3 years and
within 30 days of any process change likely to result in an increase of
airborne concentrations of tungsten or its products.
If it has been determined that the environmental concentration of 
tungsten or its products may exceed the appropriate action level or TWA 
environmental limit, then the following requirements shall apply:
(a) Personal Monitoring
(1) A program of personal monitoring shall be instituted to 
identify and measure, or permit calculation of, the exposure of each 
employee occupationally exposed to any tungsten compound or cemented 
tungsten carbide. Source and area monitoring may be used to supplement 
personal monitoring.
" (2) Samples representative of the exposure in the breathing
zone of the employee shall be collected in all personal monitoring. 
Procedures for the calibration of equipment, sampling, and analysis of 
tungsten samples are provided in Section 1(b).
(3) For each TWA concentration determination, a sufficient 
number of samples shall be taken to characterize the employee's exposure 
during each work shift. Variations in the employee's work schedules, 
locations, and duties and changes in production schedules shall be 
considered in deciding when samples are to be collected. The number of TWA
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determinations for an operation or process shall be based on the variations 
in location and job functions of employees relative to that operation or 
process.
(4) If an employee is found to be exposed above the
appropriate action level, the exposure of that employee shall be monitored 
at least once every 3 months until the measured concentration is found to 
be below the action level in two successive analyses of samples taken at 
least 1 week apart.
(5) If an employee is found to be exposed above the
appropriate TWA concentration limit, the exposure of that employee shall be 
measured at least once every 30 days, and control measures shall be 
initiated; the employee and others who work in the area while controls are 
being installed shall be notified of the exposure and of the control 
measures Seing implemented. Monitoring shall continue until two 
consecutive determinations, at least 1 week apart, indicate that the 
employee's exposure no longer exceeds the recommended environmental 
concentration limit; quarterly or triennial monitoring as applicable may 
then be resumed.
(b) Recordkeeping
Employers or their successors shall retain records of environmental 
monitoring for each employee for at least 30 years after the individual's 
employment has ended. These records shall include the name and social 
security number of the employee being monitored; job function and location 
within the worksite at the time of sampling; dates of measurements; 
sampling and analytical methods used and evidence for their accuracy; 
number, duration, and results of samples taken and TWA concentrations based
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on these samples; and the type of personal protective equipment in use, if 
any. Records for each employee, indicating the dates of employment with 
the company and changes in job assignment, shall be kept for the same 30- 
year period. These records shall be made available to designated 
representatives of the Secretary of Health, Education, and Welfare and of 
the Secretary of Labor. Employees or former employees shall have access to 
information on their own exposures. The employees or their representatives 
shall be given the opportunity to observe any measurement conducted in 
accordance with this section and to receive a full explanation of the 
significance of the measurements.
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II. INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon that were prepared to meet the need for preventing occupational 
disease or injury arising from exposure to tungsten, tungsten compounds, 
and cemented tungsten carbide. The criteria document fulfills the 
responsibility of the Secretary of Health, Education, and Welfare under 
Section 20(a)(3) of the Occupational Safety and Health Act of 1970 to 
"...develop criteria dealing with toxic materials and harmful physical 
agents and substances which will describe...exposure levels at which no 
employee will suffer impaired health or functional capacities or diminished 
life expectancy as a result of his work experience."
The National Institute for Occupational Safety and Health (NIOSH), 
after a review of data and consultation with others, formalized a system 
for the development of criteria upon which standards can be established to 
protect the health and to provide for the safety of employees exposed to 
hazardous chemical and physical agents. The criteria and the recommended 
standard should enable management and labor to develop better engineering 
controls and more healthful work practices. Compliance with the 
recommended standard should not be used as the final goal.
These criteria for a recommended standard for tungsten, tungsten 
compounds, and cemented tungsten carbide are part of a continuing series of 
documents published by NIOSH. The recommended standard applies to the 
processing, manufacturing, use, and handling of these materials in the 
occupational setting. The standard was not designed for the population-at- 
large, and any application to situations other than occupational exposures
19
is not warranted. It is intended to (1) protect against the development of 
systemic toxic effects and local effects on the eyes and skin, (2) be 
measurable by techniques that are reproducible and available to industry 
and government agencies, and (3) be attainable with existing technology.
The major concern in occupational exposure to tungsten, tungsten 
compounds, or cemented tungsten carbide is the potential for transient or 
permanent pulmonary damage. Irritation of the skin and upper and lower
respiratory tract has also been associated with inhalation of, or skin
contact with, these materials and should be considered in any work 
practices program.
There is little information now available on the toxic effects of 
tungsten on animals and man which is applicable to the setting of a 
standard for the industrial environment. Retrospective and prospective 
epidemiologic studies are needed to assess the potential occupational 
hazards from tungsten and its compounds. Also, the abilities of various 
tungsten compounds to irritate the skin and eyes need to be investigated.
Additional short- and long-term inhalation studies on animals are necessary
to assess the toxic effects of tungsten, particularly on the liver, 
kidneys, lungs, and central nervous system (CNS) . Such studies should aim 
also to distinguish the effects of exposure to tungsten and its compounds 
from those produced by mixtures containing cobalt or nickel. Chronic 
studies are also needed to investigate the carcinogenic, mutagenic, and 
teratogenic potentials of tungsten.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
Tungsten (atomic number 74) is listed in the periodic table under 
period 6 of the transition elements, along with chromium and molybdenum. 
Tungsten closely resembles molybdenum in all of its physical and chemical 
properties. In the pure metallic state, tungsten is grey and has a luster 
somewhat like that of steel. The physical and chemical properties and
formulae of tungsten and of some of its important organic and inorganic
compounds are given in Table XII-1 [2-6]. The commercial tungstate 
minerals are wolframite (Fe,Mn)W04), scheelite (CaW04), ferberite (FeW04), 
and hubnerite (MnW04). Worldwide, wolframite is the most important ore 
containing tungsten, whereas scheelite is the principal domestic ore [7]. 
Most tungsten deposits are low-grade and are upgraded by concentration 
techniques. The tungsten concentrates produced contain at least 60%
tungstic oxide.
The total US consumption of tungsten concentrate in 1975 was 14.0 
million pounds, of which 5.6 million pounds were domestically produced, 6.6 
million pounds were imported primarily from Canada, Thailand, Peru, the 
People's Republic of China, and Portugal, and the remainder was released 
from government stockpiles [8].
In 1975, the United States produced 12.634 million pounds of tungsten 
products and consumed 12.934 million pounds, including 72.5% in alloys for 
cutting and wear-resistant materials, 11.5% in mill products from metal 
powder, 9.2% in steel, 2.9% in super alloys, 2.4% in chemicals and
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ceramics, 0.03% in cast iron, and 1.47% in miscellaneous products [8].
Fairhall [9] stated that the principal health hazards from tungsten 
and its compounds arise from inhalation of aerosols during mining and 
milling operations. The principal compounds of tungsten to which workers 
are exposed are ammonium-p-tungstate, oxides of tungsten (W03, W205, W02),
metallic tungsten, and tungsten carbide. In the production and use of 
tungsten carbide tools for machining, exposure to the cobalt used as a 
binder or cementing substance (Figure XII-1) [10,11] may be the most 
important hazard to the health of the employees. Since the cemented 
tungsten carbide industry uses such other metals as tantalum, titanium, 
niobium, nickel, chromium, and vanadium in the manufacturing process, the 
occupational exposures are generally to mixed dusts. Potential 
occupational exposures to sodium tungstate are found in the textile 
industry, where the compound is used as a mordant and fireproofing agent, 
and in the production of tungsten from some of its ores, where sodium 
tungstate is an intermediate product (Figure XII-1). Potential exposures 
to tungsten and its compounds are also found in the ceramics, lubricants, 
plastics, printing inks, paint, and photographic industries. Some of the 
occupations with potential exposures to tungsten and its compounds are 
listed in Table XII-2 [12],
NIOSH estimates that at least 30,000 employees in the United States 
are potentially exposed to tungsten and its compounds, based on actual 
observations in the National Occupational Hazards Survey.
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Historical Reports
In 1927, at Essen, Germany, it was discovered that, if tungsten 
carbide was mixed with cobalt, a very serviceable cemented tungsten carbide 
(ie, hard metal) was obtained [7].
About 10 years after the commercialization of cemented tungsten 
carbide, the first report appeared on the associated health problems of the 
exposed workers. In 1940, Jobs and Ballhausen [13] examined 27 German 
workers exposed to unspecified concentrations of hard-metal dusts for 2 
years. Radiographs of the chests of eight men showed areas of fine 
nodulation in the lungs suggestive of early pneumoconiosis.
In 1945, Schwartz et al [14] investigated the incidence of dermatitis 
among employees in a tungsten carbide plant for the US Public Health 
Service. About 20 of the 1,200 workers examined had red, papular 
dermatitis on the face, neck, and extremities. Although the dust was 
abrasive, patch tests of six workers showed that it was sensitivity to 
cobalt that had caused the dermatitis in those six.
Fairhall and associates [15], in 1947, conducted an epidemiologic 
survey of 1,802 workers in the cemented tungsten carbide industry for the 
US Public Health Service. They found inflammation of the conjunctivae and 
of the mucous membranes of the respiratory tract. Radiographs of 36 
workers' lungs revealed granular or conglomerate markings, but 23 (64%) of 
these men had previously worked in unspecified mining or metal fabricating 
industries. Some workers were found to have pruritus due to sensitivity of 
the skin to cobalt.
In 1953, Miller et al [16] were the first to report cases of "hard- 
metal disease" (interstitial pulmonary fibrosis) in hard-metal grinders.
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Three men who had ground finished tools for 6.5-8.5 years complained of 
persistent coughing, with production of sputum and exertional dyspnea. 
Radiologic chest examinations showed that prominent hilar shadows and lung 
markings abated in one worker, but persisted for more than a year in the 
other two workers after they had been removed from the work atmosphere. 
However, the clinical signs and symptoms disappeared in all three men when 
they were no longer exposed to the workplace dust. The authors recognized 
that the workers were exposed to various combinations of powdered metals 
but concluded that cobalt was the most likely cause of the disease.
Effects on Humans
Occupational exposures to tungsten and its compounds have been 
reported to have primary effects on the respiratory system. In the 
cemented tungsten carbide (hard-metal) industry, exposure to a combination 
of cobalt and tungsten sometimes has resulted in hard-metal disease. The 
pulmonary involvement presented in a number of reports was characterized 
clinically by upper respiratory tract irritation, coughing, exertional 
dyspnea, and weight loss. As the condition of the workers worsened with 
prolonged exposure in this environment, extrinsic asthma, diffuse 
interstitial pneumonitis, fibrosis, pneumoconiosis, or combinations of 
these were evident.
Dorsit et al [17], in 1970, described three workers exposed to 
tungsten carbide and cobalt as having a "true, occupational, pulmonary 
disorder." These men, aged 30, 36, and 57 years, had been employed for 5, 
11, and 16 years, respectively, in work involving the use of diamond and 
tungsten carbide drills, rectifiers, and sharpeners. Workplace dust
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particles were under 3 11m in diameter, and the concentration of dust in the 
air varied from 380,000 to 5,600,000 particles/liter of air (2.3-62.3 
mg/cu m). The workers received examinations which included blood analyses, 
chest X-ray studies, and pulmonary function tests. All three workers had 
dry coughs, progressive dyspnea on exertion and subsequently at rest, 
roentgenographic signs of nodular reticulation of the lungs (diffuse 
interstitial fibrosis) of varying degrees, decreased lung capacities, 
oxyhemoglobin desaturation, hypercapnia, respiratory alkalosis, 
polycythemia, and weight loss.
Of 380 workers in the same factory, 29 men who had been employed for 
up to 17 years were examined for clinical signs and symptoms of respiratory 
disorders [17]. Of these, 15 had dry coughs, 5 showed throat irritation, 9 
had worktime dyspnea, and 3 had allergic asthma (some had more than 1 
symptom).
The authors [17] also reviewed published reports of exposure to 
cemented tungsten carbide dust and, from this study and their own work, 
concluded that affected workers were characterized as 30- to 50-year-old 
males exposed for at least 3 years. Clinical findings included dyspnea on 
exertion, a dry cough, cyanosis of lips and fingers, rales, polycythemia 
with a concurrent rise in hemoglobin, and weight loss. Observations among 
workers affected included progressive decreases in circulatory and cardiac 
function, concurrent pulmonary infections (possibly tuberculosis), and 
death within 4 years of initial onset of symptoms. The authors also 
pointed out that pulmonary function tests were more indicative of the 
severity of interstitial fibrosis than were radiographs. They concluded 
that a mixture of tungsten carbide and cobalt appeared to be the causative
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agent and advised extremely close supervision of workers in the hard-metal 
industry.
In 1971, Coates and Watson [18] reported 12 cases of diffuse, 
interstitial lung disease among tungsten carbide workers. The group 
consisted of 11 men and 1 woman, with a mean age of 40.5 years (range 22-55 
years), who were engaged in various processes in the manufacture and 
grinding of cemented tungsten carbide. The exposure levels of tungsten 
were not given, but the processes generated particles averaging less than 
2.0 nm in diameter and produced concentrations of airborne cobalt greater 
than 0.1 mg/cu m. In addition to tungsten and cobalt, the processes also 
used titanium carbide, tantalum carbide, chromium carbide, and nickel. The 
mean duration of exposure before the development of symptoms was 12.6 
years, with a range of 1 month to 28 years. Eight of the 12 workers died. 
Seven of the 12 workers were examined by one of the authors; 6 of those 
examined were tested for vital capacity, FEV1, and maximum voluntary 
ventilation (MW) .
The authors [18] noted that the pattern of clinical signs and 
symptoms was strikingly similar in all the workers, varying mainly in 
intensity. The early stages of respiratory involvement were characterized 
by a cough with scanty sputum, followed by dyspnea on exertion. An average 
weight loss of 10 pounds was noted in seven patients. Ventilatory tests of 
six patients showed that the average vital capacity was 50% of the 
predicted values (range 37-70%); the FEV1 was between 85 and 100% of the 
predicted values, and the average MVV was 76% of the predicted values 
(range 45-92%). These findings were interpreted to indicate a severe, 
restrictive ventilatory pattern without airway obstruction. From the
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findings of low carbon monoxide diffusing capacity and decreased oxygen 
saturation of the arterial blood, the authors concluded that the patients 
had a diffuse, interstitial, fibrotic response to the xenobiotic material 
that had entered their respiratory systems. In two individuals, pulmonary 
function changes preceded abnormal chest X-ray findings. Serial chest X- 
ray studies showed progressive, bilateral, nodular, and linear densities 
with gradual involvement of major portions of the lungs. Radiographic 
evidence of nonspecific, diffuse interstitial fibrosis was found.
Light-microscopic examinations of the aforementioned lung specimens 
showed interstitial cellular infiltration with slight to marked fibrotic 
tissue reaction, cystic air spaces lined by an epithelium showing a 
metaplastic change from a squamous to a cuboidal type, and desquamation 
into the alveoli of type II alveolar pneumocytes [18]. Large mononuclear 
and occasional multinucleated, giant cells were present. Electron 
microscopic findings were consistent with the changes observed by light 
microscopic examination. By X-ray diffraction analysis, the presence of 
tungsten carbide was detected in all of the lung samples analyzed. Mass 
spectrometric analysis revealed the presence of both tungsten carbide and 
cobalt. One lung biopsy sample for which quantitative data were reported 
contained 3.0 /ug of tungsten, 2.0 jug of titanium, and 0.1 /ug of cobalt/g of 
wet lung. The authors found no correlation between the amount of cobalt in 
the lung specimens and the severity of the disease from which the decedent 
had suffered. The type of interstitial lung disease seen in these people 
reportedly resembled the hypersensitivity pneumonitis of "farmer's lung" 
and beryllium granulomatosis.
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Coates and Watson [18] also briefly reported on five tungsten 
carbide workers with normal chest roentgenographs who were described as 
having occupational asthmatic bronchitis. Data such as age, sex, duration 
of exposure, and the nature of the work involved were not described. These 
workers had episodic attacks of wheezing cough which abated when they left 
work and recurred on their return. The authors referred to this form of
lung disease as "sensitization" related to preexisting lung diseases,
allergic background, or both. The authors stated that no evidence existed 
that this disease might progress to interstitial lung disease. They 
emphasized that determining workers' susceptibility to interstitial lung 
disease and diagnosing the disease in its early stages would help to 
protect workers' health. Although they presented no evidence that cobalt 
was responsible for the observed respiratory disorders, they believed it to 
be the most probable cause.
In 1974, Bech [19] described clinical and radiologic findings in 12 
workers with diagnoses of hard-metal disease and in 1 worker with allergic 
asthma among 375 hard-metal tool grinders employed in a cemented tungsten 
carbide plant. These 12 men ranged in age from 33 to 69 years, with an 
average age of 54.3 years. Although the exposure concentrations and the 
compositions of the dusts to which the men were exposed were not given, the 
typical tools contained "80-90% tungsten, 8-18% titanium carbide, 5-25%
cobalt," and occasionally small quantities of tantalum, vanadium,
molybdenum, and chromium. The 12 workers with hard-metal disease had been 
engaged in tool grinding for an average of 25.8 years (range 15-51 years), 
whereas the worker who had allergic asthma had worked at tool grinding for 
only 2 years. Eight of the men worked only part time as tool grinders.
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All workers were evaluated by physical examination and chest 
radiography. Lung tissue obtained by biopsy from one worker, by biopsy and 
by autopsy from two workers, and by autopsy only from four workers were 
evaluated microscopically. Pulmonary function tests also were conducted on 
8 of the 12 workers with hard-metal disease.
Of the 12 employees with hard-metal disease, 8 died of secondary 
consequences of their pulmonary disease [19]; four of the eight died of cor 
pulmonale and cardiac failure, whereas the other four died of emphysema. 
Except for differences in the degree and duration of the symptoms, the 
general course of the disease was similar in all 12 cases. Coughing (dry 
or with sputum production), exertional dyspnea, and occasional wheezing 
characterized the disease. Initially, the chest radiographic studies 
showed slight increases in lung markings and very sparse linear opacities 
in the mid- and lower zones. In later stages of the disease, there were 
marked radiologic changes with varying degrees of linear, micronodular, and 
nodular opacities in the midzones of the lung, prominent hilar shadows, and 
occasional honeycombing. Pulmonary function tests revealed restrictive 
ventilatory defects, with reduction in residual lung volume and total lung 
capacity (no values given). A low FEV1 and FEV and a marked reduction (50% 
of normal) in carbon monoxide uptake were noted occasionally. Examination 
of lung samples obtained by biopsy or autopsy revealed emphysema and 
varying degrees of interstitial fibrosis in seven workers. In one patient 
with hard-metal disease of recent onset, withdrawal from exposure and 
corticosteroid therapy produced clinical and radiographic evidence of 
improvement.
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The worker with allergic asthma developed wheezing, tightness and 
discomfort in the chest, and exertional dyspnea which was later manifested 
in asthmatic attacks [19]. These signs and symptoms were least severe at 
the beginning of a workday and during the weekend. However, there were 
signs of bronchospasm upon auscultation of the chest. The asthmatic signs 
and symptoms receded 2-3 months after the worker's discharge from tool- 
sharpening work.
The author [19] concluded that, since hard-metal disease is
progressive and potentially lethal, its early recognition is of the utmost 
importance. He also acknowledged that there was no correlation between the 
development of diffuse interstitial fibrosis and the onset of symptoms or 
the duration of exposure. The study does not contribute to the evaluation 
of the etiologic role of tungsten in the development of hard-metal disease.
In 1975, Baudouin et al [20] reported 5 cases of diffuse
interstitial pulmonary fibrosis among 100 men of unspecified age who worked 
in a hard-metal factory where dusts of tungsten, titanium, tantalum, and 
niobium metals, of their carbides and oxides, and of cobalt metal were 
liberated during various operations. The concentrations, particle sizes, 
and specific compositions of these dusts were not indicated. The authors 
noted that most occupational exposures occurred in operations involving the 
mixing of powders and the grinding and machining of sintered pieces. The 
workers were screened for observable and radiographic anomalies of the 
chest. Of the 100 exposed workers, 15 (aged 22-65) had signs of 
respiratory irritation after 1 month-9 years of exposure. Five of these 15 
workers developed pulmonary fibrosis within 6 months to 4 years after the 
onset of the irritative signs.
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The investigators [20] found no predisposing factor in the personal 
or family backgrounds of the five subjects with pulmonary fibrosis. The 
irritation diminished or disappeared during vacations and weekends and 
reappeared during work. When the disease progressed to fibrosis, the 
authors found rapid weight loss, fine rales, and exertional dyspnea which 
was not reversible during vacations.
No significant changes were noted in the chest radiographs of the 
workers with irritative symptoms [20]. However, reticulonodular images 
that became gradually accentuated and more generally distributed were 
characteristic of the fibrotic stage. Spirography showed low volumes of 
residual air in the lungs, indicative of a constant, restrictive disorder. 
Lung diffusion studies showed resistance to transepithelial gas exchange, 
leading the authors to suggest that such studies could be used to diagnose 
fibrosis before the appearance of radiologic signs. Blood-gas analysis 
demonstrated decreased exchange of respiratory gases between the alveoli 
and the pulmonary capillaries. Baudouin and his associates [20] reported 
that immunologic examination revealed a cellular rather than a humoral 
immune deficiency.
In one worker, the progression of clinical, radiographic, blood-gas, 
and pulmonary function changes was similar to those described above, and 
both light and electron microscopic examinations of lung tissue removed for 
biopsy revealed that diffuse, interstitial fibrosis had evolved [20]. 
Electron microscopic examinations also revealed crystalline particles, 
possibly of tungsten carbide, in the macrophages. Examination of the ashed 
lung by X-ray fluorescence revealed the presence of a large amount of 
tungsten, of an amount of titanium greater than is usual, and of small
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amounts of tantalum and niobium. The carbides of tungsten and titanium 
were demonstrated in the ashed lung by X-ray diffraction. The authors 
concluded that inhalation of dusts containing a mixture predominantly of 
tungsten metal or tungsten carbide caused diffuse interstitial fibrosis. 
Tungstosis was suggested as the name for this form of fibrosis, which was 
preceded by irritative symptoms and appeared 4-11 years after initial 
exposure. The authors suggested the registration of tungstosis as the 65th 
occupational disease in France. Although no component metal of the dusts 
was established as the causal agent, the authors [20] stated that 
tungstosis follows the inhalation of powders composed principally of 
tungsten metal or tungsten carbide.
Scherrer [21] described pulmonary interstitial fibrosis in three male 
workers exposed to tungsten, cobalt, titanium, tantalum, and niobium dusts 
at unspecified concentrations. The men, aged 34, 38, and 58 years, had 
been exposed for 3, 1, and 8 years, respectively. In each case, clinical 
symptoms, vital capacity, and chest radiographic findings were reported. A 
sample of lung was removed from the 38-year-old worker for biopsy, examined 
under a light microscope for histologic changes, and was analyzed 
spectroscopically and histochemically for the presence of tungsten and 
cobalt.
Although the course of the disease was somewhat different in each 
worker, the chief signs and symptoms were similar [21]. The illnesses of 
the three workers began with dyspnea, coughing, fever, and general malaise. 
The symptoms of the two younger workers were somewhat relieved when they 
left the dusty work environment- The condition of the 58-year-old man, 
whose illness had developed more slowly, continued to deteriorate even
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after he left work. For the 38-year-old worker, a diagnosis of hard-metal 
pneumoconiosis (pulmonary interstitial fibrosis) was made on the basis of 
chest radiographs showing miliary reticulation, wet rales heard over most 
lung areas, decreased pulmonary functions, and hypoxemia and on the results 
of examination of specimens of lung removed for biopsy. In this worker, 
the alveolar septae were thickened by fibrotic processes, and the air 
spaces were decreased by excess mucus and hyperplasia of the alveolar 
epithelium. Macrophages containing numerous foreign materials were 
present. Both spectroscopic and histochemical analyses of biopsy specimens 
of lung indicated the presence of 200 times the normal amount of tungsten, 
but no cobalt was found. The 34-year-old worker was able to return to work 
in an area free of the dusty exposures; the other two were severely 
restricted in their ability to work.
Scherrer [21] recommended that vital capacities be determined as 
early as possible in suspected exposure cases, since these measurements 
seemed to permit the earliest detection of abnormalities in hard-metal 
pneumoconiosis or fibrotic interstitial lung disease. The disease was not 
attributed to any one component of the hard-metal alloy. However, the 
author noted that individual susceptibility to hard-metal pneumoconiosis 
was a significant factor.
In 1972, Rochemaure et al [22] described the development of fibrosis 
in a 46-year-old woman who had worked with hard-metal mixtures and thus had 
been exposed to tungsten carbide and cobalt at unspecified concentrations. 
She was a nonsmoker with no history of bronchopulmonary problems. Three 
years after beginning such work, she developed a persistent, dry cough that 
lasted for 12 months and became productive during the following 6 months.
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At the end of this period, exertional dyspnea and a weight loss of 8 kg 
were noted. About 3 months later, the woman was hospitalized after X-ray 
studies of her chest revealed bilateral, reticulonodular opacities.
Except for crepitant rales, physical examination of the woman did 
not reveal any abnormalities [22]. Pulmonary function tests showed a 
decrease of more than 50% in vital capacity and decreased carbon monoxide 
diffusion (50% of the theoretical value). Blood-gas determinations showed 
a tendency toward respiratory alkalosis. Differential blood cell counts 
and liver function test results were normal. Chest radiographs revealed 
reticulonodular opacities on both sides of the chest, but mainly on the 
right side and in the basal areas of the lungs. Expectorations contained 
mucus, many bronchial cells, and macrophages, and bronchial aspirates 
contained, in addition, large amounts of blood and some inflammatory, 
cellular elements.
Ocular microscopic examination of a specimen of lung taken for 
biopsy 2 months after initial hospitalization revealed fibrosis with 
deposits of collagen, lymphocytes, and plasmocytes around the bronchi and 
vessels, which caused thickening of the alveolar septa [22]. Hyperplastic 
squamous or cuboidal epithelial cells lined the damaged alveoli, which 
contained macrophages and leukocytes and showed some evidence of edema. 
Emission spectrographic analysis of the lung specimen revealed no 
detectable levels of tungsten, titanium, or cobalt. The investigators 
attributed these negative findings to the small sample size.
The patient's clinical, radiologic, and pulmonary function tests 
showed significant improvement when she left the work environment [22]. 
Coughing, dyspnea, and reticulonodular opacities recurred when the patient
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resumed work 3 months later. Because of the severity of her signs and 
symptoms, the patient again stopped work after 3 weeks. At this time, 
pulmonary function tests showed that her vital capacity had decreased to 
60% of the predicted value and that there was a 66% decrease in carbon 
monoxide diffusing capacity. The authors stated that the recurrence of her 
signs and symptoms when she returned to work indicated that tungsten 
carbide dust played an important role in her illness, but they pointed out 
that cobalt was the most toxic agent to which she had been exposed. The 
authors suggested that individual susceptibility differences might have 
caused only some workers to experience coughing and dyspnea and still fewer 
to develop pulmonary fibrosis.
In 1967, Bruckner [23] diagnosed extrinsic asthma in a 45-year-old 
grinder of tungsten carbide-tipped tools. The worker had smoked for 17 
years before being employed in the tungsten carbide industry but had not 
smoked during the present employment. During the 4 years before the 
diagnosis, the subject had done rough grinding of tungsten carbide for 
about 16 months. He used silicon carbide and aluminum oxide wheels and had 
later performed fine, dry grinding using diamond wheels. When the worker 
changed to the latter type of grinding, he experienced shortness of breath, 
chest tightness, audible wheezing, and productive cough during work. His 
symptoms decreased or disappeared during weekends and vacations. The 
composition and concentration of dusts in the workplace air were not 
described. Because of progressive deterioration in his health, the worker 
was hospitalized twice for severe shortness of breath with audible wheezing 
and a cough productive of yellow sputum.
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Physical examinations disclosed evidence of respiratory distress, 
hyperresonarice of the chest to percussion, a depressed diaphragm, and use 
of the accessory muscles of respiration [23] . Skin tests revealed a 
positive intracutaneous reaction to house and mattress dust. The dust in 
the patient's work atmosphere was not among the substances used in skin 
tests. The chest radiographs were reported to be within normal limits. 
Films of the paranasal sinuses showed marked to moderate clouding with some 
signs of scarring from an old disease. Except for eosinophilia, all the 
values of the blood and urine analyses were within the normal ranges. When 
the patient returned to work following his second hospitalization, severe 
asthmatic episodes recurred within 1-3 minutes after he began work. The 
patient stopped working until a respirator designed to remove particles 
with a diameter of 0.6 ¡m or more was made available to him. However, he 
continued to experience asthmatic symptoms when wearing the respirator. 
Bruckner concluded that either cobalt dust or a combination of tungsten 
carbide and cobalt dust was responsible for the patient's symptoms. He 
suggested that the patient's reaction was mediated through a 
hypersensitivity mechanism because he exhibited the symptoms within 1-3 
minutes after beginning work. Although Bruckner found eosinophilia in the 
patient, he did not point it out as evidence of hypersensitivity.
Schwartz and colleagues [14], in 1945, reported the results obtained 
in studies of 1,200 persons who worked with tungsten, tantalum, and 
titanium carbides, carbon, and cobalt in a cemented tungsten carbide 
manufacturing plant. No specifics regarding age and sex were given. Work 
assignments for the group were also not mentioned. Approximately 20 of the 
workers were found to have an erythematous, papular type of dermatitis
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which was limited primarily to the sides of the neck, flexor portions of 
the forearm, and backs of the hands. In a few cases, the dermatitis was 
generalized and two sweepers each had contact dermatitis on the heel and 
ankle of one foot. This was the foot which was kept advanced during 
sweeping and was therefore exposed to the most dust. All of the affected 
workers had been employed for at least a month before the dermatitis 
appeared.
Patch tests were performed on six of the workers with dermatitis and 
on two control subjects not exposed to the aforementioned dusts. The 
reactions were read at 24 and 48 hours. The tests revealed that no subject 
with dermatitis reacted to the oxides of tungsten, tantalum, or titanium, 
or to carbon [14]. However, all six had positive reactions to metallic 
cobalt powder, to the unfused tungsten carbide, to mixtures or powders of 
cobalt, and to other materials used to make the hard metal. The control 
subjects showed no reaction to any test material. The authors concluded 
that, since the distribution of the skin eruptions was most marked in the 
areas of friction, the abrasiveness of the dust facilitated the development 
of sensitization. They concluded that sensitivity to cobalt caused the 
dermatitis and that this sensitivity was accentuated by the abrasiveness of 
the dust.
In 1963, Skog [24] described the incidence of skin disorders among 
workers in the Swedish hard-metal industry. Of 360 workers (sex and age 
not specified), 34 who had various skin disorders were examined by a
dermatologist. They worked with tungsten carbide, titanium carbide, 
tantalum-niobium carbide, and cobalt. The durations of their exposures 
were not mentioned. The industry employed good general and local exhaust
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ventilation and cleaning procedures, and the workers had used soap and cold 
cream with an organic solvent for the past 10 years to facilitate cleaning 
the hands and forearms. All workers with skin problems were given further 
dermatologic examinations, and 26 of them were given patch tests with 
various substances, including tungstic oxide, titanium oxide, cobalt 
chloride, and finished hard-metal powder.
The examinations resulted in the following diagnoses: contact
eczema, 16; pruritus without skin lesions, 8; folliculitis, 6; and 
neurodermatitis, 5 [24], The eczema and itching were localized on the
areas of the body with high dust contact, namely on the face and 
extremities. Of the observed skin disorders, only eczema and itching were 
attributed to the occupational exposures.
Patch tests on 14 workers with contact eczema revealed that 3 of 
them were sensitive to cobalt chloride and 2 of them were sensitive to 
finished, hard-metal powder as well. Seven of the eight workers with 
pruritus and the five with neurodermatitis who were patch-tested showed no 
reaction. Although an allergic reaction to cobalt was noted in a few 
workers, the author attributed both eczema and itching to the combined 
irritant effect of hard-metal dust and intensive cleaning of the skin.
Carcinogenicity Reports
The following two studies are the only ones dealing with the 
incidence of cancer in cemented tungsten carbide workers. No human studies 
are available that indicate the carcinogenic potential of either soluble or 
other insoluble tungsten compounds.
Bech et al [25] reported bronchial carcinoma in a worker suffering
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from hard-metal disease. The 63-year-old man began working as a core maker 
when he was 13 years old and held this job in various iron foundries for 32 
years. He subsequently worked in the hard-metal industry for 17 years. 
His smoking history was not reported. During the latter employment period, 
he worked in all of the operations of the hard-metal industry, including 
powder mixing. No information was provided on the level of his exposure 
and the nature of the metal components to which he was exposed. After 13 
years of working in the hard-metal tool industry, the worker reported to 
the hospital with a 3-year history of persistent dry cough, shortness of 
breath, and pain and tightness in the chest. The incipient fibrosis was 
detected by radiographic examination. The fibrosis increased during the 
next 5 years, and a mass in the lower lobe of the right lung was diagnosed 
as a neoplasm. The workman died 3 years after this diagnosis. At autopsy, 
most of the right lung was found to be invaded by anaplastic 
adenocarcinoma. There was a general appearance of nonspecific fibrosis 
which the authors considered to be unrelated to the carcinoma. Some 
neoplastic invasion of the capsule of the right kidney was also observed. 
The worker had been exposed to a number of industrial dusts of unknown 
compositions and concentrations. Therefore, the tumor cannot be attributed 
definitely to exposure to tungsten.
In 1963, Collet and associates [26] described a case of pulmonary 
fibroadenomatosis in a 57-year-old man who worked in the manufacture of 
sharp-edged tools. The study presented the results of physical 
examination, bronchoscopic examination, pulmonary function tests, and chest 
radiographs. During the 14 years before the manifestation of the disease, 
the man had been exposed to unspecified amounts of dusts of tungsten
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carbide powder, cobalt, tantalum, titanium, and cobalt oxalate, and to 
trichloroethylene vapor. After the man had worked in such an environment 
for 8 years, chest roentgenographs showed reticulation of the bases of both 
lungs and of the central portion of the left lung. After 2 more years, 
fever and breathing difficulties were reported; a year later, exertional 
dyspnea had become progressively worse. These symptoms persisted during 
the next three years, and the patient also developed an increased heart 
rate and pulmonary rales. In addition, his vital capacity was only 65% of 
the theoretical value, while the carbon monoxide diffusion capacity 
measured 19% of the theoretical value. At the end of this period, he died 
of respiratory failure and cardiovascular collapse. Seven months before 
the man's death, a sample of lung was taken for microscopic study and for 
spectrographic analysis for tungsten, tantalum, titanium, cobalt, and 
nickel.
Microscopic study of the lung sample taken 7 months before the 
worker's death led to a diagnosis of pulmonary fibroadenomatosis with 
alteration and obliteration of capillaries resulting in an endarteritis 
[26]. Proliferations of smooth muscle, elastic fibers, mucous-producing 
cells, and macrophages were also evident. The epithelial cells of the 
alveoli and septa were altered by stratification metaplasia, fibrous 
tissue, and collagen deposits. The small alveolar cells were completely 
absent. Electron microscopy confirmed the previously described findings 
and revealed that the most common changes were mitochondrial and nuclear. 
The lung tissue was stated to contain significant amounts (no values given) 
of tungsten, nickel, and titanium. The other elements, presumably tantalum 
and cobalt, were reported to be present only in traces. On the basis of
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the microscopic findings, the authors concluded that the lesion was not 
malignant, although it had some questionable features. They believed that 
the fibroadenomatosis observed in their patient was the result of
occupational exposures to dusts arising in the tungsten carbide industry. 
While this is a possibility, the unexplained spectrographic findings of 
significant amounts of nickel in the lung and the worker's exposure to 
trichloroethylene vapor make the basis for this conclusion equivocal.
Epidemiologic Studies
Studies of workers exposed to dusts of tungsten and its products in 
the cemented tungsten carbide industry show that the effects are chiefly
respiratory. Most of the reports do not distinguish the effects of
tungsten products from those due to cobalt. However, one study [27] found 
that the effects of exposure to mixtures containing cobalt are more severe 
than the effects of exposure to tungsten compounds alone.
In 1967, Mezentseva [28] reported a study of the effects on workers 
of exposure to airborne dusts of tungsten trioxide, tungsten dioxide, 
metallic tungsten, and tungsten carbide. The author determined the air 
levels of dusts present in a workshop where malleable tungsten was prepared 
and at the following stages of hard-metal production: grinding, loading
and unloading, reduction of tungsten, carbonization, and sifting. Dust
particle sizes, determined by what was described as the shadow method, were 
reported for unspecified processes in the production of hard metal; 
apparently, particle sizes were not determined in the malleable-tungsten 
workshop. Total airborne dust levels for hard-metal production were 8.3-83 
mg/cu m. The diameters of 72-82% of the particles were less than 4 //m. In
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the manufacture of malleable tungsten, the airborne dust concentrations 
were 1.3-60 mg/cu m in various stages of processing.
The author [28] described the results of physical and radiographic 
examinations of 54 workers engaged in processes associated with the 
formation of the dust of tungsten or of its compounds, but it was not clear 
from the report whether these workers were employed in the hard-metal 
industry or in the manufacture of malleable tungsten. The physical and 
radiographic examinations were not described in detail. The workers 
examined were 29-45 years old, but other details such as smoking history 
and sex, which might have had an impact on the results, were not presented. 
No control group was mentioned. The author did not mention the average 
number of years these workers were employed in operations that might 
generate significant air levels of tungsten dust. Of the 54 workers 
examined, 5 showed early radiologic signs of diffuse pulmonary fibrosis; 
one of these had been employed for 19 years, another for 24 years, and the 
rest for no more than 2-3 years. Where such wide variation in exposure 
durations exists, it is possible that other preexisting conditions which 
were not described may have contributed to the cause of the signs and 
symptoms.
Kaplun and Mezentseva [27], in 1959, reported the effects on worker 
health of exposure to dusts generated in the production of hard metal. The 
dust concentrations in various operations of tungsten carbide manufacture 
and in various stages in the production of tungsten carbide-cobalt hard 
metal were determined gravimetrically. The concentrations of cobalt dust 
generated in the production of hard metal from the tungsten carbide-cobalt 
mixture were also monitored. Records of periodic medical examinations of
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36 tungsten carbide workers who came into contact only with tungsten and 
its compounds were analyzed separately from those of 247 workers exposed to 
mixed dusts of cobalt and tungsten carbide. No control group was 
mentioned. Details of medical examinations and the age, sex, duration of 
exposure, and medical histories of the workers were not reported.
In the various processing operations in the production of tungsten 
carbide, the dust concentrations were 8.6-107 mg/cu m [27]. The dust 
concentrations in the production of tungsten carbide-cobalt hard metal were 
3-186 mg/cu m, and the cobalt concentrations were 0.27-1.75 mg/cu m. The 
authors noted that 4 of the 36 workers who came into contact only with 
tungsten compounds showed radiographic evidence of early diffuse 
interstitial fibrosis. No other changes were reported. Analysis of 
medical examinations of 247 workers exposed to mixed dusts of tungsten and 
cobalt showed that 117 workers had some damage to the upper respiratory 
tract. Of these, 33 had indications of incipient diffuse interstitial 
fibrosis, and chronic bronchitis was diagnosed in 35. It was noted that a 
significant fraction (no values given) of the workers had hypotension, 
unspecified changes in the blood, or an impaired sense of smell. This 
group of 117 workers also complained of loss of appetite, nausea, and 
coughing. The authors concluded that the harmful health effects in the 
manufacture of hard metal were produced by mixed dusts of tungsten, 
titanium, and cobalt. They also suggested that evaluation of the 
biological action of such mixed dusts should be based on the content of the 
most toxic component, cobalt.
Basing their recommendations on the percentage of cobalt present in 
the mixed dusts at the plants studied, the authors [27] advised that the
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mixed dust concentrations in the air should not exceed 2 mg/cu m. Although 
this is the first report of an attempt to distinguish the health effects of 
tungsten and its compounds from those produced by a mixture of tungsten 
carbide and cobalt, the derivation of the limit of 2 mg/cu m for mixed 
dusts is not clear. In the absence of details on the duration of exposure 
and preexisting conditions for each group, no meaningful distinction can be 
made between the results from the exposures to the two types of dust. The 
higher incidence of pulmonary disorders in the group exposed to mixed dusts 
of tungsten carbide and cobalt may be related to total dust concentrations 
that were somewhat higher than those found for the group with pure tungsten 
exposures.
Lichtenstein et al [29], in 1975, reported the results of a study of 
the effects of airborne tungsten carbide and cobalt on the health on 
workers in an operation that involved grinding tool bits and inserts made 
of two commercial grades of cemented tungsten carbide. One grade contained 
72% tungsten carbide, 8% titanium carbide, 11.5% tantalum carbide, and 8.5% 
cobalt; and the other contained 94% tungsten carbide and 6% cobalt. About 
70% of the tool-grinding activity involved the latter grade. Approximately 
75% of the tool work involved regrinding old carbide tips, and 25% involved 
grinding new carbide tips. The air was sampled with filters in the
workers' breathing zones, and the filter contents were analyzed for
tungsten and cobalt by atomic absorption spectrometry. The concentrations
of tungsten ranged between 0.2 and 12.8 mg/cu m, while those of cobalt were
0.04-0.93 mg/cu m. Mean concentrations were 5.16 mg/cu m for tungsten and 
0.28 mg/cu m for cobalt. Of the 25 samples taken, 40% exceeded 5 mg/cu m 
for tungsten and 60% exceeded 0.1 mg*/cu m for cobalt.
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To evaluate the employees' health status, the authors [29] examined 
22 tungsten carbide grinders, 31-60 years old, including 6 nonsmokers, 10 
smokers, and 6 ex-smokers who had ground tungsten carbide tools for 1-30 
years, for a mean duration of 11 years.
Radiographic examinations revealed no evidence of pulmonary fibrosis 
in any of the workers. For all tool grinders, the mean FVC and FEV1, 
expressed as percentages of the predicted values (based on normal values 
from persons of the same sex, age, and physical stature), were 88.7 and 
95.1, respectively, and the mean FEV1/FVC was 86.8%. The small number of 
workers tested, especially when subdivided into smokers and nonsmokers, did 
not permit a statistical evaluation of the pulmonary function test data. 
However, the authors suggested that the reduced FVC, the near-normal FEV1, 
and the elevated FEVl/FVC ratio may be indicative of an early stage of 
restrictive ventilatory impairment.
The mean red blood cell counts of all 22 grinders were within the 
normal range [29]. Exertional dyspnea was recorded for 1 smoker and 2 ex­
smokers, while 3 of 6 nonsmokers and 5 of 10 smokers complained of
productive coughs. The authors concluded that, in this study, cobalt
exposure provided a good index of the total dust exposure, since 
concentrations of the tungsten dust above its TLV were recorded only when 
the concentration of cobalt dust exceeded its TLV. They did not observe
increases in red blood cell counts or indices of pulmonary fibrosis. The 
authors noted that exposures to cobalt at levels above the TLV might occur 
in the cemented tungsten carbide tool-grinding industry during wet process 
grinding in the absence of local exhaust ventilation. Although the TLV’s 
of both tungsten and cobalt were exceeded in the cemented tungsten carbide
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tool grinding operations, the authors concluded that cobalt rather than 
tungsten exposures caused the observed changes. However, the data 
presented do not clearly distinguish the effects of the two metals.
In a medical surveillance program, developed as a consequence of the 
above study, Bartl and Lichtenstein [30] found one case of pulmonary 
fibrosis in the same population of cemented tungsten carbide tool grinders. 
The 34-year-old tool grinder had worked in a variety of jobs for 15 years. 
During this period, he had ground tools or drills for a total of 7 years, 
42 months of which had involved work with tungsten carbide alloys. 
Approximately 9 years elapsed between the time he began working with 
tungsten carbide alloys and the examination at which the diagnosis of 
pulmonary fibrosis was made.
At this examination, his chest radiographs showed diffuse, 
bilateral, poorly delineated, parenchymatous densities distributed evenly 
in the upper and lower lung lobes [30] . His FVC and FEV 1 were 77 and 89% 
of normal, respectively. However, the carbon monoxide diffusion capacity 
was normal, and the worker did not develop shortness of breath during 
exercise. A sample of lung removed for biopsy was described as diffusely 
nodular with a slightly increased palpable density [30] .
Microscopic examination of the same lung sample showed multi-focal 
pulmonary scarring associated with patchy interstitial fibrosis and 
nonspecific reactive changes in a hilar lymph node. The authors concluded 
that the observed interstitial fibrosis in this employee was consistent 
with the magnitude of his potential exposure to hard-metal dust containing 
cobalt.
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Bech et al [25], in 1961, examined the medical histories of 255 hard- 
metal shapers, grinders, and powder workers who had been employed for 1 
month-20 years. Chest radiographs of the 113 shapers, 120 grinders, and 
22 powder workers were also examined. Their age, sex, and smoking history 
were not specified, and no control group was mentioned. Forced expiratory 
volume and airway resistance tests were performed on 19 volunteers (7 
powder workers and 12 shapers) at the beginning and end of a working 
day. In addition, concentrations of airborne dust were measured (by 
gravimetric analysis) and the dust was analyzed for particle size and 
composition.
The breathing zone samples contained 195-1,230 particles/ml, the
particles being less than 5 p  in diameter. The dust contained 90%
tungsten and 6% cobalt, the remaining 4% consisting of titanium, silica, 
aluminum, magnesium, and iron. An unspecified number of these workers
complained of wheezing and tightness of the chest during the workday. Of 
the volunteers who underwent pulmonary function tests, two shapers who 
complained of wheezing and tightness exhibited considerably decreased 
(13.4-17.6%) ventilatory capacity accompanied by appreciably increased 
(24.3-31.8%) airway resistance. Among the 255 workers whose medical
reports were examined, 1 case of hard-metal disease was diagnosed by chest 
radiograph; early signs of pulmonary fibrosis were noted in an unspecified 
number of radiographs.
Barborik [31] reported studies in 1966 on the health of 193 employees 
(104 men and 89 women) working in the production of hard metal. The 
workers, with average ages of 43 and 40 years (range 19-66 years) for men 
and women, respectively, were exposed to dust levels of 13-100 mg/cu m
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while handling powders consisting of 70-90% tungsten carbide, 8-18% 
titanium carbide, and 5-25% cobalt. The composition of the airborne dust 
was not given. Although the particle sizes were not measured, the author 
concluded from data in published reports that most dust particles generated 
in this process were respirable. The average length of work experience was 
6 years (range 1-13 years). The workers were examined for signs and 
symptoms of disease and for changes in chest radiographic findings.
Ninety workers (36 men and 54 women) complained of coughing, and 
half of this number had coughs that varied from irritant to barking [31]. 
Sixty-seven workers, including approximately equal numbers of men and
women, complained of dyspnea. Other upper respiratory difficulties, such 
as burning or dryness of throat and anosmia, were less frequently reported. 
Hoist or markedly crepitant rales were heard on auscultation in an 
unspecified number of workers. Of the 116 workers who were examined by 
spirometry, 25 showed moderate to severe disturbances in pulmonary 
ventilation. Roentgenologic abnormalities were reported in 31 of the 
workers. In 13 of the 31, the abnormalities were described as incipient, 
atypical, pulmonary reticulations, while in the remaining 18, they were 
said to be more clearcut and indicative of pronounced pulmonary fibrosis.
Barborik [31] concluded that metallic cobalt powder played a
substantial role in the etiology of the disease and that its effect may 
have been potentiated by tungsten carbide. The author probably based his 
conclusion on the autopsy findings from one of the five case studies 
presented in the report. This worker had 12.5 and 78.6 ng of cobalt/10 g
of dry tissue in the lungs and hilar lymph nodes, respectively.
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Vengerskaya and Salikhodzhaev [32] studied the effects of aerosols 
of tungsten, cobalt, and their compounds on workers in a hard-metal plant. 
The study included measurement of atmospheric concentrations of tungsten 
and cobalt at various operations by unspecified methods.
Of the 178 hard-metal workers (52 men and 126 women), 81% were about 
30 years old [32] . About 84% of the workers had been engaged in hard-metal 
operations for 3 years. The concentrations of tungsten in the work 
atmosphere during various operations varied from 0.75 to 6.1 mg/cu m, while 
those of cobalt were 0.6-3.2 mg/cu m. No control group was described.
Among the 178 workers, 88 persons complained of dyspnea, coughing, 
pounding of the heart, headache, dizziness, nausea, loss of appetite, and 
impaired sense of smell [32] . The range of the mean tungsten 
concentrations was 0.8-1.1 mg% in the blood of 45 workers and 0.6-1.1 
mg/liter in the urine of 40 workers. Tungsten was not detectable in the 
blood of 11 workers and in the urine of 7. Although it is not clear from 
the information given in the report, the workers may have been exposed to 
both soluble and insoluble tungsten compounds. The concentration of 
chlorides in the blood, measured in 30 workers, was slightly above normal 
in 20 and below normal in 10, while the chloride content of the urine was 
somewhat depressed in 32 of 39. Blood sugar levels were slightly higher 
than normal (no values given) in 8 of 37 workers examined, and the glucose 
tolerance curve in 8 of 14 workers was elevated. In 9 of 34 persons, 
hippuric acid elimination after loading with sodium benzoate was above 80% 
of the theoretical maximum conversion; it was 71-80% in 6, 61-70% in 8, and 
below 60% in 11 persons.
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The authors [32] concluded that tungsten can be found in the blood 
and urine of workers exposed to aerosols of tungsten and cobalt, that the 
workers' blood sugars were somewhat elevated, and that there was some 
impairment of the detoxication of benzoic acid by the liver. They did not 
describe the methods used to determine tungsten concentrations either in 
the air or in body fluids. Therefore, the significance of the instances in 
which tungsten was undetectable cannot be assessed. The authors also did 
not elaborate on the absence of a relationship between the concentrations 
of tungsten in the body and the results of liver function tests or of blood
changes. They did not measure cobalt concentrations in tissue and body
fluid when they were aware that the exposure levels of cobalt exceeded the 
maximum permissible concentration (MPC) of 0.5 mg/cu m. Furthermore, they 
neither tried to define the causal factors involved in the study nor
explained what the measured changes implied.
In 1962, Heuer [33] reported the respiratory effects in 208 workers 
engaged in hard-metal production, where dust levels of 277-4,064 mg/cu m 
were generated. Thirty-nine of the 208 employees worked in the mixing 
room, where the airborne dust was composed of 67.8% tungsten, 21.2% cobalt, 
2.25% iron, 1.75% titanium, and 7% volatiles (not described). In the 
granulating room, 99 workers were exposed to dust containing 76.1%
tungsten, 7.6% cobalt, 0.3% iron, and 16% volatiles. The remaining 90 
workers were engaged in processing the finished hard metal. The airborne 
dust in this area was not analyzed for its components. The average size of 
99.2-99.9% of the particles generated in various operations during hard- 
metal production was below 5/ng.
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During routine medical evaluations, 15 mixing room workers had 
complaints of cough, 14 of dyspnea, and 3 of asthma. While the physical 
examinations showed 5 cases of bronchitis and 14 cases of emphysema in 
these workers, chest radiographs revealed 3 cases of bronchitis, 10 cases 
of emphysema, and 23 cases of fibrosis that varied in severity. Forty of 
the 99 workers from the granulating room complained of coughs, and 34 
reported dyspnea. Clinical signs and symptoms indicated 10 cases of 
bronchitis and 7 cases of emphysema among these 99 workers, while chest 
radiographs revealed the incidence of bronchitis in 9, emphysema in 6, and 
incipient or mild fibrosis in 18. Thirty-three of the 70 workers who 
handled the finished hard metal complained of coughs, and 16 reported 
dyspnea. Among these 70 workers, 10 cases of bronchitis and 2 cases of 
emphysema were diagnosed from clinical signs and symptoms, while chest 
roentgenograms showed that 7 had bronchitis, 13 had emphysema, and 14 had 
incipient or mild fibrosis.
On the basis of reported complaints, workers in the mixing room were 
the only ones to develop asthma, and they had the highest incidence of 
pulmonary fibrosis. The pulmonary fibroses found in these workers were 
more advanced or severe than those of the employees who worked in the 
granulating room or with the finished products. The author attributed the 
asthma and pulmonary fibrosis to exposure to high concentrations of dust 
containing the pure components of the hard metal. Analyses of the lung 
specimens obtained by autopsy from a mixing room worker who had severe 
fibrosis showed that dust particles accounted for 0.96% of the dry weight 
of the lung.
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Chemical analyses of the dust from the lung revealed 14.4% tungsten, 
9.8% calcium oxide, 9.2% phosphorus pentoxide, 5.6% silicon dioxide, 2.9% 
cobalt, 2.8% ferric oxide, 2.05% titanium, and 1.1% aluminum oxide, while 
50.3% of the sample was lost during annealing.
The author noted that mixing room employees with mild to severe 
pulmonary fibrosis had worked for 4-8 years in hard-metal production. 
However, other employees who worked for 12 years in the same room had no 
adverse signs or symptoms. According to Heuer, this difference indicated 
that individual susceptibility was an important factor in the development 
of occupationally related pulmonary problems in hard-metal workers.
Animal Toxicity
Short- and long-term animal experiments revealed that the effects of 
inhalation or intratracheal introduction of insoluble tungsten compounds 
were limited to the respiratory system, and the effects of ingestion of 
soluble tungsten compounds such as sodium tungstate, were not clearly 
identifiable in any organs of the body. Few reports were found on the 
dermatologic effects of tungsten and its products in experimental animals.
Mezentseva [28] studied the effects of dusts of tungsten and its 
compounds on 55 white rats. Either metallic tungsten, tungsten trioxide, 
or tungsten carbide was injected intratracheally in single doses of 50 mg 
of material suspended in 0.5 ml of physiologic saline. Tungsten carbide 
was also administered by inhalation for 1 hour/day for 5 months to another 
group of animals. The tungsten carbide concentration in the exposure 
chambers was 600 mg/cu m, with up to 77% of the particles measuring less 
than 5 fxm in diameter. The age, weight, sex, strain, and number of rats
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subjected to each experimental condition were not reported. Six rats 
served as controls. No details of their management were given. In the 
intratrachel studies, rats were killed 4, 6, or 8 months after
administration of the suspensions and their lungs were examined
microscopically. Animals exposed by inhalation were monitored for general 
health and body weight. At the end of the exposure period, all rats were 
killed and examined macroscopically for changes in unspecified internal 
organs.
At 4 months, the lungs of rats given metallic tungsten showed
infiltration by macrophages, chiefly around the pulmonary blood vessels, 
and thickening of the walls between the alveoli [28] . Around the bronchi, 
large numbers of round cells were seen surrounding the dust particles at 6 
months. Collagen fibers had overgrown these foci by 8 months; the
endothelium was swollen and the walls of small vessels were thickened. 
Metallic tungsten did not cause macroscopic changes in the internal organs 
of rats at either 4, 6, or 8 months. No details of the general health and 
weight gain of the rats were given.
Four months after the administration of tungsten trioxide, the lungs 
showed considerable thickening of the walls between the alveoli and 
infiltration of macrophages around the vessels of the bronchi. The 
endothelium was swollen, with thickening of the walls of small blood 
vessels [28]. Eight months after the intratracheal injection, cellular 
proliferation persisted. Lesions surrounding the dust particles were
characterized by fine, collagenous fibers and sclerosis of the vascular 
walls and peribronchial areas. In rats given tungsten trioxide, no 
macroscopic changes in the internal organs were observed either 4 or 8
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months after the injection.
In rats administered tungsten carbide intratracheally, thickening of 
the walls between the alveoli and accumulation of macrophages around the 
bronchi and blood vessels were noted 4 months after treatment [28]. Lungs 
examined at 6 months showed cellular proliferation around the blood 
vessels, with overlying, collagenous fibers. At this examination, swelling 
of the endothelium and thickening of the walls of the small blood vessels 
were evident, and some hyperplasia of the tracheal lymph nodes containing 
free dust particles was observed. Microscopic findings in animals killed 
after 8 months were similar to those in animals killed at 6 months. The 
report did not discuss the effects of intratracheal administration of 
tungsten carbide on macroscopic changes of the other internal organs, on 
general health, or on weight.
Rats exposed to tungsten carbide dust by inhalation at 600 mg/cu m 
remained healthy and gained weight well during the experiment [28] . Those 
killed at the end of 5 months1 exposure at this concentration showed no 
macroscopic changes in the internal organs. According to the author, the 
findings from microscopic examination of the lungs were essentially the 
same as those observed 6 months after intratracheal administration of 
tungsten carbide.
Mezentseva [28] concluded that metallic tungsten, tungsten trioxide, 
and tungsten carbide dusts did not cause severe changes. These changes 
were described as being more marked after the intratracheal administration 
of tungsten trioxide than after that of either metallic tungsten or 
tungsten carbide. From the experimental findings and medical data, the 
author concluded that these tungsten substances can cause a mild, diffuse
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interstitial lung fibrosis. A permissible maximum level of exposure of 6 
mg/cu m for tungsten dust was suggested.
Miller et al [16] studied the effects of intratracheally-introduced 
pure tungsten carbide on rat lungs. Tracheotomies were performed on 15 
white rats under ether anesthesia, and 1 ml of a 10% suspension of tungsten 
carbide in isotonic saline was administered intratracheally. The age, sex, 
weight, and strain of the animals were not mentioned, the control group was 
not described, and the size of tungsten carbide particles in the 
administered suspension was not reported. An unspecified number of rats 
was killed at 2-week intervals for 18 weeks. The animals were examined 
macroscopically for exudate on the surface of the lungs, for fluid in the 
chest cavity, for the distribution of dust in the lungs, which were 
examined also for microscopic changes, and for alterations in reticulin and 
collagen contents.
Gross examination of the lungs 2 weeks after the tungsten carbide 
injections revealed that particles were present in all lobes, particularly 
the lower ones [16]. The lungs reportedly felt somewhat firmer than those 
from control animals killed at this time. The treated animals had neither 
exudates on the surfaces of the lungs nor fluid in the chest cavities. 
Microscopic examination at this time showed that, although particles were 
visible within the septa, most of the tungsten carbide remained free in the 
alveoli. Tungsten carbide was observed consistently within the alveoli 
throughout the experiment.
By 4 weeks, there had been some mobilization of the septal cells and 
engulfment of the tungsten carbide particles; these particles were found 
also in the perihilar lymph nodes and around the peribronchial and
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perivascular connective tissue fibers [16] . Results of examinations 6-14 
weeks postexposure were not reported. After 16- or 18-week examinations, 
findings were essentially unchanged from those at 4 weeks. Although more 
dust was found within the alveolar walls and lymphoid tissue of the lungs, 
dust was still present in the air sacs. Lung reticulin and collagen did 
not increase; there was no evidence of inflammation caused by bacteria.
The authors described the observed effects as responses to an inert 
dust and noted that tungsten carbide did not provoke a necrotizing or 
fibrosing response in rat lung parenchyma [16] . Commenting on these 
findings of Miller et al, Schepers [34] speculated that industrial cases of 
lung fibrosis and pneumoconiosis in tungsten carbide-tool and hard-metal 
industries might be caused by the coexisting exposures to cobalt.
Delahant [35] studied the effects of selected rare metals and other 
chemicals on guinea pig lungs in 1943 and presented the results in 1955. 
These experiments were undertaken to determine the particulate metallic 
component in cemented tungsten carbide that might provoke lung lesions. 
Dusts of tungsten metal or of tungsten carbide and carbon in a ratio of 
94:6 were injected intratracheally into groups of six guinea pigs. The 
average weight of the guinea pigs was approximately 600 g. The age, sex, 
and strain of the animals were not given, and no control group was 
described. A 10% suspension of each dust in sterile isotonic saline was 
prepared. Although attempts were made to obtain dusts of 3 /nm in diameter 
or less, when this was not possible dusts were used as received. Thus, the 
particle size of the dusts injected in most cases was unknown. A total of 
150 mg of each dust was injected intratracheally in three equal doses at 
weekly intervals. Animals were killed after 1, 4, 8, and 12 months, and
lung specimens were prepared for microscopic examination. None of the 
guinea pigs injected with either tungsten metal or tungsten carbide and 
carbon died during the experimental period.
Gross examinations of the lungs of animals given tungsten metal or 
tungsten carbide and carbon were performed [35]. Large, circumscribed 
pigmented lesions were found. Beneath the visceral pleura, widely 
distributed, small, discrete foci of pigmentation were occasionally 
observed. There was no appreciable temporal change in the character of the 
lesions. The author concluded from these findings that dusts of tungsten 
metal or of tungsten carbide and carbon produced relatively benign effects 
on lung tissue.
Schepers [36] also studied the effects of tungsten metal dust on the 
lungs of the guinea pigs exposed by Delahant [35]. One month after 
injection, microscopic examinations of the lungs showed proliferation of 
interstitial cells; moderate thickening of alveolar walls was most marked 
around massed tungsten particles. A considerable amount of macrophage 
infiltration into the alveoli was noted. Around the capillary blood 
vessels of the lung, numerous focal cellular lesions were observed. The 
mucosae of the bronchi and bronchioles were slightly inflamed, with some 
bronchioles partially or wholly closed. The investigator noted no effects 
on the lymphoid tissue.
Guinea pig lungs examined 1 year after the intratracheal introduction 
of tungsten metal dust were reported [36] to have residual lesions. These 
included persistent, focal, interstitial, cellular infiltration in relation 
to the retained particles. There were various degrees of peribronchial, 
peribronchiolar, and perivascular fibrocellular reactions, with
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bronchiolitis obliterans and bronchial inflammation. Slight atrophic 
vesicular emphysema was also present. The author concluded that tungsten 
was probably a relatively benign substance. Commenting on the occupational 
significance of his findings, he remarked that exposures to the dust
generated by pulverizing tungsten in the tungsten carbide industry would be 
relatively, though not wholly, free from risk.
Schepers [34] also microscopically examined the effects of 
intratracheally injected tungsten carbide and carbon (94:6) on the 
respiratory systems of guinea pigs. The animals used in this investigation 
were those described by Delahant [35] . Schepers reported that the
immediate response was a diffuse hyperemia and inflammation of the
bronchial mucosa. After 1 month, much of the tungsten carbide and carbon 
mixture had been engulfed by multinucleated macrophages. While some of 
these cells penetrated the alveolar walls, most were still within the 
alveoli. Some of the dust particles observed had aggregated in the small 
vascular components.
The author [34] compared these findings with those from his 
investigations on tantalum and cobaltic oxides and noted that the tungsten 
carbide and carbon mixture did not readily reach the perivascular 
lymphatics. Marked lymphocytic hyperplasia with infiltration of the
adjoining alveolar walls and some hyperemia were observed in these areas. 
Such alterations in the lymphoid tissues reportedly continued for several 
months after the acute reactions had subsided. Confluent interstitial 
pneumonitis in relation to trapped dust masses or isolated foci were 
observed 12 months after the exposure. Most massed granules in the mixture 
of tungsten carbide-carbon were engulfed by multinucleated, giant cells
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within the relatively atrophic alveoli. Subp-leural granulomata with a 
minor degree of fibrocyte formation were noted occasionally. Bronchiolitis 
and peribronchial and perivascular fibrosis were not persistent. Schepers 
concluded that the mixture of tungsten carbide and carbon was less harmful 
to lung tissue than tungsten metal.
Delahant [35] also reported the effects of intratracheal 
instillations of a 91:9 mixture of tungsten carbide and cobalt dusts and of 
inhalation exposures to a 3:1 mixture on the lungs of guinea pigs. Six
guinea pigs were injected intratracheally with a total of 150 mg of the
tungsten carbide and cobalt mixture, containing particles of 3 nm or less 
in diameter, in three equal doses at weekly intervals. For inhalation 
exposures, Delahant exposed 20 guinea pigs to particles of the mixed
tungsten carbide-cobalt dust, measuring 0.5-2.0 jLtm in diameter. The total 
exposure period was 35 days, and the dust concentration range was 8,800- 
10,600 particles/cu cm for the first 20 days; after a 5-day recovery 
period, the animals were exposed to the dust mixture for an additional 15 
days at a concentration of approximately 2,800 particles/cu cm. The age, 
weight, sex, and strain of the guinea pigs were not given, and no control 
group was described.
In the group injected intratracheally, none of the guinea pigs died 
during the experimental period [35] . Their lungs had well-circumscribed 
linear and diffuse patterns of black pigmentation. The time of this
observation was not given. All lungs were reported to be normally soft 
with no observed progressive change in the character of the lesions during 
the study.
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Animals that died during the inhalation experiment and two animals 
that were killed after 181 and 585 days of recovery in normal air following 
the second period of exposure were examined for gross changes in their 
lungs [35]. Five animals died during the first period of exposure, and 
three more died during the 5-day inter-exposure recovery period. During 
the second exposure, six more animals died, two each on days 10, 13, and 15 
of exposure. Post-mortem examinations showed that some of the animals had 
acute pneumonitic consolidations of their lungs. The lungs of guinea pigs 
killed 181 and 585 days after the termination of the second exposure had 
faint, diffuse pigmentation by dust.
From the mortality rates and the nature of the gross pulmonary 
reactions, Delahant [35] concluded that particulate tungsten metal and a 
mixture of tungsten carbide and carbon were relatively inert and that, when 
cobalt was mixed with tungsten carbide, the toxic and lung irritant 
characteristics of the cobalt component were dominant.
In another study, Schepers [37] evaluated the effects of mixtures of 
tungsten carbide and cobalt on guinea pig lungs. The lung tissue used in 
these investigations was obtained from the animals Delahant [35] exposed to 
the dust mixtures by both inhalation and intratracheal injection. Guinea 
pig lungs were examined 1 or 12 months after the intratracheal instillation 
of tungsten carbide and cobalt in a ratio of 91:9. Lungs of animals 
exposed by inhalation to the dust of a 3:1 mixture of tungsten carbide and 
cobalt were removed for examination at the end of the first exposure, at 
the end of the second exposure, and 181 and 585 days after the second 
exposure.
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One month after the intratracheal instillation, there were areas of 
dense fibrosis in the lungs wherever a massive deposition of the dust had 
occurred [37] . Infiltration of the alveolar walls by lymphocytes had 
produced almost confluent pneumonitic areas, and there was infiltration of 
lymphocytes into the perivascular areas. There was no involvement of the 
hilar lymphatics. While most of the bronchial epithelium was not damaged, 
in areas of massive dust deposition the bronchial mucosa showed a firm 
fibrous reaction with some development of bronchial crypts. One year after 
the injection, massed dust particles were still seen in the alveolar 
spaces. Other residual damage included patches of pneumonitis and mild 
cellular and fibrous reactions around the dust deposits. The hilar lymph 
nodes reportedly contained some particulate matter which could be 
subsequently deposited in the perilymphatic zones.
The exposure to a 3:1 mixture of tungsten carbide and cobalt provoked 
a diffuse inflammatory reaction at an unspecified time [37], At the end of 
the first exposure, the lungs were hemorrhagic. Alveoli were infiltrated 
with erythrocytes, plasma cells, lymphocytes, polymorphonuclear leukocytes, 
and a fair number of macrophages containing ingested particles. "Prominent 
septal cells" lined the alveolar walls at numerous points. No changes were 
observed in the bronchi and larger blood vessels. Examination after the 
first exposure showed considerable recovery with mild residual atrophic 
vesicular emphysema and limited infiltration of polymorphonuclear 
leukocytes and macrophages into the alveoli. A considerable amount of dust 
was still retained, mainly within the pulmonary macrophages. The author 
attributed a specific lesion, namely, proliferation of the cortical 
reticuloendothelioid cells of the hilar lymph nodes, to the mixture of
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tungsten carbide and cobalt. Neither tungsten carbide nor cobalt alone was 
capable of provoking a similar reaction.
After the second exposure, alveolar edema and diffuse hyperemia were 
once again evident [37]. Six months after the second exposure, metaplastic 
hyperplasia of the bronchial epithelium and the formation of villous 
papillomas were seen. Proliferating epithelial cells and papillomas 
occluded the bronchi, producing regional focal emphysema. Some undefined 
residual effects of tungsten carbide and cobalt were still noticeable 21 
months after the exposure. Epithelial hyperplasia and metaplasia of the 
trachea and bronchi were present at this later examination. The 
characteristic foci of hyperplasia of epithelioid elements of the hilar 
lymph nodes persisted.
Schepers [37] commented that the pronounced proliferative and 
metaplastic epithelial changes may have reflected a sensitizing property of 
cobalt. The author also cautioned that, if observations in guinea pigs 
have any bearing on the way in which human lungs may react, extreme care 
should be exercised to control inhalation exposure to metal powders. Since 
the 91:9 ratio of tungsten carbide and cobalt used is comparable with those 
to which industrial workers might be exposed, these results have direct 
relevance to occupational exposure.
Kaplun and Mezentseva [38] conducted experiments on white rats in an 
attempt to establish the etiologic roles of tungsten, cobalt, and their 
mixtures in affecting workers' health in the hard-metal industry. In 4 
series of experiments, 100 white rats of unspecified age, weight, sex, and 
strain were used. Groups of rats were given intratracheal injections of 
10, 15, 25, or 50 mg of one of the following mixtures: (1) 8% cobalt and
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92% tungsten, (2) 15% cobalt and 85% tungsten, and (3) 8% cobalt, 14%
titanium, and 78% tungsten. The particle sizes of the dusts and the
vehicle of administration were not reported, and no control group was
described. Each dust mixture was administered to eight rats in the 50-mg 
series and to five rats in the 25-mg series; the number of rats used in the
15- and 10-mg series were not specified.
Injection of 50 mg of any of the three dust mixtures caused. 100% 
mortality within 2 days after administration [38]. Within 5-7 days the 
rats that received 25 mg doses had 40, 100, and 60% mortalities in dust 
mixture groups 1, 2, and 3, respectively. At dosages of 15 mg, all the
rats in group 2 died, and two each died in groups 1 and 3. At the 10-mg
dose level, there were no deaths in groups 1 and 3, but 5 of 13 rats died 
within 2-3 days in group 2. The absolute lethal dose for the dust mixture 
of 15% cobalt and 85% tungsten was 15 mg (2.25 mg cobalt), while that of 
the other two groups was 50 mg (4 mg cobalt). The minimum lethal dose was 
10 mg (1.5 mg cobalt) for the 15:85 mixture and 15 mg (1.2 mg cobalt) for 
the mixtures containing 8% cobalt. The authors, without presenting 
details, noted that the minimum and absolute lethal doses of pure metallic 
cobalt were 5 and 10 mg, respectively; however, the absolute lethal dose of 
the 15% cobalt dust mixture contained only 2.25 mg of cobalt. They 
concluded that the dust mixtures were more toxic than the separate dust 
components and that the toxicity of cobalt was increased in the presence of 
tungsten and titanium carbides. However, since the absolute lethal doses 
of the dust mixtures containing cobalt were 50-400% greater (15 and 50 mg) 
than that alleged for metallic cobalt alone (10 mg), it is probable that 
the dust mixture itself exerted some toxic effects.
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Without making distinctions among the three dust groups, the authors
[38] reported that animals dying after receiving doses of 25 mg or 50 mg of 
the dusts had thickened interalveolar septa that sometimes fused together 
to form solid areas of airless, homogeneous tissue containing many free- 
lying dust particles. The thickening of the septa was attributed to severe 
hyperemia and cellular infiltration by lymphocytes and macrophages. Large 
amounts of dust and secretions were observed in the bronchial lumina. In 
addition, marked hyperemia and cellular granulo-nodular degeneration were 
seen in the livers; and the kidneys of these animals showed granulomatous 
degeneration of the cells of the convoluted and descending tubules and 
obstruction in the glomeruli and proximal tubules.
Single doses of the three dust mixtures were administered 
intratracheally in the following amounts: 10 mg for the first mixture, 15
mg for the second mixture, and 10 mg for the third mixture [38]. The 
lungs, liver, and kidneys of animals given the first, second, and third 
mixtures were examined after 6, 4, and 6 months, respectively. The lungs 
of rats exposed to the first dust mixture showed extensive areas of dense 
tissue around the dust particles resulting from infiltration by lymphoid 
elements. Massive lymphocytic accumulations were observed around the small 
and medium-sized bronchi, and the mucosae of the bronchi were hypertrophic, 
with adenomatous proliferation and formation of papillomata. Changes in 
the walls of the blood vessels caused exudation of plasma, and there was 
excessive connective tissue around the small and medium-sized vessels. The 
liver and kidneys showed marked hyperemia. The lungs of rats exposed to 
the second dust mixture were similarly affected, but the adenomatous 
proliferation was more marked. Some hypertrophic adenomatous tissue was
overgrown by fine strands of connective tissue. In the third group, in 
addition to the lung changes seen with the first two dust mixtures, diffuse 
sclerosis of the lung tissue was observed. The effects of the second and
third dust mixtures on the liver and kidneys were not described. The
authors [38] concluded that the changes produced by the three dusts were 
similar and that they were more marked than those produced by metallic 
cobalt. These investigations indicated that the activity of cobalt is 
enhanced when tungsten and cobalt act together. The authors hypothesized 
that the solubility of cobalt might be increased in the presence of 
tungsten.
To test their hypothesis, Kaplun and Mezentseva [38] determined the 
solubilities of 100 mg of powered metallic cobalt and of (the first two) 
dust mixtures containing 100 mg cobalt in unstated volumes of 0.3% 
hydrochloric acid, which has a pH equivalent to that of gastric juice. 
During a period of 24 hours, only 3 mg of cobalt dust was dissolved, while
12 and 15 mg of cobalt were dissolved from the 8:92 and 5:85 dust mixtures.
Although the universality of this solubility behavior was not tested in 
other solvents, the authors believed that their hypothesis on the enhanced 
toxicity of cobalt in the presence of tungsten might still be acceptable. 
Although this conclusion was based on the cobalt content of the mixtures 
and on the assumption that dust mixtures containing tungsten or tungsten 
and titanium are more toxic than is pure cobalt, the data do not show 
clearly that the toxicity of cobalt was enhanced by the presence of 
tungsten or titanium.
Schepers [39] also assessed the biologic actions of a number of 
industrial chemicals that pose potential occupational hazards. Among these
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were manganese tungstate, tungsten, and tungsten carbide. An unspecified 
number of guinea pigs were injected intratracheally with either a 
suspension or a solution of each of the above compounds, and the animals 
were examined after 12 months for pulmonary lesions, including 
epithelialization (proliferation of epithelial cells) and neoplasia. The 
experimental design was not described, and the nature of lung evaluation 
and rating was not stated.
Manganese tungstate was rated as slightly reactive in producing 
pulmonary lesions and moderately reactive in inducing epithelialization
[39]. In comparison, both tungsten and tungsten carbide were graded as 
slightly reactive in inducing both pulmonary lesions and epithelialization. 
According to Schepers, none of the three materials induced tumors. 
Although the assessment of the reactivity of these substances included the 
number of animals affected, there was no report of the incidence rate of 
pulmonary lesions and the nature of their distribution.
Brakhnova and Samsonov [40] compared the toxicities of silicides of 
three transition metals, titanium, molybdenum, and tungsten. Albino rats 
of unspecified age, weight, sex, and strain were given tungsten silicide by 
inhalation or intratracheal injection for 1-6 months. The control group 
was not described, and the concentrations of tungsten silicide and the 
precise durations of exposure to it were not given. The toxicities of the 
silicides were evaluated (time not specified) qualitatively from 
microscopic examination of the lungs; the quantitative effects on the 
concentrations of collagen and ascorbic acid in the lungs served as 
estimates of the fibrogenic activity. The authors did not distinguish the 
effects of tungsten silicide administered by inhalation from those caused
66
by its intratracheal injection.
Pulmonary tissue obtained from rats exposed to tungsten silicide for 
1-6 months exhibited hyperplastic lymph nodes, localized thickening of 
alveolar walls, perivascular infiltration by lymphocytes, and nodules 
composed of fibroblasts, lymphocytes, and macrophages [40]. Compared with 
the other silicides studied, tungsten silicide produced degenerative 
changes in various organs, including the liver, kidneys, and heart, that 
were considerably less pronounced. Vascular permeability was not affected 
by tungsten silicide. The concentrations of collagen in the lung were 
increased to 51.6 and 56.9% above the control levels at 1 and 6 months, 
respectively, after the exposure. Ascorbic acid synthesis in the lungs of 
animals exposed to tungsten silicide was elevated from 50 to 60% above that 
in the controls. The authors concluded that the results supported the 
maximum permissible concentration (MPC) of 6 mg/cu m for tungsten silicide 
established at that time in the USSR. However, it is not clear how the 
authors reached this conclusion.
Spiridonova and Suvorov [41] conducted several studies to assess the 
biologic effects of tungsten hexachloride and the products of its 
hydrolysis on rats and mice. In the authors' short-term experiments, rats 
were either given 1,800 mg/kg of tungsten hexachloride intragastrically or 
exposed to 0.043-0.14 mg of tungsten hexachloride/liter of air for an 
unspecified period. The age, weight, sex, and strain of the animals were 
not mentioned, and no control group seems to have been used.
The orally dosed animals had necrotic foci in the mucosa and 
submucosa of stomach and intestines and in the liver and kidneys [41]. 
Rats exposed to tungsten hexachloride at 0.043-0.14 mg/liter of air
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lacrimated, had profuse blood-stained oral and nasal discharges followed by 
necrosis of the skin and mucosa, and died of pulmonary edema. No data were 
presented on the number of deaths. The authors, comparing the LD50's in 
mice of tungsten hexachloride (1,086.5 mg/kg of body weight by gavage) and 
of tungstic oxide (A,786 mg/kg of body weight by ip injection), suggested 
that the chloride form was more toxic than the oxide because the former 
probably was hydrolyzed in vivo, releasing a sufficient number of chloride 
ions to be toxic. Since the total buffer capacity of the blood is 
approximately 45-50 meq/liter and the stated LD50 dose of tungsten 
hexachloride corresponds to about 213 meq of HCl/liter of blood, this 
hypothesis seems tenable.
In a second series of experiments, the authors [41] used male white 
mice weighing 18-22 g to compare the toxicities of tungsten chloride in 
various stages of hydrolysis. Groups of 10 mice were given ip injections 
of 1 of 5 aqueous solutions made by starting with a sufficient dose of 
tungsten hexachloride to yield 3.3 meq/kg of Cl (216 mg/kg of tungsten 
hexachloride). This was administered immediately after preparation, after 
neutralization with sodium hydroxide, 30 minutes after preparation, on the 
following day, and on the following day after filtration. If the tungsten 
hexachloride were completely hydrolyzed, this dose would release about 44 
meg of HCl/liter of blood. This would be sufficient to neutralize 
completely, or almost completely, the total buffer capacity of the blood. 
Neutralization reduced the mortality by 50%, while hydrolysis more than 
doubled the mortality. The toxic hydrolysis product was filterable. The 
investigators concluded that toxicity of the tungsten hexachloride was 
produced by its chloride ions and that the toxic effect of free ions in the
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thoroughly dissociated hydrochloric acid was greater (100% mortality after 
1 day) than that of the rare metal chlorides. They concluded further that 
the chloride ion plays a major role in the production of the acute toxic 
effects of tungsten hexachloride.
While these conclusions may be valid, it is not clear how the data 
relate to industrial exposure, since the route of administration in most 
studies was ip injection. Although inhalation exposures were conducted and 
deaths of animals from pulmonary edema were reported, the authors did not 
indicate the percentage of the experimental animals affected. They 
concluded that the chloride form of tungsten was more toxic than the oxide. 
However, their conclusion is not necessarily a valid one, because the LD50 
comparisons cited were for different routes of exposure.
Gol'dman et al [42] reported the results of a study on the effects of 
a charge of calcium-magnesium-tunsgtate phosphor and finished calcium- 
magnesium-tungstate phosphor in rats. The chemical composition of the 
charge was: tungstic oxide, 75%; calcium oxide, 18%; magnesium oxide, 5%;
and lead dioxide, up to 3%. The charge and the finished product (after 
heating of the charge) differed in physical structures (not specified). 
The particle size of neither product was described. Rats in 2 groups of 10 
were given intratracheally single doses of 50 mg suspensions of either the 
charge or the finished calcium-magnesium-tungstate material brought to 0.5 
ml in a sterile physiologic solution. The age, weight, sex, and strain of 
the rats were not presented, and no control group was described. Six 
months after dosing, rats from each group were killed and their liver, 
kidneys, spleen, and heart were examined for macroscopic changes. Changes 
in the lungs were evaluated by microscopic examination.
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No gross changes were observed in the internal organs of either 
group, but the lungs, 6 months after the administration of the charge of 
calcium-magnesium-tungstate, showed evidence of cellular proliferation, 
mainly of lymphocytes and macrophages, with considerable thickening of the 
interalveolar septa [42] . Cellular infiltration was noted around the 
bronchi and vessels, and most dust particles had been engulfed by the 
infiltrated cells. In some areas, accumulations of the dust, with marked 
cellular proliferation around them, were seen. Some cellular foci were 
rich in collagen fibers. In the lungs from rats given the finished 
product, some interalveolar walls were thickened; in other places, the 
walls of the alveoli were thin, smooth, and torn. The dust was lying free, 
mostly as separate granules. The lungs showed some emphysematous areas and 
cellular proliferation around the bronchi and vessels. It was noted that, 
although the charge of calcium-magnesium-tungstate and the finished product 
caused similar lung changes, the former had the more severe effect.
Referring to the study of Mezentseva [28], Gol'dman and associates 
[42] commented that the changes in the lungs produced by the charge of 
calcium-magnesium-tungstate and those produced by tungsten trioxide were 
similar but that those caused by the former were the more marked. Since 
the phosphor contained other potentially toxic substances, such as lead 
dioxide, the comparison may not be a valid one.
Lauring and Wergeland [43] investigated the ocular toxicity of 12 
industrial metals, including tungsten, in rabbits. Two rabbits with body 
weights of 1.5 and 2.0 kg were used in the experiments with tungsten. In 
one rabbit, the left eye, which was sham-operated, served as a control, 
while a particle of tungsten metal less than 1 mm in diameter was
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introduced under general anesthesia into the midvitreous region of the 
right eye through a stab incision. In the second rabbit, one eye was left 
intact and untreated while the other received the metal in the midvitreous 
region by the same method. The age and sex of the rabbits were not 
mentioned. The rabbits were examined at weekly intervals for the first 4 
postoperative weeks and then at monthly intervals for 1 year. The 
evaluated parameters included the size and shape of the pupils, the degree 
of anterior segment inflammation, the presence of cataracts, and the degree 
of vitreous inflammation. From these pathologic evaluations, the authors 
classified tungsten as "completely inert." No changes were noted in either 
the control or the untreated eyes of these rabbits.
Kinard and Van de Erve [44], in 1943, reported the effects of 
tungsten metal powder on the growth of rats. They used 38-day-old animals 
from mixed Wistar albino and Minnesota piebald strains. Groups of 10 rats, 
5 of each sex, were caged separately and fed ad libitum with ground dog 
chow containing 2, 5, or 10% tungsten metal powder; controls were given the 
ground dog chow without tungsten. Food consumption was determined from the 
food remaining in the containers after each feeding. The weight gains of 
rats were recorded at 10-day intervals for 70 days. Animals were killed 
after 70 days, and their gastrointestinal tracts were examined grossly.
During the 70-day period, the weight gains of male rats fed diets 
containing 2, 5, or 10% tungsten were 94, 113, and 108% of those of male 
rats fed the control diet, while the weight gains of female rats fed the 
three experimental diets were 104, 97, and 85% of control weight gains 
[44]. During the dosing period, each male rat fed the 2% tungsten diet 
consumed an average of 21 g of tungsten, while those on 5 and 10% consumed
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54.5 and 104 g, respectively. Female rats, in the same period, consumed an 
average of 14.8, 41.0, and 75.0 g of tungsten when fed the diets containing 
2, 5, and 10% tungsten metal powder, respectively. The authors attributed
the different weight gains by male and female rats fed diets containing 10% 
tungsten to the reduced food consumption of the female rats. They did not 
find any exudation of blood into the mucous membranes of the small or large 
intestines in rats fed tungsten for 70 days. They concluded that tungsten 
metal powder did not show marked toxic action at the levels used in their 
experiment.
In 1924, Karantassis [45] reported the toxic effects of sodium 
tungstate (Na2W04.2H20) on guinea pigs. In one study, three guinea pigs 
with an average body weight of 616 g were each given a single dose of 
either 0.50 or 0.75 g of sodium tungstate by gastric intubation. In 
another study, five guinea pigs, weighing an average of 635 g, were given 
subcutaneous injections of sodium tungstate. Three guinea pigs received 
single doses of 0.50 g each, and the remaining two received daily doses of 
0.10 g until their deaths at 16 and 17 days. The age, sex, and strain of 
the guinea pigs used were not reported. No control group was mentioned. 
In both studies, the author monitored the general visible signs before 
death, the time at which death occurred, the results of gross examination 
at autopsy, and the presence of tungsten in the gastrointestinal tract, 
lungs, liver, kidneys, bones, blood, and urine.
Guinea pigs from both experiments had anorexia, colic, uncoordinated 
movements, sudden jumps, trembling, and breathlessness [45]. Although the 
signs were similar in both groups, they were more pronounced and prolonged 
in the guinea pigs given sodium tungstate subcutaneously. Dose-related
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differences were not reported.
In both studies, guinea pigs given 0.50 g of sodium tungstate died
16-23 hours later [45]. In the guinea pigs given sodium tungstate orally, 
autopsy revealed that the stomach contained a bloody, greenish substance, 
and the large intestine contained bloody, diarrheic fecal matter. The 
liver showed small, discolored lesions and the lungs contained small, 
hemorrhagic spots. The peritoneum and all other organs, including the 
small intestine, spleen, testes, brain, kidneys, and suprarenal capsules, 
appeared normal. In subcutaneously dosed animals, post mortem examination 
showed an intense congestion of the liver, large infarcts in both lungs, 
dark blood in the heart, bloody diarrhea, and an appearance of 
asphyxiation. The condition of the brain, testes, peritoneum, 
gastrointestinal tract, and suprarenal capsules was not reported. No 
distinction was made between the effects of 0.75- and 0.50-g doses in the 
orally dosed group. Subcutaneous injections of 0.10 g of sodium 
tungstate/day for 16-17 days caused necrotic and indurated patches in 
unspecified tissues and a 23% loss in body weight; detachment of a small 
portion of abdominal skin and yellow patches of degeneration in the liver 
and kidneys were also noted.
Analysis of the tissues of animals from both experiments showed that 
tungsten was present in the stomach, intestines, liver, kidneys, lungs, 
blood, and urine [45]. In the orally dosed group, tungsten was also 
present in the walls and in the contents of the gastrointestinal tract. In 
the subcutaneously injected group, tungsten was present in bones and in 
necrotic and indurated patches in unspecified tissues.
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At the lower subcutaneous dose-level (0.10 g/day), the total lethal 
dose of sodium tungstate for each guinea pig was 1.65 g, while the lethal 
dose for a single administration was about 0.50 g [45]. Expressed as 
elemental tungsten, the single lethal doses for intragastric and 
subcutaneous administrations were estimated to be 0.55 and 0.45 g/kg, 
respectively. Because of the small sample size and lack of statistical 
analyses, the significance of these values is difficult to assess. 
However, this is the first published study attempting to distinguish 
between the oral and subcutaneous toxicities of sodium tungstate.
In a 1942 abstract, Selle [46] presented the results of a study of 
the effects of sodium tungstate on rats. Male and female rats were given 5 
ml/kg daily of a 0.1 M aqueous solution of sodium tungstate (0.164 g/kg 
body weight) either subcutaneously or orally. The age, weight, and strain 
of the rats were not reported. Although controls were indicated, the 
treatment of the controls and their number were not described. The number 
of doses and the duration of sodium tungstate administration were not 
given. At an unspecified time after the administration of sodium 
tungstate, body weights were recorded, the rats were killed, and the 
weights of the kidneys and adrenal glands were determined. At an 
unspecified time, tungsten excretion in feces and urine was measured, and 
rectal temperature was monitored.
The subcutaneous injection of sodium tungstate resulted in body 
weights of male and female rats that were 26 and 11%, respectively, below 
those of controls [46]. The kidneys of these animals were 45 and 42% 
heavier in male and female rats, respectively, than in the controls, and 
the adrenal glands of the males were 43% heavier than those of controls.
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The subcutaneous injection of sodium tungstate produced a severe drop in 
rectal temperature, about 8 F in 2 hours, with a return to normal in 8 
hours. Most of the subcutaneously administered tungsten was eliminated in 
the urine within 12 hours, while that administered orally was excreted in 
urine and feces within 12-24 hours. When sodium tungstate was administered 
orally, no changes in kidney, adrenal, or body weights resulted; this may 
be a significant finding, since sodium tungstate administered 
subcutaneously was slightly more toxic than that given orally.
In 1940, Kinard and Van de Erve [47] compared the influence of age, 
sex, and postprandial conditions on the effects of subcutaneously injected 
sodium tungstate in rats. Rats, in equal numbers of each sex, were fed dog 
chow during the experiment. In the first experiment, aimed at determining 
the influence of postprandial conditions on the toxicity of sodium 
tungstate, 2 groups each containing 27 rats were fasted for 24 hours. One 
group was weighed after food had been withheld for a day, injected with a 
calculated dose of sodium tungstate, and then fed. A second group was 
weighed after fasting, fed, and then injected 1-3 hours later with sodium 
tungstate at a dose based on body weight before feeding. The age and 
weight of the rats and the amount of sodium tungstate administered were not 
reported. Mortality was recorded in both groups for an unspecified period.
Mortality was 40.7% in the first group and 14.8% in the second [47]. 
The authors concluded that rats were less susceptible to sodium tungstate 
administered during the periods of active absorption and metabolism that 
follow a meal than to administration following fasting. They conceded, 
however, that the data presented did not reveal whether the observed effect 
was caused by impairment in the direct absorption and utilization of
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nutrients or by changes in the absorption of tungsten.
The second part of the study [47] was designed to evaluate the 
effects of age on the toxicity of subcutaneously injected sodium tungstate. 
Five groups of rats, ranging in age from 30 to 365 days, with an average of 
23 rats per group, were fasted for 24 hours and weighed individually. 
Sodium tungstate was injected subcutaneously at a dose of 150 mg of 
tungsten/kg body weight. Mortality was recorded for an unspecified period. 
For rats 30, 44, 66, 170, 195, and 365 days of age, mortalities were 0, 30, 
59, 100, 89.5, and 100%, respectively, ie, there was an increase in 
mortality with increased age. Analysis of deaths in the groups with 10-80% 
mortality revealed a 15:13 ratio of males to females, indicating that the 
male rats are slightly more susceptible to injected sodium tungstate than 
females.
In the third experiment, the dose-response relationship of sodium 
tungstate in 66-day-old rats was studied [47] . The sex and weight of the 
rats were not given. Rats were fasted for 24 hours, weighed, injected with 
sodium tungstate, and then fed. Nine groups of rats, with an average of 25 
in a group, were given subcutaneous injections of sodium tungstate in doses 
equivalent to 100-250 mg of tungsten/kg of body weight. Mortality data 
were obtained during the 5 days after injection. The authors reported that 
the LD50 of subcutaneously injected sodium tungstate for 66-day-old rats 
was 223-255 mg/kg (140-160 mg/kg of tungsten). Their data did not indicate 
the times after the injection when the first and the most deaths occurred.
Kinard and Van de Erve [48] evaluated the comparative toxicities of 
tungstic oxide, sodium tungstate, and ammonium-p-tungstate. They used 
equal numbers of 37-day-old male and female rats, caged separately in
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groups of five or six animals. Diets for experimental animals were 
prepared by incorporating 0.1, 0.5, or 2.0% tungsten equivalents of sodium 
tungstate, 0.1, 0.5, or 3.96% tungsten equivalents of tungsten trioxide,
and 0.5, 2.0, or 5.0% tungsten equivalents of ammonium-p-tungstate into
ground dog chow. Control animals were fed the dog chow only. The 
experiment continued for 70 days.
Rats had 100% mortality when fed diets containing ammonium-p- 
tungstate equivalent to 5.0% tungsten, tungstic oxide equivalent to 3.96% 
tungsten, or sodium tungstate equivalent to 2.0% tungsten [48]. However, 
ammonium-p-tungstate caused 80% mortality at a level equivalent to 2% 
tungsten. Tungstic oxide given at a level equivalent to 0.5% tungsten 
caused 80 and 66% mortalities in male and female rats, respectively, while 
sodium tungstate at the same level caused 50 and 66% mortalities. In 
comparison, 0.5% tungsten in the diet as ammonium-p-tungstate caused no 
deaths. Diets containing either sodium tungstate or tungstic oxide in a 
concentration equivalent to 0.1% tungsten caused no fatalities.
After 70 days, the male and female rats fed ammonium-p-tungstate 
equivalent to 0.5% tungsten weighed 3.9 and 5.3% less, respectively, than 
the controls [48]. Male and female rats receiving tungstic oxide at a 
tungsten equivalent of 0.1% weighed, respectively, 6.3 and 7.4% less than 
controls; for male and female rats given the same concentration of sodium
tungstate, the weight decreases were 8.8 and 10.6%. Corresponding to the
decreased weight gains in various groups, there were moderate-to-sharp 
declines in food intake which appeared to be dose-related. Thus, in male 
rats fed sodium tungstate at levels of 0.1, 0.5, and 2.0% of tungsten 
equivalents, the food intakes were 83, 47, and 20% of that of controls,
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respectively, while in females they were 96, 72, and 31%. Similarly, the 
food intakes of tungstic oxide groups at levels of tungsten equivalent to 
0.1, 0.5, and 3.96% were 91, 33, and 20% of control values for males and
100, 72, and 51% for females. With diets containing 0.5, 2.0, and 5.0%
tungsten as ammonium-p-tungstate, the food intakes of male rats were 102, 
27, and 46% of control values. Females fed ammonium-p-tungstate at levels 
of tungsten equivalent to 0.5 and 2.0% had food intakes 96 and 82% of that 
of the controls.
It is noteworthy that the proportional decreases in body weight in 
female rats were greater than those of males, although the tungsten 
compounds had a smaller effect on the intake of food by the females than on 
that by the males. This suggests that tungsten exerted some effect that 
was specific, or at least relatively specific, for females on either 
digestion and absorption of food stuffs or metabolic utilization of 
foodstuffs. Balance studies, especially of nitrogen, might be useful in 
deciding between these two possibilities. Johnson et al [49] found that 
tungsten could be incorporated into such enzymes as xanthine oxidase and 
sulfite oxidase in place of molybdeum to yield inactive proteins. This 
suggests that the second of the two general possiblities mentioned above 
may be the correct one. Johnson et al used only male rats and fairly high 
doses of tungsten (25 ppm in the drinking water) to obtain their results. 
If females were more sensitive to tungsten in this regard than were male 
rats, the effect on their metabolic activities catalyzed by these important 
enzymes would be much greater than those of males. Knowledge of the role 
of sex in this regard seems to be of some importance.
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From the mortality and body weight data, the authors [48] concluded 
that ammonium-p-tungstate was the least toxic of the three compounds. 
Although the data were not analyzed statistically, this is the first report 
which reveals that tungstic oxide and ammonium-p-tungstate are less toxic 
than the soluble sodium tungstate.
Nadeenko [50] compared the acute toxicities of sodium 
phosphotungstate, sodium tungstate, and tungstic oxide by determining their 
oral lethal doses in 300 mice and 40 albino rats. The author did not 
present the experimental details. After brief excitation, all mice and 
rats given the three tungstate compounds sat with backs arched; their 
muscle tone was decreased; and the hind legs of some of the mice became 
slightly paralyzed. From these observations, Nadeenko concluded that the 
animals exhibited inhibited motor functions. The durations and doses at 
which these symptoms occurred were not reported. These experiments were 
evaluated statistically by probit analysis, with the results expressed as 
elemental tungsten.
The oral LD50 of sodium phosphotungstate was 700 ± 79 mg/kg for mice 
and 1,600 ± 201 mg/kg for rats [50]. The oral LD50 of sodium tungstate was 
240 ± 13.5 mg/kg for mice and 1,190 ± 129.5 mg/kg for rats. Administration 
of tungstic oxide at 840 mg/kg killed half of the animals (species not 
stated); however, there was no further increase in the percentage of deaths 
with doses up to 2,500 mg/kg body. Nadeenko concluded that this compound 
was less toxic than either sodium tungstate or sodium phosphotungstate. He 
suggested that the lower toxicity of tungstic oxide was a result of its 
lower solubility.
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Nadeenko [50] also studied the toxic effects of sodium tungstate on 
rabbits, guinea pigs, and rats. As in the above study, the experimental 
design was not presented. The oral LDO, LD50, and LD100 were reported as 
500, 875, and 1,500 mg/kg respectively, for rabbits, 500, 1,152, and 2,000 
mg/kg for guinea pigs, and 700, 1,190, and 2,000 mg/kg for rats. The
author concluded that rabbits were more susceptible to the toxic action of 
sodium tungstate than were either rats or guinea pigs.
To study the selective effect of tungsten on individual physiologic 
functions and systems of animals, Nadeenko [50] conducted a set of subacute
experiments for an unspecified period of time on albino rats and rabbits.
The animals were given sodium tungstate orally at presumably daily doses of 
100, 50, 25, or 10 mg/kg. The number, age, sex, weight, and strain of the
animals were not reported, and no control group was described.
Nadeenko [50] reported that, at all doses, the growth of the rats was 
retarded and their blood cholinesterase activities were lowered; in 
rabbits, the sulfhydryl (SH) concentrations of whole blood and serum were 
decreased and synthesis of glycogen in the liver was disturbed. Stained
sections of the gastrointestinal tract and kidneys showed signs of
increased vascular permeability, hemorrhages, degenerative dystrophic 
changes, and moderate proliferative cellular reactions.
Nadeenko [50] also attempted to determine the noneffective and 
threshold chronic oral doses of tungsten in rats and rabbits. Sodium 
tungstate was administered to rabbits in doses of 5, 0.5, 0.05, or 0.005 
mg/kg daily for 8 months and to rats in doses of 0.5, 0.05, or 0.005 mg/kg 
daily for 7 months. There were seven animals in each dosage group. Their 
sex, age, weight, and strain were not presented. Control groups of the
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same size were used, but it was not clear how they were treated. 
Throughout the exposures, the general behavior and body weight of the 
animals were monitored. The blood SH content and cholinesterase and 
alkaline phosphatase activities were measured in the rabbits. Blood 
cholinesterase and alkaline phosphatase activities were determined at 
monthly intervals. The glycogen-forming function of the liver was measured 
in rabbits after loading them with galactose. In rats, the conditioned 
reflexes were monitored on animals trained to respond to the sound of a 
bell and to a light, and this test was used as a measure of the functional 
state of the CNS. The intervals at which such measurements were made were 
not given. At the end of the experimental period, the SH contents of brain 
and liver tissues of rats were determined. The author reported, without 
identifying the species, that, after the termination of chronic poisoning, 
he determined the tungsten concentrations in blood, liver, femur, 
intestines, and kidneys; he also conducted macroscopic and microscopic 
examinations of the gastrointestinal tract, lungs, liver, spleen, and brain 
of both species.
In rabbits, sodium tungstate at doses of 5 and 0.5 mg/kg of body 
weight decreased the availability of SH groups in serum during months 5-8 
of the experiment and produced decreases of about 23 and 16%, respectively, 
in blood cholinesterase activity at the end of 8 months [50] . Sodium 
tungstate at doses of 0.05 and 0.005 mg/kg caused no changes in either the 
SH content or the blood cholinesterase activity of rabbits. Blood alkaline 
phosphatase activity was inhibited by as much as 18% (P<0.01) by sodium 
tungstate at a dose of 5.0 mg/kg during months 4-8 of the experiment. 
However, in the 0.5-mg/kg and 0.05-mg/kg groups, changes were sporadic and
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inconsistent and, in the 0.005-mg/kg group, the blood alkaline phosphatase 
activity was not inhibited. Rabbits receiving sodium tungstate doses of
5.0 and 0.5 mg/kg of body weight had concentrations of glucose in their 
blood 20-25% higher than control levels 1 hour after iv loading with 
galactose. Nadeenko noted this change at months 6 and 7 of the experiment 
and interpreted it as an indication that the glycogen-forming function of 
the liver had decreased. No changes in the glycogen-forming function of 
the liver were observed in the 0.05 and 0.005 mg/kg groups. None of the 
rabbits showed pathologic changes in the esophagus, large intestines, 
lungs, liver, or spleen. In rabbits given tungsten at 5 mg/kg, some areas 
of the intestinal mucosae showed an increase in lymphoid infiltration of 
the villi and necrosis of their terminal portions.
In rats, sodium tungstate at doses of 0.5 and 0.05 mg/kg caused 
pronounced disturbances in conditioned reflexes [50]. The latent periods 
of sodium tungstate-treated animals were 1.6-1.7 seconds for the bell and 
2.4-2.7 seconds for the light, compared to 0.9 and 2.0 seconds, 
respectively, for controls. Animals given the maximum doses of sodium
tungstate exhibited a larger number of extinctions of the conditioned 
reflexes. Disturbances of conditioned reflexes were indicated by a 
statistically significant increase in the number of equalizing and 
paradoxical phase states (For explanation of terminology, see reference
[51]). No data were presented on the statistical analyses. Nadeenko noted 
that study of extinction and recovery of the conditioned response to a bell 
revealed a pronounced decrease in the lability of nervous processes in the 
cerebral cortices of the 0.5 and 0.05 mg/kg dose-groups. No changes were
noted in the conditioned reflex with a dose of 0.005 mg/kg. Necrotic
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lesions and destruction of the apical portions of the intestinal villi were 
also evident in rats given sodium tungstate at 0.5 mg/kg. No animal had 
pathologic changes in the esophagus, large intestine, lungs, liver, or 
spleen.
Although he gave no values, Nadeenko [50] reported that analyses of 
the concentrations of tungsten in various tissues of experimental animals 
(species unspecified) revealed that the highest concentrations existed in 
groups receiving 5 and 0.5 mg/kg of sodium tungstate. A less pronounced 
but significant accumulation of tungsten was found in tissues of animals 
given sodium tungstate at 0.05 mg/kg, while a dose of 0.005 mg/kg produced 
increases only in the concentration of tungsten in the blood and 
intestines. From these findings, the investigator concluded that tungsten 
has cumulative toxicity. Nadeenko believed that the daily dose of 0.05 
mg/kg was below the threshold level, since it did not cause appreciable 
biochemical changes in the animals, although it did affect the conditioned 
reflexes of rats.
In 1945, Kinard and Aull [52] described the distribution of tungsten 
in rat tissues after dietary feeding of tungsten or its compounds. Rats of 
an unspecified strain, 37 days old, were caged in groups of two males and 
two females. During the 100-day experimental period, the control group 
received ground dog chow, while the experimental groups were fed this basal 
diet with the incorporation of tungsten or tungsten compounds at one of the 
following levels: tungstic oxide and sodium tungstate at levels equivalent
to 0.1% tungsten; ammonium-p-tungstate at 0.5% tungsten; tungsten metal at 
2 and 10% tungsten; and purified tungsten metal (purified to remove any 
trace of oxide from the metal) at 10% tungsten. Diet and water were given
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ad libitum to each group of rats.
Analysis of the tissues removed at the end of the 100-day period
revealed that bone and spleen were the major sites of tungsten deposition
[52]. The concentrations of tungsten ranged from 8 to 18 mg% in bone and
from 2 to 14 mg% in the spleen, with averages of 11.5 and 7.5 mg%,
respectively. Only traces of tungsten (less than 1 mg%) were present in 
skin, kidneys, and liver. The blood, lungs, testes, and muscles showed 
traces of tungsten only in some cases. Except for a single instance for
each organ, the brain, heart, and uterus were free of tungsten. The
investigators concluded that there were no marked differences among the 
distribution patterns of the various tungsten compounds tested. Since the 
doses of tungsten administered as various tungsten compounds were not 
comparable and since quantitative results were not presented for all the 
tissues that were analyzed, this conclusion may not be entirely valid.
Aamodt [53] measured the metabolism of inhaled tungstic oxide in
dogs. Six purebred beagles, of unspecified sex and age, were anesthetized
with pentobarbital at 27 mg/kg. They then inhaled a mist of radiolabeled
181W-tungstic oxide of 98 microcuries/ml specific activity through a face- 
mask for 6 hours. The dogs were killed 165 days after exposure, and tissue 
samples were collected from all dogs.
Measurements of the radioactivity in inhaled and expired air showed 
that 1.9-8.0 microcuries of tungstic oxide were deposited in the 
respiratory tract [53] . Sixty percent of the inhaled activity was 
deposited in the lower part of the respiratory tract. In the partial body 
measurements made over the lung area, about 69% of the activity was lost 
with a biologic half life (tl/2) of 4 hours, the next 23% with a tl/2 of 20
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hours, 4.6% more with a tl/2 of 6.3 days, and 3% with a tl/2 of 100 days. 
In contrast, measurements taken for the lower half of the body showed 94% 
with a tl/2 of 9 hours, whereas 4.1% had a tl/2 of 6.3 days. The remaining 
1.6% of the radioactivity was removed with a tl/2 of 139 days. Without 
giving any actual experimental values, Aamodt indicated that the activity 
was lost rapidly from the blood, although there were some variations in the 
measured activity which, he explained, were caused by biologic variation in 
the clearance patterns in individual dogs. Of the organs tested, the lungs 
and kidneys were found to retain maximum radioactivity, 47.7 millionths and 
41.3 millionths of the inhaled activity/g of tissue, respectively. Other 
tissues contained only about 10% as much activity as did the lungs and 
kidneys. In terms of total burden of radioactivity, most of the activity 
was found in the skeleton (37%), lungs (31%), kidneys (15%), liver (9.7%), 
and skeletal muscle (5.7%).
The reported effects of insoluble tungsten or cemented tungsten 
carbide administered intratracheally or by inhalation were chiefly 
respiratory in nature. No studies are available of the effects of soluble 
tungsten compounds given by similar routes of exposure. Moreover, the oral 
administration studies did not clearly distinguish the principal organs 
affected by soluble tungsten. Few reports are available on the dermal 
effects of tungsten compounds or cemented tungsten carbide in experimental 
animals.
Correlation of Exposure and Effect
Effects of both short-term and long-term occupational exposures to 
tungsten and its compounds have been identified among employees in the
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cemented tungsten carbide industry (Table III-l). The only work areas in 
this industry that permit specific evaluation of the effects of tungsten 
and its compounds are those processing stages that precede the 
incorporation of other toxic metals into the final products. Only two 
human studies meeting this criterion were obtainable [27,28]. These 
studies showed that the effects of inhaled tungsten and tungsten compounds 
are exerted chiefly on the respiratory system. Radiologic signs of 
pulmonary fibrosis were reported by Mezentseva [28] and by Kaplun and 
Mezentseva [27] in 9-11% of the hard-metal workers who were exposed to 
dusts of tungsten and its compounds.
In both short- and long-term animal experiments, the major effects of 
inhalational or intratracheal exposure to tungsten and its compounds were 
similarly limited to the respiratory system, while the effects of ingestion 
were not so clearly apparent in any organs (Table III-2). As in the 
reports of the human studies, no dermatologic effects were described in 
these animal reports. Mezentseva [28] reported that lungs of rats exposed 
by inhalation to tungsten carbide at 600 mg/cu m, 1 hour/day, for 5 months 
showed proliferative reactions of the lymphoid histiocytic elements and 
uniform thickening of the alveolar walls followed by mild fibrosis. 
Mezentseva [28] also stated that rats given single intratracheal doses of 
50 mg of either metallic tungsten, tungsten carbide, or tungsten trioxide 
showed no severe pulmonary changes upon microscopic examination.
Dusts of metallic tungsten or tungsten carbide, given intratracheally 
to guinea pigs by Delahant [35] as a total dose of 150 mg in three equal 
weekly doses, did not irritate the lung tissue. Similarly, 1 ml of a 10% 
suspension of tungsten was given intratracheally to rats by Miller et al
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[16], who found that the only changes in the animals’ lungs, such as 
mobilization of septal cells, engulfment of pigment, and accumulation of 
particles in the air sacs, lymphoid tissue, and alveolar walls, were those 
typically produced by an inert dust.
However, Schepers [34] found that the intratracheal injection of 3 
weekly doses of 50 mg of a 94:6 mixture of tungsten carbide and carbon 
caused acute hyperemia and bronchial inflammation in guinea pigs. Minor 
residual changes, such as the development of subpleural fibrocellular 
granulomata, were also noted in their lungs. Brakhnova and Samsonov [40] 
reported that inhalational and intratracheal exposure of rats to tungsten 
silicide for 1-6 months caused hyperplasia of the lymph nodes, sporadic 
thickening of the alveolar walls, and increased collagen in the lungs. 
These results suggest that tungsten and some of its compounds, such as
those most frequently encountered in the cemented tungsten carbide 
industry, have distinct toxicities.
While opportunities for occupational exposures to soluble tungsten 
compounds are limited, a number of animal studies are available delineating 
their toxicities. In 1924, Karantassis [45] administered single 
intragastric and subcutaneous doses of sodium tungstate to guinea pigs and 
observed anorexia, colic, incoordination of movement, trembling, dyspnea, 
and loss of weight prior to death. Rats injected subcutaneously with 
sodium tungstate also had congested livers and large infarcts in both
lungs. Smaller subcutaneous doses of sodium tungstate also produced 
degenerative patches in liver and kidneys. Selle [46] also noticed that
rats given subcutaneous doses of sodium tungstate had increased kidney
weights.
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Two studies attempted to differentiate between the toxicities of the 
soluble and the insoluble tungsten compounds. Kinard and Van de Erve [48] 
fed young male and female rats diets containing 0.1-5% tungsten equivalents 
of tungstic oxide, sodium tungstate, and ammonium-p-tungstate. At these 
levels, 100% mortality was caused by a 2% tungsten equivalent of sodium 
tungstate, by a 3.96% tungsten equivalent of tungstic oxide, and by a 5% 
tungsten equivalent of ammonium-p-tungstate. Tungsten equivalents of 0.5% 
in the diet caused no deaths in the ammonium-p-tungstate group; tungstic 
oxide, at the same concentration of the metal caused 88 and 66% deaths in 
males and females, respectively, and sodium tungstate caused 50 and 60% 
deaths. Sodium tungstate was concluded to be the most toxic of the three 
compounds.
Nadeenko [50] compared the oral toxicities of tungstic oxide, sodium 
tungstate, and sodium phosphotungstate in rats and mice. After brief 
periods of excitability, all mice and rats given the three tungsten 
compounds sat with backs arched; their muscle tone was decreased, and the 
hind legs of some mice became slightly paralyzed. In mice, the oral LD50 
of tungstic oxide was 840 mg/kg, while those for sodium phosphotungstate 
and sodium tungstate were 700 and 240 mg/kg, respectively. Nadeenko 
concluded that tungstic oxide was the least toxic of the three and 
suggested that its lower solubility, compared with those of the other two 
compounds, was the cause. Thus, soluble tungsten compounds were 
considerably more acutely toxic in experimental animals than the insoluble 
compounds.
Most reports of occupational exposure to tungsten and its compounds, 
with the exception of the two studies already described, deal with the
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effects of mixed dusts containing cobalt [27,28]. The effects of such 
mixed dusts were chiefly respiratory in nature, although some dermal 
effects were evident. The pulmonary involvement reported in a number of 
these studies was characterized by exertional dyspnea, coughing, and weight 
loss [15,17-19,25]. These clinical signs sometimes progressed to extrinsic 
asthma [23], diffuse interstitial pneumonitis [18], or fibrosis [17,20,22]. 
The type of pneumoconiosis seen in the cemented tungsten carbide industry 
is referred to as "hard-metal disease." While the total dust levels and 
cobalt concentrations were reported in most studies, tungsten 
concentrations were documented in only a few cases. Most dust particles 
generated in various operations in which tungsten is processed and used are 
less than 5 /zm in diameter and hence are in the respirable size range 
[17,25,28,42,54].
Some authors described the pulmonary responses of cemented tungsten 
carbide workers as hypersensitivity [17,20], This response was so
described because of the reversibility of some clinical symptoms, the 
occasional radiologic improvement on withdrawal from exposure, and the
recurrence of symptoms on reexposure. Bruckner [23] diagnosed extrinsic 
asthma in a cemented tungsten carbide worker and attributed it to a
hypersensitivity mechanism. This worker experienced asthmatic symptoms 1-3 
minutes after beginning work, even though he wore a respirator designed to 
remove particles of 0.6 ¿im diameter or larger.
Two studies [14,24] described the dermatologic effects of
occupational exposures to unspecified levels of dusts in cemented tungsten 
carbide industries. Schwartz et al [14] stated that 20 workers employed 1 
month or more in this industry developed erythematous, papular dermatitis,
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mainly on the sides of the neck, the eyelids, and the forearms. While the 
abrasiveness of the dust reportedly contributed to the sensitization 
process, cobalt sensitization was concluded to be the cause of the 
dermatitis. Skog [24] reported skin effects including contact eczema, 
pruritus, folliculitis, and neurodermatitis, in 34 (9.4%) of the 361
workers in the cemented tungsten carbide industry. Cobalt sensitization 
was detected by patch tests in 3 of the 14 workers with contact eczema, 
found mainly on the eyelids and between the fingers. This author [24] 
concluded that the primary irritant effect of the combined metal dusts 
produced most of the contact eczema.
Although these studies are well documented in terms of the observed 
effects, it is difficult to distinguish the effects of tungsten and its 
compounds from those produced by cobalt and perhaps other metals and 
compounds. However, most of the authors attributed the effects of these
mixed exposures primarily to the presence of cobalt.
The effects of exposures of experimental animals to tungsten-cobalt 
mixtures on the respiratory system are well documented, but dermatologic 
effects were not described in laboratory animals. In a collaborative 
experiment with Delahant [35], Schepers [37] noted that guinea pigs, 
exposed by inhalation to a 3:1 mixture of tungsten carbide and cobalt for 
20 days at 8,800-10,000 particles/cu cm and then at 2,800 particles/cu cm 
for 15 days developed acute inflammation of the respiratory tract, followed 
by focal pneumonitis and residual bronchial epithelial hyperplasia and 
metaplasia. He emphasized that the unusual epithelial reaction was the 
characteristic feature of exposure to a mixture of tungsten carbide and
cobalt. Delahant [35] noted that five animals died during the 20-day
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exposure and that an additional six died during the following 15-day 
exposure. Delahant [35] and Schepers [37] also examined the responses of 
guinea pigs to intratracheal administration of 3 weekly 50-mg doses of a 
91:9 mixture of tungsten carbide and cobalt. They reported pneumonitis and 
mild cellular and fibrotic reactions around the dust deposits in the lungs 
of these guinea pigs. Delahant [35] and Schepers [37] concluded that the 
intense irritant property of cobalt was dominant when cobalt was combined 
with tungsten carbide. Kaplun and Mezentseva [38] injected rats 
intratracheally with the following dust mixtures: (1) 15% cobalt and 85% 
tungsten, (2) 8% cobalt and 92% tungsten, or (3) 8% cobalt, 14% titanium, 
and 78% tungsten. The rats that received 25 mg of dust had 100, 40, and 
60% mortalities in groups 1, 2, and 3, respectively, within 5-7 days. At 
the 10 mg-dose level, 5 of the 13 rats in group 1 died within 2-3 days, but 
none of the rats in groups 2 and 3 died.
The absolute lethal dose for the dust mixture containing 15% cobalt
was 15 mg (2.25 mg cobalt)/rat, while that for the other two mixtures was 
50 mg (4 mg cobalt) [38] . Comparing these values with the absolute lethal 
dose of metallic cobalt alone (10 mg), the authors suggested that the
toxicity of cobalt was enhanced in the presence of tungsten because the 
latter increased the solubility of the former. However, as the absolute 
lethal doses of the three dust mixtures were 50-400% greater than that of 
metallic cobalt, the results do not necessarily support the hypothesis of 
enhanced toxicity of cobalt; cobalt and tungsten may, however, have
synergic actions that are additive to some degree.
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Carcinogenicity, Mutagenicity. Teratogenicity, and Effects on Reproduction
In 1961, Bech et al [25] reported a case of cancer in a 63-year-old 
man who had been exposed to hard-metal dusts containing tungsten for 17 
years and who had previously worked as a core maker in various iron 
foundries for 32 years. Ten years after beginning employment in the hard- 
metal industry, he developed a persistent dry cough, dyspnea, and pain and 
tightness in the chest. Radiologic chest examinations revealed hilar 
shadows, linear markings, and micro-nodular opacities. Four years later, 
there were signs of progressive deterioration with increased shadows above 
the right portion of the diaphragm. The subject died 3 years later with an 
anaplastic adenocarcinoma of the right lower lobe of the bronchus. The 
hilar and paraaortic glands were also invaded by the tumor, and a 
neoplastic invasion of the right renal capsule was noted at autopsy. Since 
the worker had been exposed to a number of industrial dusts of unknown 
composition and amounts, the tumor cannot be attributed specifically to 
exposure to tungsten.
Collet and coworkers [26], in 1963, described a case of pulmonary 
fibroadenomatosis in a 57-year-old worker employed for 14 years in the 
manufacture of hard-metal tools. During this period, he was known to have 
been exposed to dusts of tungsten carbide, metallic cobalt, tantalum, 
titanium, and cobalt oxalate, and to trichloroethylene vapor. After he had 
worked in this environment for 8 years, radiologic examination of his chest 
revealed reticulation at the bases and in the left central portion of the 
lungs. After 2 more years, fever and breathing difficulties were reported; 
a year later, exertional dyspnea had become more severe. During the next 
three years, clinical observations and pulmonary function tests indicated
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that his condition had deteriorated further. At the end of this period, he 
died of respiratory failure and cardiovascular collapse. A biopsy of lung 
tissue performed 7 months before his death led to the diagnosis of 
pulmonary fibroadenomatosis; spectrographic analysis of the tissue taken 
for biopsy demonstrated what were described as large amounts of tungsten, 
nickel, and titanium in his lungs, although he had no known occupational 
exposure to nickel. In this case, as in the case reported by Bech et al 
[25], the worker had been exposed to a mixture of metal dusts and to the 
vapor of trichloroethylene at unknown concentrations [26], The precise role 
of tungsten in the development of the fibroadenoma cannot therefore be 
determined.
The aforementioned reports indicate that tungsten and its compounds 
are neither confirmed nor suspected as carcinogens, mutagens, or 
teratogens.
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TABLE III-l
EFFECTS OF OCCUPATIONAL EXPOSURE 
TO TUNGSTEN-CONTAINING SUBSTANCES
Composition
of
Substances
Exposure 
Concentration 
and Duration
Number
of
Workers Effects
Ref­
erence
Tungsten carbide 8.6-106.6 mg/cu m 36 Diffuse pulmonary fibrosis in 4 27
M 8.3-83 mg/cu m 
7-10 yr
54 Diffuse pulmonary fibrosis in 5 28
Cemented tungsten carbide 
90% tungsten,
6% cobalt,
4% titanium, silica, 
aluminum, mag­
nesium, iron, etc
195-1,230 particles/ 
ml
255 Hard-metal disease in 1; in 12 
given pulmonary function tests, re­
duced ventilatory capacity and rise 
in airway resistance in 2, rise in 
respiratory airway resistence in 2, 
wheezing in 4; slight change in 
chest X-rays of several
25
Cemented tungsten carbide 
70-90% tungsten carbide, 
8-78% titaniam carbide, 
5-25% cobalt
13-100 mg/cu m 193 Coughing in 47%, dyspnea in 35%, 
disturbance of pulmonary ventila­
tion in 21.5% of 116 examined by 
spirometry; reticulation in chest 
X-rays in 16% of 93 workers
31
Cemented tungsten carbide 
0.27-1.75 mg/cu m of cobalt
3-186 mg/cu m 247 Damage to upper respiratory tract 
in 117; chronic bronchitis in 35; 
incipient pulmonary fibrosis in 33
27
Cemented tungsten carbide 
2.4-4.1% cobalt
2.1-3.5 mg/cu m 
6 yr
1,802 Inflammation of conjunctivae, upper 
respiratory tract, and mucous mem­
branes; chest X-ray abnormalities 
in 36; cobalt sensitivity
15
Cemented tungsten carbide 
0.6-3.2 mg/cu m of'cobalt
0.75-6.1 mg/cu m 
up to 3 yr
178 Dyspnea, coughing, impaired sense 
of smell in 88; some impairment of 
liver function
32
Cemented tungsten carbide 
0.04-0.93 mg/cu m of cobalt 
0.28 mg/cu m mean
0.2-12.8 mg/cu m
as tungsten; 
5.1 mg/cu m mean 
1-30 yr
22 Reduced FVC and elevated FEV 1/FVC 
ratio; exertional dyspnea in 3; 
productive cough in 8
29
Cemented tungsten carbide 
80-90% tungsten carbide, 
8-18% titanium carbide, 
5-25% cobalt
375 Allergic asthma and exertional 
dyspnea in 1, reversed on removal 
from work environment; coughing; 
dyspnea, restrictive ventilatory 
defect, and micronodular or linear 
opacities on chest X-rays in 12, 
with death of 8 from bronchopneu­
monia or cardiorespiratory failure
19
Cemented tungsten carbide 2.3-62.3 mg/cu m 
up to 17 yr
29 Dry cough, exertional dyspnea in 9; 
allergic asthma in 3; pulmonary 
fibrosis in 1
17
Cemented tungsten carbide
pure metals, car­
bides, and oxides 
of tungsten, ti­
tanium, tantalum, 
and niobium, and 
cobalt metal
“
100 Irritation of upper respiratory 
tract in 15, diminishing on removal 
and recurring on reexposure; ex­
ertional dyspnea (not reversible), 
rapid weight loss in 5
20
Cemented tungsten carbide
94
5 Episodic wheezing and couching, re­
lieved by removal frosi work environ­
ment and recurring upon return; no 
chest X-ray abnormalities
18
TABLE XXI-1 (CONTINUED)
EFFECTS OF OCCUPATIONAL EXPOSURE 
TO TUNGSTEN-CONTAINING SUBSTANCES
Composition
of
Substances
Exposure 
Concentration 
and Duration
Number
of
Workers Effects
Ref­
erence
Cemented tungsten carbide 
75% tungsten carbide,
3-25% cobalt, small
amounts of ti­
tanium carbide, 
chromium carbide, 
and nickel
Cemented tungsten carbide 
67.8%-76.l%tungsten,
7.6-21.2% 
0-1.7% 
0.3-2.3%
cobalt, 
titamium,
  iron,
7.0%-16% volatiles 
(paraffin)
12-28 yr
277-4,064 particles/ 
cu m
Cemented tungsten carbicie
tungsten, cobalt, 
titanium, tanta­
lum, niobium, or 
their oxides and 
carbides
Cemented tungsten carbide
tungsten, cobalt, 1 yr 
or tantalum
Cemented tungsten carbide
tungsten carbide, 7 yr 
cobalt, sometimes 
titanium and 
tantalum carbide 
High speed steel containing 
cobalt
12 Cough, exertional dyspnea, progres­
sive interstitial fibrosis; cor 
pulmonale leading to cardio­
respiratory arrest in 8
208 Asthmatic symptoms, bronchitis, 
emphysema, pulmonary fibrosis
18
33
21Coughing, expectoration, exertional 
dyspnea, diffuse bilateral cloud­
ing, nonresonant wet rales; re­
strictive ventilatory impairment; 
improved on removal from work en­
vironment
Exertional dyspnea, dry irritated 21
cough, fever, cyanosis, rales, re­
strictive ventilatory, impairment of 
lung function; small lungs with 
striated or honeycomb pattern; no 
improvement on removal from work 
environment
Diffuse bilateral densities from 30
chest X-rays; reduced vital capaci- 29
ty; lung biopsy showed multifocal 
pulmonary scarring with patchy, 
interstitial fibrosis
Cemented tungsten carbide
tungsten, tanta­
lum, and titanium 
carbides, cobalt
Cemented tungsten carbide 
0-95% tungsten carbide,
0-40% titanium car'iide,
0-20% tantalum-nio ¿lum
carbide,
5-25% cobalt
Cemented tungsten carbide
tungsten carbide, 
metallic cobalt, 
tantalum, cobalt 
oxalate
Vapors of trichlorceihylsne
1 mon or more
14 yr
20 Erythematous, papular eruptions on 14
of neck, eyelids, forearms, backs of
1,200 hands and ankles; patch tests on 6
showed sensitivity to cobalt powder
34 Contact eczema in 16; pruritus with- 24
of out skin lesions in 8; follicilitis
361 in 6; neurodermatitis in 4; patch
testing in 14 who had contact ec­
zema revealed that 3 reacted to co­
balt chloride and 2 to hard-metal 
powder as well
1 Fever, exertional dyspnea, reticulo- 26
nodular opacities on chest X-rays; 
reduced vital capacity; death from 
respiratory failure and cardioasvacu- 
lar collapse; diagnosis of pulmon­
ary iibroadenomatosis
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TABLE III-l (CONTINUED)
EFFECTS OF OCCUPATIONAL EXPOSURE 
TO TUNGSTEN-CONTAINING SUBSTANCES
Composition
of
Substances
Exposure 
Concentration 
and Duration
Number
of
Workers Effects
Ref­
erence
Cemented
90%
6%
4%
tungsten carbide 
tungsten, 
cobalt,
titanium, alumi­
num, magnesium, 
iron, etc
195-505 particles/ml 
22 mon-22 yr
6 Persistent dry cough; dyspnea, and 
pain and tightness in chest; hilar 
shadows, linear markings, and micro- 
nodular opacities in chest X-rays; 
one died from anaplastic adenoma of 
lower lobe of bronchus
25
Cemented tungsto.n carbide 
primarily tung­
sten carbide
34 mon
1 Wheezing, respiratory distress, 2 
asthma attacks requiring hospital­
ization; asthmatic symptoms re­
curred on reexposure to work en­
vironment; diagnosis of extrinsic 
asthma
:>3
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TABLE III-2
EFFECTS ON ANIMALS OF INHALATION EXPOSURE AND INTRATRACHEAL INJECTION OF
TUNGSTEN-CONTAINING SUBSTANCES
Composition
of
Substance
Route of 
Exposure Species
Exposure 
Concentration, 
Duration
Ref-
Effects erence
Tungsten
hexachlo-
ride
Inhalation Rats 43 - 140 
mg/cu m
Lacrimation, profuse 
blood-stained oral 
and nasal discharges; 
death
41
Tungsten
carbide:
cobalt
75:25
I t Guinea
pigs
8,800 - 10,600 Lung inflammation, 
particles/cu m dilation of alveo- 
x 20 d, then lar-wall capillaries, 
2,900 particles/ infiltration by 
eu m x 15 d lymphocytes and plasma 
cells
37
Tungsten
carbide:
cobalt
10:1
Intratracheal t l 50 mg/dose 
1 dose/wk 
x 3 wk
Pneumonitic areas in 
lungs, lymphocytic 
infiltration of peri­
vascular areas, 
bronchial crypts
37
Tungsten
carbide:
cobalt
94:6
t l I f 50 mg/dose 
1 dose/wk 
x 3 wk
Hyperemia and bron­
chial catarrah, minor 
interstitial pneumo­
nitis , lymphoid 
hyperplasia, 
trapped dust masses in 
lungs, pleural fibro- 
cellular granulomata
34
Tungsten
dust
I f f t 50 mg/dose 
1 dose/wk 
x 3 wk
Interstitial pneumo­
nitis and bronchi­
olitis
36
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EFFECTS ON ANIMALS OF ORAL DOSES OF TUNGSTEN-CONTAINING SUBSTANCES
TABLE III-3
Route of 
Composition Exposure Species
Exposure
Concentration
Duration Effects
Ref­
erence
Powdered
tungsten
Oral Rats 10% in diet Weight loss in females 
15.4%; no effects in 
males
44
Sodium
tungstate
! 1 Guinea
pigs
2,000 mg/kg LD50 50
11 II 11 1,152 mg/kg II 50
II ! ! 11 500 mg/kg LD0 50
ir 11 Mice 240 mg/kg LD50; arched backs, 
decreased muscle tone, 
slight paralysis of 
hindlegs
50
ft II Rats 2,000 mg/kg LD100 50
?! 1? 1? 1,190 mg/kg LD50 50
?! II II 700 mg/kg LD0 50
! 1 ?! 11 2%
in diet for 
70 d
Death of 100% 48
! 1 f? II 0.5% 
in diet for 
70 d
Death of 80% 48
1! 11 Rabbits 1,500 mg/kg LD100 50
I! 11 II 875 mg/kg LD50 50
?r II II 500 mg/kg LD0 50
r? 1! Guinea
pigs
0.50 - 
0.75 g/
600 g
Anorexia, colic, 
uncoordinated move­
ments, trembling,
45
dyspnea; death at 16- 
23 hr
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TABLE III-3 (CONTINUED)
EFFECTS ON ANIMALS OF ORAL DOSES OF TUNGSTEN-CONTAINING SUBSTANCES
Route of 
Composition Exposure Species
Exposure
Concentration
Duration Effects
Ref­
erence
Sodium
tungstate
Oral Guinea
pigs
0.55 g/kg Single lethal dose 45
Sodium
phospho-
tungstate
I Mice 700 mg/kg LD50; arched backs, 
decreased muscle tone 
slight paralysis of 
hindlegs
50
9
Tungstic
oxide
II I 840 mg/kg 1 50
M It Rats 0.5% 
in diet for 
70 d
LD50 48
Ammonium-
p-tung-
state
It II 2%
in diet for 
70 d
Death of 80% 48
11 II II 0.5% 
in diet for 
70 d
No deaths
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IV. ENVIRONMENTAL DATA AND ENGINEERING CONTROLS
Environmental Concentrations
Most of the environmental data available on tungsten and its 
compounds are derived from cemented tungsten carbide (hard-metal) 
industries (Table IV-1) [29,55-60]. Depending on the stage and type of the 
process, the proportions of tungsten, cobalt, and other components in the 
airborne dusts vary considerably [59] . The initial stages of processing 
the ore involve exposure to primary ore dusts, namely those of scheelite 
and wolframite. In the course of production and use of tungsten, 
aerosols of sodium tungstate (Na2W04.2H20), ammonium-p-tungstate 
[5(NH4)20.12W03.11H20], tungstic oxide (W03), tungsten pentoxide (W205), 
tungsten dioxide (W02), metallic tungsten (W), tungsten carbide (WC), and 
their mixtures may be generated. In the stages following the preparation 
of tungsten or tungsten carbide, exposures may occur also to aerosols of 
such binder metals as cobalt and nickel and to other commonly added metals 
and their derivatives (Figure XII-1).
Except for the studies by Lichtenstein et al [29], Fairhall et al 
[56], and McDermott [60], very little information is available on the 
environmental concentrations of tungsten, cobalt, or total dust in the 
cemented tungsten carbide industry in the United States. Because of 
differences in work practices and engineering controls, it is not possible 
to extrapolate directly from the observations of foreign investigators on 
environmental concentrations in industry to occupational exposures in the 
United States. However, the basic steps in manufacturing cemented tungsten 
carbide are quite similar throughout the world, so that a review of foreign
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reports would provide a valuable comparative assessment of potential 
exposure sites in the industry. A number of factors might contribute to 
the observed variations in the environmental concentrations of tungsten, 
cobalt, or total dust among the various studies. Values might be affected 
by the sampling zone selected, ie, breathing or general atmosphere, and by 
the sampling and analytical methods. In addition, Fairhall et al [56] 
suggested that individual plant structure, ventilation, layout of machines 
and processes, and the segregation of the dustiest operations from the 
others were factors influencing the environmental concentrations and 
operator exposures.
Fairhall et al [56] determined the average dust and cobalt content of 
air in powder processing and tool and die operations in three cemented 
tungsten carbide plants (Table IV-1). The total dust concentrations in the 
general atmosphere were 20% and 50% lower than the operators' exposures in 
the powder processing and tool and die operations, respectively. The 
cobalt concentrations in the powder processing and tool and die operations 
were, respectively, 10% and 5% of the total dust concentrations. The 
authors emphasized that the total dust values are given as averages and 
that there are operations, such as calcination of cobalt nitrate, which 
produced total dust concentrations as high as 123 mg/cu m with cobalt 
concentrations as high as 79 mg/cu m. Operations such as screening 
powders, weighing and milling, and cleaning the mills were also reported to 
produce excessive exposures to dust and cobalt. Powder processing was the 
dustiest operation surveyed. Fairhall and his colleagues also noted the 
presence of cobalt in all areas of the plants, including those where no 
manufacturing was done, a significant finding.
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To determine typical dust exposures, McDermott [60] studied the 
atmospheric cobalt levels of various operations in seven cemented tungsten 
carbide plants. The cobalt concentrations in the 173 samples ranged from 
undetected to 0.8 mg/cu m. Basing his conclusions on the present United 
States Federal occupational environmental limit for cobalt (0.1 mg/cu m), 
he found that 70% of the samples represented acceptable working conditions.
Lichtenstein et al [29] reported the airborne tungsten and cobalt 
concentrations in operations involving wet-grinding of tool bits and 
inserts made of two commercial grades of cemented tungsten carbide: one
contained 72% tungsten carbide, 8% titanium carbide, 11.5% tantalum 
carbide, and 8.5% cobalt; the other contained 94% tungsten carbide and 6% 
cobalt. About 70% of the tool-grinding activity involved the latter grade. 
Approximately 75% of the tool-work involved regrinding old carbide tips, 
and 25% involved grinding new carbide tips. The air was sampled with 
filters in the workers' breathing zones, and the filters were analyzed for 
tungsten and cobalt by atomic absorption spectrometry. The concentrations 
of tungsten ranged between 0.2 and 12.8 mg/cu m, while those of cobalt were 
0.04-0.93 mg/cu m. Mean concentrations were 5.16 mg/cu m for tungsten and 
0.28 mg/cu m for cobalt. Of the 25 samples taken, 40% exceeded 5 mg/cu m 
for tungsten and 60% exceeded 0.1 mg/cu m for cobalt. Since such airborne 
levels of tungsten and cobalt could not be effectively controlled by an 
existing exhaust ventilation system, Lichtenstein et al designed an 
improved exhaust ventilation system which is described in the Engineering 
Controls section. A follow-up study done after the installation of the 
improved system reportedly showed cobalt concentrations well below the 
detection limit of an atomic absorption spectrophotometer and TWA exposures
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one order of magnitude below the TLV for cobalt.
Reber and Burckhardt [57] evaluated the potential exposures of 
workers to airborne total dust, tungsten, and cobalt in operations such as 
mixing, die casting, forming, and grinding of sintered pieces in five Swiss 
hard-metal plants. The results showed that the cobalt limit of 0.5 mg/cu m 
was exceeded by 13% of the measurements in the mixing division and by 25% 
of the values in the forming area. However, cobalt concentrations in the 
die casting division never reached the limit. In comparison, the limit of 
6 mg/cu m for tungsten was rarely exceeded in these operations. The 
authors attributed the high dust and cobalt concentrations in mixing and 
forming divisions to the machining of unfinished pieces with large 
diameters, a process which generates sufficiently large amounts of the 
dusts to exceed the capacity of the exhausts. In the grinding of sintered 
pieces, Reber and Burckhardt found that dry grinding produced high total 
dust and cobalt concentrations, and they suggested that wet grinding gave 
concentrations far below the appropriate limits.
Salikhodzhaev and Vengerskaya [59] examined the airborne 
concentrations of total dust, tungsten, and cobalt generated in various 
processing stages of hard-metal production in the USSR. During the powder 
processing stage, the dust levels were between 10 and 693 mg/cu m with 
averages of 3-130 mg/cu m for various operations. The dust levels were 
between 3.3 and 153 mg/cu m (averages 5.5-48 mg/cu m for various 
operations) during casting and between 3.3 and 32.5 mg/cu m (average 13 
mg/cu m) during forming operations. Thus it appears that high levels of 
dust are generated during all stages of processing, although powder 
processing generated the highest levels. However, in all of the
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operations, the average tungsten concentrations were well below the limit 
for tungsten. In the powder processing operation, the 0.5 mg/cu m limit 
for cobalt was exceeded. The authors did not explain why the tungsten 
concentrations were well below the limit when the dust levels were quite 
high in many of these operations.
In general, dust concentrations generated in hard-metal production 
were higher during the powder processing and forming stages than during 
either die casting or grinding of sintered products. The dust levels 
presented in Table IV-1 indicate that the highest exposures might occur in 
the powder processing and forming operations.
Engineering Controls
To decrease the concentration of tungsten to the recommended limit or 
below it, engineering controls must be instituted where the airborne 
concentrations of tungsten exceed the TWA concentration limits. Industrial 
experience indicates that closed-system operations are commonly used in 
manufacturing processes. Such systems must be used whenever feasible to 
control tungsten and its compounds wherever they are manufactured, 
processed, packaged, or used. Closed systems should operate under negative 
pressure whenever possible so that, if leaks develop, the flow of air will 
be inward. Closed-system operations are effective only when the integrity 
of the system is maintained. The system should be inspected frequently and 
leaks should be repaired promptly.
A ventilation system may be required if a closed system proves to be 
impractical, and is desirable as a standby if the closed system should
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TABLE IV—1
C O N D IT IO N S  OF T U N G S T E N -C O B A L T  EXPOSURES  
IN TH E H A R D -M E T A L  IN D U S T R Y
Total Dust
Concentration Tungsten Cobalt Sample
Type of Operation (mg/cu m) (mg/cu m) (mg/cu m) Type* Location Reference
Powder processing 14.9 7.7 0.95 G Austria 55
(Stages from
Ammonium paratungstate 
to tungsten carbide are 
shown on Figure X II-1 )
10. -  14
2.0 -  3.3  
0.3 -  9.8 1.8 -  8.24
1.05
0.12
0
-  1.67 
- 0 .2 2  
- 0 .5 5
B
G
B
United States
n
Switzerland
56
56
57
1.1 -  32.0
3.1 -1 3 0 .3
0.88 -  25.6  
2.2 -  3.5
0.09
1.8
-2 .7 2  
-  2.0
n
G
Sweden
USSR
58
59
- - 0.01 - 0 . 8 B United States 60
- - 0 -0 .1 4 G " 60
Tool and die operations 1.0 -  5.0 _ 0.05 -0 .2 3 B •• 56
0.5 -  2.2 - 0.01 -0 .0 7 G " 56
Casting 0.22 -  7.5 0.52 -  4 .56 0 -0 .4 1 B Switzerland 57
15 12 0.21 " Sweden 58
0.7 -  3.0 0.6 -  2.6 0.04 -0 .1 9 G 58
5.5 -  47.7 1.4 -  2.1 6.8 " USSR 59
21.5 17.6 1.14 " Austria 55
- - 0 -0 .0 8 B United States 60
Forming 0.5 -  24.6 0.97 -  26.7 0.03 -  1.75 Switzerland 57
0.1 -  7.5 0 .0 8 -  5.9 0.008 - 0 .5 6 1« Sweden 58
0.2 -  0.7 0 .1 7 -  0.58 0.01 -0 .0 4 G tt 58
3.3 - 3 2 .5 - -
n USSR 59
11.1 8.8 1.12 B Austria 55
- - 0.001 - 0 .8 H United States 60
- - 0.01 -0 .1 5 G " 60
Grinding of sintered
pieces
Dry grinding without exhaust 6.6 -  44 - 0.04 -  2.44 B Switzerland 57
Wet grinding without exhaust - 0.2 -  12.8 0.04 - 0 .9 3 n United States 29
B = breathing zone; G = general air
fail. The principles set forth in Industrial Ventilation— A Manual of 
Recommended Practice [61] published by the American Conference of 
Governmental Industrial Hygienists, Fundamentals Governing the Design and 
Operation of Local Exhaust Systems, ANSI Z9.2-1971 [62], published by the 
American National Standards Institute, and NIOSH's Recommended Industrial 
Ventilation Guidelines [63] should be applied to control workplace 
atmospheric concentrations of tungsten. These principles and guidelines 
have been used to control the concentrations of aerosols in the cemented 
tungsten carbide industry [29,57,60]. Because large accumulations of fine 
dust in dust collectors may pose a fire hazard, such systems should be 
located away from the other structures and areas where employees may be 
exposed. Internal sprinkler systems with fusible-link activation should 
also be considered.
From the data collected during a survey of five Swiss cemented 
tungsten carbide plants, Reber and Burckhardt [57] found that wet-grinding 
of sintered pieces produced cobalt concentrations far below the recommended 
limit of 0.5 mg/cu m. Although no exhaust was required for automatic 
machinery, grinding machines with manual adjustment reportedly required an 
efficient localized exhaust system. The authors concluded that individual 
exhaust pipes, with suction systems similar to vacuum cleaners which are 
attached directly to the lathe or grinding machine, are best for dust 
removal. They also recommended daily clean-up of the system to ensure its 
continuing efficiency. Reber and Burckhardt noted that the use of an 
exhaust ventilation system in an operation liberating total dust 
concentrations of 6 mg/cu m (of which 10% was cobalt) reduced the dust 
levels to 0.3-0.6 mg/cu m. They also mentioned that too small exhaust pipe
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inlets, improper adjustment of exhaust pipe inlets, cut grinding, and 
machining of large pieces contributed to the buildup of high dust 
concentrations. Although Salikhodzhaerv and Vengerskaya [59] gave no 
details of the ventilation system, they stated that, in the work places 
equipped with a local dust extraction system, the dust concentration was 
reduced from 153 mg/cu m to 28 mg/cu m and the tungsten level decreased 
from 3 to 0.3 mg/cu m. They recommended mechanization of the processes, 
hermetic sealing of the sifting devices, and use of local dust extraction 
systems as measures to control dust concentrations.
Lichtenstein et al [29] successfully used a local exhaust ventilation 
system to control worker exposures to tungsten and cobalt during wet - 
grinding. Well-fitted hoods, equipped with sliding doors controlling the 
designed air quantity of 400 cu ft/min, were installed around tool grinding 
wheels. Each hood was connected to a bench plenum by short flexible 
ducting with a smooth-walled interior, and each outlet was provided with an 
individual blast gate. All branch plena were connected to a main plenum. 
The measured air transport velocities of both the main and branch plena 
exceeded 4,500 ft/min. To allow for the draining of the coolant used in 
grinding and to reclaim the diamond dust from grinding wheel breakdown, 
swing check valves were provided in the plena. The plena also had 
provisions for cleanout. The authors recommended that regular maintenance 
and cleaning schedules be adopted for the exhaust system to prevent its 
degradation.
McDermott [60] recommended an efficient low-volume-high-velocity 
ventilation system (Figure XII-2) to reduce worker exposures to total dust 
and cobalt in the cemented tungsten carbide industry. In this system, the
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exhaust fittings, because of their small duct size, are mounted near the 
dust source. According to McDermott, the system has significant 
advantages: an improved recovery rate for valuable material which would
reduce the additional cost of such equipment; and, in climates where
compensating makeup air must be tempered, a smaller volume of makeup air
units to control specific operations, thus resulting in greater
conservation of energy. The latter advantage may take on added importance, 
since many jurisdictions do not permit recirculation of toxic dusts.
Ventilation systems of this type will require regular inspection and 
maintenance to ensure effective operation. A program of scheduled 
inspection should be established in which the ventilation systems are 
checked routinely. These routine checks should include face velocity 
measurements of the collecting hood, inspection of the air mover and 
collector, and measurements of workroom airborne concentrations. Any 
changes which may affect the ventilation system or the operations being 
ventilated must be assessed promptly to ensure that engineering controls 
continue to provide adequate protection of employees.
Sampling and Analysis
In general, two types of sampling methods, electrostatic 
precipitation and filtration, have been reported for collecting dusts in 
industrial atmospheres that contained tungsten and its compounds. 
Electrostatic precipitators have been used to collect general room dust 
samples and samples taken near the breathing areas of employees [16,56,60]. 
Total air volumes of 45-180 cu ft were sampled within 15-60 minutes (85 
liters/min) [60]. Although some tasks would allow positioning of the
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sampler in the general breathing area of an employee, electrostatic 
precipators are generally used for area monitoring.
Filter sampling, using glass fiber [64], paper [54,58], and membrane 
filters [10,29], has been applied to the collection of area air samples and 
to personal monitoring. In one study [54], an average of 3 cu m of air/hr 
(50 liters/min) was drawn through 9-cm filter papers, except in areas where 
dust concentrations were low, where flowrates up to 6 cu m of air/hr (100 
liters/min) were used. In another study, Lundgren and Ohman [58] collected 
general air samples and samples close to the breathing areas of employees 
for several hours through filter paper at a flowrate of 25 liters/min. The 
specific sampling time and collection efficiency data were not provided. 
However, these high flowrates are not suitable for personal monitoring.
Measurements of general airborne dust concentrations only indicate 
possible employee exposure. The concentrations of tungsten dust close to a 
machine or process may be quite different from that in the breathing zone 
of an employee. Therefore, collection of breathing zone samples is 
essential if one is to determine employee exposure. A breathing zone 
sampling device should be small enough to be conveniently attached to an 
employee's clothing without interfering with that person's normal 
activities and should ideally contain no fragile glassware or liquids. 
Membrane filter collection of dust using a battery-operated personal 
sampling pump satisfies these conditions.
Personal sampling has been performed using membrane filters at 
flowrates of 2-2.5 liters/minute for 2-6 hours [11]. Lichtenstein et al 
[29] reported using Millipore Type AA membrane filters at a flowrate of 4.3 
liters/minute to sample the general room air and at a flowrate of 2.5
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liters/minute for 2-4 hours to obtain breathing zone samples.
Airborne tungsten present in work areas is predominantly in the form 
of highly dispersed aerosols of negligible volatility. For the collection 
of these aerosols, personal monitoring by the membrane filter method 
(described in NIOSH Method No. P & CAM 173 [65]) is recommended. This
method for the collection of aerosols containing tungsten and its compounds 
consists of drawing a known volume of air through a membrane filter as 
described in Appendix I. Although this sampling method has not been 
evaluated by NIOSH for this specific application, it is recommended for 
metals in general.
The analytical chemistry of tungsten has been reviewed, including 
detailed discussions on the precipitation, gravimetric, colorimetric, 
polarographic, amperometric, emission spectroscopic, atomic absorption, X- 
ray fluorescence, and neutron activation methods [66,67]. Of the methods 
available for determining tungsten, colorimetric [68-70], emission 
spectrographic [71], atomic absorption [10,29], neutron activation [72-77], 
and X-ray fluorescence [78] analyses have been used to determine its 
concentrations in air. Most of these methods were applied to multi- 
elemental analysis with no special modification for tungsten determination.
The colorimetric method is based on the principle that, in 
hydrochloric acid or in a sulfuric/hydrochloric acid solution, tungsten(VI) 
forms a yellow complex with thiocyanate in the presence of a reducing agent 
such as stannous or titanous chloride. The complex contains tungsten(V) 
and has a maximum absorption at about 400 nm [66]. Salyamon and 
Krashenitsyna [68] studied the usefulness of two thiocyanate methods, using 
either titanium trichloride or stannous chloride as a reducing agent, to
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analyze tungsten and Its compounds in air. In the method which used 
titanium trichloride, the color was stable for 4 hours with a minimum 
detection limit of 0.5 jug. The color developed by stannous chloride
reduction was stable for only 1.5 hours with a minimum detection limit of 
0.1 Mg-
Urusova [70] reported that when stannous chloride was used, although 
most of the tungsten was converted to the colored complex after 1 hour, the 
intensity of the color continued to increase even after 2 hours. However, 
when titanium(III) was used as the reducing agent, the color developed more 
rapidly and stabilized sooner. Urusova stated that the sensitivity of the 
method was 5 jug of tungsten in the colorimetric volume. Peregud and Gernet 
[69] reported the sensitivity of the method to be 0.1 mg/cu m, using 
stannous chloride as the reducing agent, and they found no interferences in 
the method from titanium, cobalt, iron, vanadium, molybdenum, manganese, 
chromium, and thorium. Fogg et al [79] concluded from a review of
literature that vanadium, iron, and molybdenum interfered with the method. 
Sample preparation for the method generally involved ashing the filter
containing the sample in a muffle furnace at 500-600 C until tungstic oxide 
was formed [68,69]. Urusova [70] believed that, in samples containing
mixtures of cobalt, titanium, and tungsten, protective coatings might be 
formed when they were ashed. Hence, the author recommended that, for a 
complete decomposition of such samples, concentrated sulfuric acid and
ammonium sulfate be used.
Seeley and Skogerboe [71] described the use of an emission 
spectrographic method to determine atmospheric concentrations of several 
elements, including tungsten. Porous cup graphite spectrographic
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electrodes were used as filters for atmospheric particles, collected at 1 
liter/minute for 30 minutes, to determine concentrations of less than 0.1 
jug/cu m. The samples were analyzed directly by a spectrograph (with an 
absolute detection limit of 5 ng) at 400.8 nm for tungsten and with a 
precision and an accuracy of 10-20% of the amount present. The authors 
found that, for the spectrographic determination, vaporization of 
refractory elements such as tungsten was not completely effective because 
the bottom of the electrode did not reach a sufficiently high temperature. 
This problem was corrected by forming metal chlorides with the vapor of 
hydrochloric acid in the sample chamber.
A nondestructive neutron activation analytical procedure for the 
determination of 33 elements, including tungsten, in air polluting 
particles was reported by Dams et al [73] and Linch et al [76] . Aerosols 
were sampled by using a polystyrene filter with a flowrate of 12 
liters/minute/sq cm. The samples were irradiated for 5 minutes at a flux 
of 2 x 10*12 neutrons/sq cm/second (* means "to the power of") and counted 
in a Ge(Li) detector. Tungsten in the irradiated samples was measured at 
photopeaks of 479.3 and 685.7 Kev as 187W having a half-life of 24 hours. 
The detection limit for tungsten was 0.005 jug, and the minimum 
concentration detected in a 24-hour urban air sample was 0.0005 /ug/cu m. 
These reports [73,76] indicated that the standard deviations of the 
analysis were greater than 40% when the elements were in concentrations 
near the limit of detection. However, the authors did not report specific 
deviations for tungsten analysis.
Peirson and associates [77] similarly analyzed atmospheric trace 
elements by neutron activation analysis and found that the concentrations
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of tungsten ranged from less than 0.1 to 0.3 ng/kg of air (0.12-0.36 
ng/cu m). There were no data on the sensitivity or precision of the method 
in determining tungsten. Pszenny and Russell [75] also determined 
environmental levels of various elements using neutron activation analysis. 
However, they ashed the filter paper containing the sample in a furnace at 
450 C before irradiating for 8 hours in a flux of 2 x 10*13 neutrons/sq 
cm/sec. The elements, including tungsten, were assayed by a high- 
resolution gamma-ray spectroscope using a Ge(Li) detector. The 
concentrations of airborne tungsten were between 19 and 25 ng/cu m with a 
standard deviation of greater than 50%. Because of the high resolution of 
the method, Mamuro and his colleagues [72] recognized the usefulness of 
neutron activation analysis in the determination of tungsten in airborne 
dust, yet they believed that it was not suited for routine evaluation of 
air contaminants.
Dzubay and Stevens [78] and Roberts [74] discussed the usefulness of 
X-ray fluorescence analysis for determining trace elements in aerosols. 
Although the authors stated that it was one of the most sensitive available 
methods, its application for determining tungsten was not discussed in 
either report. The method requires a homogeneous sample for better 
reproducibility and hence a special sampling device that separates the dust 
particles by size [11,78].
In general, neutron activation, emission spectrographic and X-ray 
fluorescence analyses are sensitive methods. However, no reports were 
found in which any of these methods were examined for their ability to 
determine tungsten in samples of air from industrial environments. In 
addition, the methods were used primarily for general analysis of trace
113
elements, so any interferences in determining tungsten alone, accuracy for 
tungsten, or details of specific sample preparation for tungsten were not 
discussed. Such information is required to assess the suitability of these 
methods for determining environmental concentrations of tungsten in 
industrial atmospheres.
Although a colorimetric method using thiocyanate was successfully 
used by Russian investigators [68-70] to determine tungsten in air, there 
are potential interferences in the method if the sample contains vanadium, 
iron, or molybdenum. Other variables, such as the type of reducing agent 
used in developing the colored complex and sample preparation, have 
substantial influence on the tungsten values and have not been adequately 
investigated. Thus, although the colorimetric method may be useful for 
determining tungsten at the recommended TWA concentration, interferences 
and lack of standardized procedures would make this method unacceptable 
unless improvements were made and procedures were standardized.
Of all the analytical methods discussed in the recent literature, 
atomic absorption stands out as the most acceptable, particularly because 
it is simple, rapid, sensitive, selective, and suited for use with 
generally available laboratory equipment and personnel. Lichtenstein et al 
[29] successfully analyzed hard-metal workplace breathing zone air samples 
by atomic absorption. The membrane filter containing tungsten carbide and 
cobalt was divided into two portions which were separately analyzed for 
tungsten and cobalt. For analyzing tungsten, the filter and sample were 
digested in aqua regia and brought up to 10-ml volume by adding deionized 
water. The solution was analyzed by atomic absorption spectrophotometry 
against known concentrations of each metal. The accuracy of the method was
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noted to be ±0.1 mg in the total sample. In the cemented tungsten carbide 
industry, the authors found that tungsten concentrations were 0.2-12.8 
mg/cu m.
In two other plants producing cemented tungsten carbide, atomic 
absorption was used to determine levels of airborne tungsten [11]. The 
levels of tungsten found in these plants were 2.6-36.3 mg/cu m and 0.13-1.3 
mg/cu m. The details of analysis were not available for one plant, but at 
the other the filter was dissolved in a suitable acid and tungsten was 
determined by using a reducing nitrous oxide-acetylene flame. Husler [80] 
recommended dissolution of the tungsten sample in a mixture of nitric and 
hydrofluoric acids as particularly advantageous since this reagent keeps 
tungstic oxide from precipitating out of solution. Edgar [81] showed that
tungsten samples contaminated with molybdenum, chromium, manganese,
vanadium, and nickel gave 50-60% higher absorbance readings and that the 
addition of 2% of sodium sulfate eliminated such interference and enhanced 
the sensitivity of tungsten absorbance. In most of these studies, the fuel 
was acetylene and the oxidant was nitrous oxide.
Since analysis by atomic absorption is generally available to 
industry, possesses the required precision and sensitivity, and has been 
successfully used by several companies in the cemented tungsten carbide 
industry to determine concentrations of airborne tungsten, the method
outlined in Appendix II is recommended for use in determining adherence to 
the recommended standard. The recommended procedure is based on Method No. 
P & CAM 173 of the NIOSH Manual of Analytical Methods [65] with suggested 
modifications derived from other appropriate literature [80-84]. The 
recommended procedure is a synthesis of the best available methods, but it
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has not been validated by NIOSH. The disadvantages of this method include 
its inability to determine tungstic oxide, an acid-insoluble compound, and 
to distinguish insoluble compounds from water soluble ones. Methods shown 
to be at least equivalent in precision and sensitivity to the recommended 
method may also be used.
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V. WORK PRACTICES
Most exposures to tungsten compounds in the occupational environment 
occur during the production of tungsten metal from the ore and in the 
preparation of tungsten carbide powders. Exposures to cemented tungsten 
carbide occur in the manufacturing and grinding of cemented tungsten 
carbide (hard-metal) parts [9]. Dusts and mists of tungsten and its 
compounds or cemented tungsten carbide are produced during crushing, 
mixing, ball milling, loading and unloading, sintering, and grinding 
operations. Because of the high melting points of tungsten compounds and 
of cobalt, exposure to their vapors or fumes is negligible. Exposures to 
sodium tungstate, a soluble compound, are limited and occur primarily 
during the first few stages of processing the ore (see Figure XII-1). 
Although NIOSH is aware that exposures also occur during filament 
manufacture and that processes such as high-voltage smelting and wire­
drawing pose specific safety problems, it is not possible to elaborate on 
control measures for these operations because of lack of access to this 
portion of the industry.
To control the exposure of employees to tungsten compounds and 
cemented tungsten carbide in these industries, engineering controls and 
work practices should be designed and applied to minimize or prevent 
inhalation or ingestion of, or skin contact with, the aerosols.
Properly designed and maintained ventilation systems will minimize 
dispersal of tungsten compounds and cemented tungsten carbide in the work 
atmosphere, not only controlling exposure to the airborne compounds but 
also reducing their accumulation on surfaces. These systems will minimize
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maintenance problems and the chance of redispersal during cleanup. 
Ventilation practices and principles to control workplace air 
concentrations of tungsten should be based on those set forth in the ACGIH 
manual Industrial Ventilation: A Manual of Recommended Practice [61],
Fundamentals Governing the Design and Operation of Local Exhaust Systems
(ANSI Z9.2-1971) [62], and NIOSH's Recommended Industrial Ventilation
Guidelines [63]. Exhaust air should be adequately cleaned before it is 
discharged outside the plant to ensure that it meets applicable federal, 
state, and local air standards. The airflow, static pressure, and leakage 
of the ventilation system should be monitored frequently by trained
personnel to ensure proper functioning of the system. A logbook showing 
the airflow design and the results of periodic ventilation monitoring
measurements should be maintained. In areas where crushing, mixing, ball 
milling, loading and unloading, sintering, and grinding operations are 
performed, local exhaust ventilation should be located as close to the
operation as feasible and in accordance with good industrial hygiene
engineering practices [61-63], Alternate means of control for certain 
processes may include the reduction in density of production equipment and 
a decrease in equipment speed. Mechanization and enclosure of processes 
offer additional engineering controls which may be effectively used under 
some circumstances [11].
In addition to using sound engineering controls, employers should 
institute a program of work practices which emphasizes good sanitation and
personal hygiene. These practices are important in preventing skin and
respiratory irritation caused by tungsten compounds or cemented tungsten 
carbide. Skin irritation has not been found to be a problem with insoluble
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tungsten compounds in the occupational environment, but the dermatologic 
problems observed in cemented tungsten carbide workers were attributed in 
part to the abrasiveness of the powder. In experimental animals, tungsten 
hexachloride, a soluble tungsten compound, caused necrosis of the skin and 
membranes [41]. Workers handling soluble tungsten compounds or cemented 
tungsten carbide must thoroughly wash their hands and face before drinking, 
eating, or smoking. Employees must not store and use food, beverages, 
tobacco, or other materials that may be placed in the mouth, in these 
exposure areas. Rest areas, eating facilities, and smoking areas should be 
physically separated from these work areas. In addition, workers should be 
advised to shower or bathe after the workday. If skin irritation is 
observed, the employee should be referred to a physician for appropriate 
protective measures.
Respirators should not be used as a substitute for proper engineering 
controls in normal operations. However, during emergencies and during 
nonroutine repair and maintenance activities, exposures to airborne dusts 
or mists of tungsten compounds or cemented tungsten carbide might not be 
reduced either by engineering controls or by administrative measures to the 
levels specified in Chapter I, Section 1(a). If this occurs, then 
respiratory protection may be used only: during the time necessary to
install or test the required engineering controls; for operations such as 
maintenance and repair activities causing brief exposure at concentrations 
above the TWA concentration limits; and during emergencies when airborne 
concentrations may exceed the TWA concentration limits. Respirators 
conforming to the Respirator Selection Guides in Tables 1-1, 1-2, and 1-3 
should be provided to employees, and a respiratory protective program
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meeting the requirements of 29 CFR 1910.134 should be established. The 
Respiratory Protective Devices Manual [85] should be consulted for further 
information on respirators. Emphasis should be placed on providing clean, 
well-maintained, well-fitted respirators for use in unusual circumstances 
and emergencies. Contamination of the interior of the facepiece should be 
guarded against.
Eye irritation has rarely been a problem for employees involved in 
handling tungsten compounds or cemented tungsten carbide [15], but 
operations, such as grinding, which produce and scatter fine particles into 
the air, require eye protection in accordance with 29 CFR 1910.133. Both 
individual sensitivity to cobalt and the abrasiveness of powdered metals 
may contribute to skin irritation [14,24]. Gloves or other protective 
clothing may be helpful, but employees experiencing skin irritation should 
be referred to a physician to ensure effectiveness of the protective 
measures.
Spills of tungsten compounds or cemented tungsten carbide should be 
promptly cleaned up to minimize inhalation or contact. Liquid material 
spills should be copiously flushed with water and channeled to a treatment 
system or a holding tank for reclamation or proper disposal. Spills of dry 
material should be removed by vacuuming, wet mopping, or hosing, first with 
a mist of water that dampens the spilled material and then with a more 
forceful stream that flushes it into a holding tank or other facility for 
handling contaminated water. No dry sweeping or blowing should be 
permitted. All waste material generated in the handling of tungsten 
compounds or cemented tungsten carbide should be disposed of in compliance 
with local, state, and federal regulations.
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Most tungsten compounds pose no fire or explosive hazards. However, 
powders of submicron-size tungsten metal or tungsten-aluminum-titanium 
alloys, tungsten metal powders of less than 100 mesh, and ferrotungsten 
powders of less than 200 mesh are classified as actively combustible [86] 
and should be handled with caution. Lamprey and Ripley [87] reported that 
tungsten powder of submicron size which came in contact with hot chlorine 
gas in a large glass receiver reacted violently and shattered the 
equipment. These materials should be stored in tight drums under argon or 
helium gases. The drums should never be vented in air. Great care must 
also be exercised in handling hexamethyl tungsten, since it is potentially 
explosive [88,89]. Similarly, tungsten carbonyls were reported to be 
moderate fire hazards when exposed to flame [90].
Warning labels indicating the potential fire or explosion hazards, 
skin and respiratory effects, and ventilation requirements should be placed 
on containers used to transport tungsten compounds or cemented tungsten, 
carbide. In all industries where soluble tungsten compounds or cemented 
tungsten carbide are handled, written instructions informing employees of 
the particular hazards of these materials, the methods of handling, 
procedures for cleaning up spilled material, and the use of personal 
protective equipment must be on file and available to employees. Employers 
may use the Material Safety Data Sheet in Appendix III as a guide in 
providing the necessary information.
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VI. DEVELOPMENT OF STANDARD
Basis for Previous Standards
In 1967, the Threshold Limits Committee of the American Conference of 
Governmental Industrial Hygienists proposed a threshold limit value (TLV) 
of 5 mg of tungsten/cu ffl for tungsten and its insoluble compounds and a TLV 
of 1 mg of tungsten/cu m for soluble tungsten compounds [91]. These 
proposed limits were adopted by the ACGIH in 1969 [92]. The 1971
Documentation of the Threshold Limit Values for Substances in Workroom Air 
[93] cites a number of reports which were used to support the need for 
separate limits for soluble and insoluble tungsten compounds. Karantassis 
[45] found that the toxic single doses of sodium tungstate, administered 
intragastrically and subcutaneously to guinea pigs, were 0.55 and 0.45 g of 
tungsten/kg, respectively. These guinea pigs suffered from anorexia, 
colic, incoordination of movement, trembling, dyspnea, and weight loss 
before a delayed death. Kinard and Van de Erve [47] reported the LD50 of 
subcutaneously injected sodium tungstate for rats to be 0.14-0.16 g/kg and 
ascribed death to generalized cellular asphyxiation. Kinard and Van de 
Erve [48] suggested that, when administered orally to rats, sodium 
tungstate was more toxic than the insoluble compounds, tungsten trioxide 
and ammonium-p-tungstate.
Emphasizing the relatively low toxicity of the insoluble compounds, 
the documentation [93] also cited the studies of the following 
investigators to support separate standards for soluble and insoluble 
tungsten compounds: Kinard and Van de Erve [44] stated that female
weanling rats fed a diet containing 2-10% of tungsten metal powder gained
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15.4% less weight than did either female controls or male weanling rats on 
a tungsten-free diet. Frederick and Bradley [94] found that the LD50 of 
tungsten metal powder injected intraperitoneally in rats was 5 g/kg and 
that it did not produce a distinct fibrosis. Delahant [35] administered 
150 mg of tungsten metal powder or tungsten carbide intratracheally to
guinea pigs in three weekly doses and concluded that it did not irritate
lung tissue. Schepers [36] examined the lungs of these guinea pigs
microscopically and found that tungsten metal caused moderate interstitial 
cellular proliferation. He concluded that tungsten metal dust was 
relatively inert and that exposures of human beings to it would be
relatively safe, though not wholly free from risk. Harding [95] reported
no "unexpected" effects of intratracheal injections of tungsten metal and 
tungsten carbide powders on guinea pig lungs. Mezentseva [28] showed that, 
while rats given tungsten intratracheally had a proliferation of the intra- 
alveolar septa, those exposed by inhalation to dusts of tungsten, tungsten
dioxide, and tungsten carbide had only minor changes in the lungs.
In 1976, the ACG1H also recommended short term exposure limits 
(STEL's) of 10 mg and 3 mg of tungsten/cu m of air for insoluble and
soluble compounds, respectively [96], The STEL was defined by the ACGIH as 
a maximum allowable concentration, or absolute ceiling, not to be exceeded 
at any time during a 15-minute excursion period.
The 1975 USSR maximum workplace concentrations were 6 mg/cu m for 
tungsten, tungsten carbide, and tungsten silicide, and 2 mg/cu m for 
tungsten carbonyl [97]. In 1970, the maximum allowable concentration (MAC) 
in Rumania for tungsten and tungsten carbide was 6 mg/cu m [98]. The 1973 
standard for tungsten, tungsten carbide, and tungsten oxide in the German
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Democratic Republic was an MAC of 6 mg/cu m with a 30-minute excursion 
limit of 12 mg/cu m [99] . No bases for these foreign standards have been 
found. Brakhnova [97] recommended standards for tungsten sulfide (6 
mg/cu m), tungsten selenide (2 mg/cu m), and tungsten telluride (0.01 
mg/cu m) , but they seem not to have been approved yet by the USSR State 
Sanitary Inspection Office.
There is currently no US Federal Standard for tungsten or its 
compounds.
Basis for the Recommended Standard
(a) Permissible Exposure Limits
Almost all reports of human exposure to tungsten and its compounds 
deal with the effects observed after exposure to mixtures of dusts 
encountered in the hard-metal (cemented tungsten carbide) industry. The 
components of hard metal include tungsten carbide, cobalt, and sometimes 
tantalum, titanium, niobium, chromium, nickel, iron, or derivatives of 
these metals. Only two studies [27,28] were found which described the 
effects of occupational exposure to tungsten and its compounds without 
concurrent exposure to other toxic metals.
In 1960, Mezentseva [28] reported that radiologic examination of 54 
workers engaged in the production of malleable tungsten or in the early 
process stages of hard-metal production, where dust exposure was limited to 
tungsten trioxide, metallic tungsten, and tungsten carbide, showed early 
signs of diffuse pulmonary fibrosis in 9%. Total dust levels measured 
ranged from 1.3 mg/cu m in the breathing zone of workers loading furnaces 
for malleable tungsten production to 83 mg/cu m during loading and
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unloading of mills in the production of hard metal. The diameters of 72- 
82% of the particles were less than 4 /xm.
Kaplun and Mezentseva [27] compared results of periodic medical 
examinations of 36 workers in contact only with tungsten and its compounds 
with those of 247 workers exposed to dusts of mixed compounds (cobalt and 
tungsten carbide) in hard-metal production. Radiologic signs of early 
diffuse pulmonary fibrosis were found in 11% of the first group, while 
almost 50% of the second group showed damage to the upper respiratory tract 
in addition to a 13% incidence of pulmonary fibrosis. Subjective symptoms, 
such as loss of appetite, nausea, coughing, and olfactory disorders, were 
also reported for the second group, along with abnormalities, such as 
hypotension and blood changes, which were not limited to the respiratory 
system. Total concentrations of dust measured in areas where only tungsten 
compounds were released were 8.6-106 mg/cu m. The total concentrations of 
the mixed dusts in other parts of the plants were 3-186 mg/cu m, with 
cobalt content contributing 0.3-1.75 mg/cu m.
Studies with animals disclosed the effects of single and multiple 
exposures to tungsten and its compounds by inhalation, intratracheal 
administration, and ingestion. The major effects of inhalation and 
intratracheal administration were limited to the respiratory system, while 
the effects of ingestion were not so clearly apparent on any organ of the 
body. Although no report was found on the dermal effects of tungsten and 
its compounds in humans, exposure of rats to aerosols of tungsten 
hexachloride reportedly [41] caused irritation of the skin and mucosa.
In the inhalation study conducted by Mezentseva [28], rats were 
exposed to tungsten carbide at a concentration of 600 mg/cu m (77% of the
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particles were less than 5 jum in diameter) for 1 hour/day for 5 months. 
Microscopic examination of the lungs showed proliferative reactions of the 
lymphoid histiocytic elements, particularly at sites of dust accumulation, 
and subsequent mild fibrosis. Thickening and homogeneity of the pulmonary 
walls were also noted. Mezentseva also reported that rats intratracheally 
exposed to a single 50-mg dose of metallic tungsten, tungsten carbide, or 
tungsten trioxide similarly showed no severe pulmonary changes upon 
microscopic examination. Totals of 150 mg of metallic tungsten dust or 
tungsten carbide dust introduced intratracheally in three equal doses at 
weekly intervals by Delahant [35] did not irritate the lungs of 
experimental animals. Miller et al [16] observed that 1 ml of a 10%
suspension of tungsten carbide administered intratracheally to rats 
produced no changes in the lungs other than those typical of an inert dust 
after 18 weeks. Schepers [34] stated that intratracheal administration of 
tungsten carbide and carbon (in a 94:6 ratio), in three equal weekly doses 
totaling 150 mg, caused acute hyperemia, bronchial inflammation, and minor 
residual changes in the lungs, such as the development of subpleural 
fibrocellular granulomata. These reports suggest that tungsten and its 
compounds, when encountered without concomitant cobalt exposure, have a 
distinct but less severe toxicity than tungsten-cobalt mixtures.
The effects of exposure to mixed tungsten-cobalt dusts, reported 
almost exclusively from the cemented tungsten carbide industry, also relate 
to the respiratory system, with some effects seen on the skin. A number of 
reports of such studies identified pulmonary involvement as the outstanding 
result of the exposures [15,18,25,100], The signs and symptoms included 
weight loss, exertional dyspnea, and cough which might progress to
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extrinsic asthma [23], diffuse interstitial pneumonitis [18], or fibrosis 
[17,20,22]. The type of pneumoconiosis seen in the cemented tungsten 
carbide industry is referred to as "hard-metal disease" [21,25,101].
Skog [24] reported skin changes, including contact eczema, pruritus, 
folliculitis, and neurodermatitis, that affected 34 (9.4%) of 361 workers 
involved in production of hard metal. Contact eczema was observed mainly 
on the eyelids and between the fingers. Of the workers with contact 
eczema, 3 of 14 patch tested were allergic to cobalt. Although cobalt 
sensitization was apparent, Skog concluded that most of the cases of 
contact eczema were caused by the primary irritant effect of the combined 
metal dust.
Similar dermatologic effects have not been reported from experiments 
on animals, but the effects of tungsten-cobalt mixtures on the respiratory 
system have been well documented. In animals injected intratracheally with 
suspensions of tungsten carbide and cobalt (in a 10:1 ratio), Schepers [37] 
noted a transient inflammatory response with residual fibrosis. The 
inhalation of tungsten carbide and cobalt in a 3:1 ratio produced acute 
inflammation, followed by focal pneumonitis with residual hyperplasia and 
metaplasia of the bronchial epithelium. The author emphasized that the 
unusual epithelial reaction was a unique feature of exposure to the 
tungsten carbide-cobalt mixture. Both Delahant [35] and Schepers [37] 
found that the intense irritant property of cobalt was dominant when cobalt 
was combined with tungsten carbide.
Since the use of tungsten in soluble form constitutes only 3% of the 
total usage of tungsten and its compounds [8], occupational exposures to 
soluble tungsten compounds are limited except in the early stages of
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production of tungsten from its ores. Occupational exposure effects from 
the soluble compounds of tungsten are virtually unknown. However, 
comparisons have been made of the toxicity of soluble and insoluble 
tungsten compounds when administered to experimental animals. Karantassis 
[45] found that the lethal single doses of sodium tungstate, administered 
intragastrically and subcutaneously to guinea pigs, were 0.55 and 0.45 g of 
tungsten/kg of body weight, respectively. Guinea pigs given the toxic dose 
had anorexia, colic, incoordination of movement, trembling, dyspnea, and 
loss of weight before a delayed death. Death was attributed to generalized 
cellular asphyxiation. Kinard and Van de Erve [47] found that the LD50 of 
subcutaneously injected sodium tungstate in rats was 0.14-0.16 g/kg. 
Kinard and Van de Erve [48] concluded that, when administered orally to 
rats, tungsten trioxide and ammonium-p-tungstate were less toxic than 
soluble sodium tungstate. Comparing the LD50 values of orally administered 
sodium tungstate, sodium phosphotungstate, and tungstic oxide (W03), 
Nadeenko [50] concluded that tungstic oxide was the least toxic of the 
three compounds. He suggested that the lower toxicity of W03 was caused by 
its lower solubility.
Insoluble tungsten, soluble tungsten, tungsten carbide-cobalt 
mixtures, and the much less common tungsten carbide-nickel mixtures 
constitute four different potential exposures with different types and 
degrees of hazard for employees. NIOSH, therefore, recommends separate 
environmental limits on the following bases:
(1) Dusts of insoluble tungsten compounds pose a hazard 
considered to be somewhat greater than that of nuisance dust. Generally 
accepted characteristics of lung-tissue reaction to nuisance aerosols are:
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the architecture of the air spaces remains intact; collagen (scar tissue) 
is not formed to a significant extent; and the tissue reaction is 
potentially reversible. The 9-11% incidence of pulmonary fibrosis in two 
studies [27,28] in which employees were exposed to tungsten without 
concomitant cobalt exposure indicates that the respirable fraction of 
insoluble tungsten compounds should be limited to below the respirable 
nuisance dust standard of 5 mg/cu m. Dust of insoluble tungsten compounds 
has been found to contain a high percentage of respirable particles 
(approximately 72-90% less than lOjum) [28,42,54]. In addition, collection 
of total dust is less difficult than size selective sampling. Therefore, 
NIOSH recommends that dust containing insoluble tungsten be limited to 5 
mg/cu m measured as tungsten, which allows both a margin of safety and ease 
of sampling.
(2) Soluble tungsten compounds are considered to be 
potentially more toxic than insoluble compounds, although the magnitude of 
the difference is not precisely known. Comparison of acute toxicity of 
tungstic oxide and sodium tungstate in mice (oral LD50's of 840 mg/kg and 
240 mg/kg, respectively) [50] gives a 3.5-fold difference. A calculated 
limit of 1.4 mg/cu m for soluble tungsten compounds is suggested when the 
ratio of the LD50's is applied to the recommended limit for insoluble 
compounds. In addition, the effects of insoluble tungsten compounds are 
confined to the respiratory system, while soluble sodium tungstate has been 
found to cause systemic effects involving the gastrointestinal tract and 
CNS in guinea pigs. [45]. NIOSH considers the broader range of toxic 
effects an indication of the need for a somewhat increased margin of safety 
beyond the 3.5-fold difference and therefore recommends a limit of 1
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mg/cu m for soluble tungsten compounds.
(3) The majority of industrial exposures to tungsten and 
its compounds occur along with exposure to cobalt, used in cemented 
tungsten carbide in percentages ranging from 3-25%. Whenever employees are 
involved in the manufacture, use, storage, or handling of cemented tungsten 
carbide containing more than 2% cobalt, such exposures shall be limited to 
the current US federal standard for cobalt. If a future NIOSH 
recommendation for an occupational exposure limit for cobalt differs from 
the US federal standard for cobalt, this new recommendation should be 
considered to replace the current recommendation for an occupational 
exposure limit for dusts of cemented tungsten carbide containing more than 
2% cobalt.
(4) Some cemented tungsten carbide is made with nickel or 
iron as the cementing substance. Iron dust constitutes no great hazard and 
can be controlled adequately by adherence to the occupational exposure 
limit for tungsten. Nickel presents a different sort of situation, 
however, because it seems to be able to induce pulmonary cancers. When 
nickel is used as a binder rather than cobalt and the nickel content of the 
mixture exceeds 0.3%, then the NIOSH recommended standard for nickel of 15 
pg/cu m should apply [1].
(b) Sampling and Analysis
Personal sampling with a membrane filter is recommended, since most 
of the compounds in the industrial environment exist as aerosols. Analysis 
by atomic absorption spectrophotometry has been successfully used in 
monitoring air for tungsten and cobalt at the necessary sensitivity ranges. 
The method is relatively simple, quick, and highly sensitive. It has few
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interferences, and they can be corrected. The method has not been tested 
by NIOSH, and it does distinguish insoluble from soluble tungsten 
compounds. In the absence of differential sampling and analysis, 
application of the environmental limits for insoluble or soluble tungsten 
compounds depends on knowledge of the processes within a building or 
independent structure. Plant observations [11] indicate that only 
insoluble compounds exist in some operations, and these will be adequately 
controlled by adherence to the recommended standard for insoluble tungsten 
compounds. However, when soluble compounds are final, intermediate, or 
starting products and sampling and analysis can be performed only for total 
tungsten, concern for worker health and safety dictates that the 
recommended standard for soluble tungsten compounds should apply throughout 
that building.
(c) Medical Surveillance and Recordkeeping
Preplacement medical screening is recommended to identify any 
preexisting pulmonary conditions that might make a worker more susceptible 
to exposures in the work environment. Periodic medical examinations will 
aid in early detection of any occupationally related illnesses which might 
otherwise go undetected because of either delayed toxic effects or subtle 
changes. Maintenance of medical records for a period of 30 years is 
recommended.
(d) Personal Protective Equipment and Clothing
Since much of the dust and mist generated in the tungsten industries 
falls within the range of particle sizes generally considered to include 
the respirable fraction, respiratory protective equipment may be used when 
necessary under the following conditions:
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(1) During the time necessary to install or test the 
required engineering controls.
(2) For operations, such as maintenance and repair 
activities, that cause brief exposure at concentrations above the TWA 
concentration limits.
(3) During emergencies when airborne concentrations may 
exceed the TWA concentration limits.
Eye protection is required for operations which produce and scatter 
fine particles into the air, such as grinding, in accordance with 29 CFR 
1910.133. Skin irritation may occur, especially in individuals sensitive 
to cobalt or to the abrasive action of hard-metal dust, even at 
environmental concentrations below the action level. Appropriate 
protective and therapeutic measures should be recommended by a physician. 
These may include fingerless gloves, protective sleeves, or creams.
(e) Informing Employees of Hazards
Employee awareness is important in an overall effort to reduce 
occupational injuries and illness. Therefore, employees should be informed 
through discussion and the Material Safety Data Sheet (see Appendix III) of 
the possible effects of exposure to tungsten compounds and to dust from 
cemented tungsten carbide and of the measures being taken to protect the 
workers against such exposures. In addition, labels and posters should be 
readily visible to employees.
(f) Work Practices
Exposures to tungsten and its compounds in occupational environments 
can best be prevented by engineering controls and good work practices. 
Since tungsten compounds and dusts from cemented tungsten carbide affect
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chiefly the respiratory system, measures are recommended that will reduce 
the atmospheric concentrations of tungsten in the work atmosphere. 
Adoption of these measures during normal operations will also minimize the
possibility of skin contact or accidental ingestion.
(g) Monitoring and Recordkeeping Requirements
It is recognized that many workers are exposed to tungsten compounds
or cemented tungsten carbide at concentrations considerably below the 
recommended TWA limits. Under these conditions, it should not be necessary 
to comply with many of the provisions of this recommended standard. 
However, concern for worker health requires that protective measures be 
instituted below the enforceable limits to ensure that exposures do not 
exceed the standards. For this reason, "Occupational exposure to tungsten 
and cemented tungsten carbide" has been defined as exposure above half the 
recommended TWAs, thereby delineating those work situations which do not 
require the expenditure of health resources for compliance with such 
provisions as performance of frequent environmental monitoring and 
associated recordkeeping. For cemented tungsten carbide products in which 
nickel is the binder, the NIOSH definition of occupational exposure to 
nickel shall apply [1].
To relate the employee's known occupational exposure to possible 
chronic sequelae which do not appear during the period of employment, 
records of environmental monitoring should be kept for the same 30-year 
period as the medical records.
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VII. RESEARCH NEEDS
Proper assessment of the toxicity of tungsten and evaluation of its 
potential hazard to the working population require further animal and human 
study. The following aspects of epidemiologic and toxicologic research are 
especially important.
(a) Epidemiologic Studies
Further research is desirable to assess the effects of long-term 
occupational exposure to tungsten. Therefore, detailed long-term 
epidemiologic studies, retrospective and prospective, of worker populations 
exposed at or below the recommended environmental limits should be 
conducted. Such studies should consider the pulmonary, dermal, ocular, and 
metabolic effects of tungsten and should distinguish exposures to tungsten 
and its compounds from mixed exposures to tungsten and to compounds of 
tungsten and cobalt, nickel, vanadium, chromium, or other metals and 
compounds of these metals. As a minimum, these studies should include 
environmental air measurements, medical histories, pulmonary function 
studies, histories of known or suspected acute exposures to tungsten, and 
comparisons with morbidity and mortality information for the general 
population.
(b) Acute and Chronic Animal Studies
No definitive acute or chronic inhalation studies have been found for 
many of the tungsten compounds currently in use. There is some indication 
of the skin and eye irritation potential of tungsten hexachloride and of 
tungstic acid, respectively [41,102], Hence, dermal and eye irritation 
studies should be undertaken to aid in evaluating the toxic effects of
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tungsten and its compounds with and without concurrent exposure to cobalt 
or other metals commonly used in the production of hard metal. Some 
studies are available which indicate the possible effects of tungsten and 
its compounds on the liver, kidneys, adrenals [38,46], and central nervous 
system [50]; however, these studies are not conclusive. Hence, additional 
studies are needed to assess the toxic effects of tungsten and its 
compounds, especially on the liver, kidneys, adrenals, lungs, and central 
nervous system of various species. Studies should use exposure schedules 
simulating occupational exposure and should involve routes of exposure 
which are likely to occur in occupational contact with tungsten (ie, 
inhalation, ingestion, and absorption through the skin). These results may 
then provide insight into probable effects of tungsten on human health. 
Similar studies should also be planned to determine the synergistic or 
potentiating effects of other metals and compounds commonly found where 
tungsten and/or its compounds is used.
In experimental animals, high doses of tungsten have been 
incorporated into such enzymes as xanthine oxidase and sulfite oxidase by 
competing with molybdenum and producing inactive proteins [49,103-106]. 
Since xanthine oxidase affects purine and pyrimidine metabolism, a study of 
its effect through alterations in nitrogen metabolism may reveal some new 
information about the toxicity of tungsten.
(c) Studies on Carcinogenicity, Mutagenicity, Teratogenicity, and 
Effects on Reproduction 
At present the available literature [25,26] does not supply the 
information necessary for an evaluation of the carcinogenic, mutagenic, or 
teratogenic potential of tungsten and its products. No studies were found
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which addressed effects of tungsten on reproduction. Hence, further 
research concerning these possible effects of tungsten should be conducted. 
These studies should include microbial tests and extensive long-term and 
multigeneration experiments to evaluate the synergistic and carcinogenic 
actions, if any, of tungsten carbide. Properly designed and performed 
experiments can furnish information on all three types of effects resulting 
from reactions with nucleic acids.
(& ) Sampling and Analysis
Investigations of sampling and analytical techniques are encouraged, 
especially those concerned with developing an analytical method which 
distinguishes aerosols of soluble tungsten compounds from those which are 
insoluble in water. NIOSH is currently conducting an analytical methods 
development project which will distinguish tungsten carbide and tungsten 
trioxide from sodium tungstate as examples of acid soluble, base soluble, 
and water soluble tungsten compounds.
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IX. APPENDIX I
This sampling method is adapted from NIOSH Method No. P & CAM 173 
[65]. Although this method of sampling is recommended, other methods shown 
to be at least as efficient may be used.
General Requirements
Collect personal samples in the breathing zone of individual 
employees without interfering with the employees' freedom of movement.
Enough samples should be obtained to permit calculation of a TWA 
concentration and to evaluate the exposure of each employee at every
operation or location in which there is occupational exposure to tungsten. 
Record the sampling locations and conditions, including ambient temperature 
and pressure, equipment used, time and rate of sampling, and any other 
pertinent information.
Equipment for Air Sampling
(a) Filter: Cellulose ester membrane filter with a pore size of
0.8 /urn mounted with backup pad in a 2- or 3-piece closed-face cassette.
(b) Battery-operated personal sampling pump: The pump should have
a means for attachment, such as a clip, to the employee. All pumps and 
flowmeters must be calibrated using a calibrated test meter or other
reference, as described in the Section on Calibration of Equipment.
METHOD FOR SAMPLING TUNGSTEN AND ITS PRODUCTS IN AIR
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Battery-operated pumps should be capable of operating at flowrates of 1.5- 
2.5 liters/minute and must be capable of at least 4 and preferably 8 hours 
of continuous operation without recharging.
Calibration of Equipment
Since the accuracy of an analysis can be no greater than the accuracy 
with which the volume of air is measured, the accurate calibration of the 
sampling pump is essential. The frequency of calibration required depends 
upon the use, care, and handling to which the pump is subjected. Pumps 
should be recalibrated if they have been abused or if they have just been 
repaired or received from the manufacturer. Maintenance and calibration 
should be performed on a routine schedule, and records of these should be 
maintained.
Ordinarily, pumps should be calibrated in the laboratory both before 
they are used in the field and after they have been used to collect a large 
number of field samples. If extensive field sampling is performed, 
calibration may also be performed periodically during sampling to ensure 
the continuous satisfactory operation of the pump and sampler. The 
accuracy of calibration depends on the type of instrument used as a 
reference. The choice of calibration instrument will depend largely upon 
where the calibration is to be performed. For laboratory testing, a 
spirometer or soapbubble meter is recommended, although other calibration 
instruments, such as a wet test meter, dry gas meter, or rotameter can be 
used. The calibration instrument should be calibrated to ±5%. The actual 
setups will be similar for all instruments.
The calibration setup for a personal sampling pump with a membrane
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filter is shown in Figure XII-3. Since the flowrate given by a pump 
depends on the pressure drop across the sampling device, the pump must be 
calibrated while operating with a representative filter in line.
Instructions for calibration with the soapbubble meter follow. If another 
calibration device is selected, equivalent procedures should be used.
(a) Check the voltage of the pump battery with a voltmeter to 
ensure adequate voltage for calibration. Charge the battery if necessary.
(b) Place a membrane filter in the holder.
(c) Assemble the sampling train as shown in Figure XII-2.
(d) Turn on the pump and moisten the inside of the soapbubble 
meter by immersing the buret in the soap solution and drawing bubbles up 
the inside until they are able to travel the entire length of the buret 
without bursting.
(e) Adjust the pump flow controller to provide the desired 
flowrate.
(f) Check the water manometer to ensure that the pressure drop 
across the sampling train does not exceed 13 inches of water (approximately 
1 inch of mercury).
(g) Start a soapbubble up the buret and measure with a stopwatch 
the time the bubble takes to move from one calibration mark to another.
(h) Repeat the procedure in (f) at least 3 times, average the 
results, and calculate the flowrate by dividing the volume between the 
preselected marks by the time required for the soapbubble to traverse the 
distance.
(i) Record the data for the calibration including volume measured, 
elapsed time, pressure drop, air temperature, atmospheric pressure, serial
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number of the pump, date, and the name of the person performing the 
calibration.
Collection of Samples
(a) Assemble a sampling train consisting of a 0.8-yitm cellulose
ester membrane filter with a portable, battery-operated personal sampling
pump.
(b) The recommended sampling flowrate is 2-2.5 liters/minute. 
Establish the calibrated flowrate as accurately as possible, using the 
manufacturer's directions.
(c) Measure and record the temperature and pressure of the 
atmosphere being sampled.
(d) Record the elapsed time. The sample volume is obtained by 
multiplying the flowrate by the elapsed time.
(e) Immediately after sampling, seal the filter container.
(f) Treat at least one filter in the same manner as the sample
(open and reclose cassette, seal, and ship), but do not draw air through
it. This filter will serve as a blank.
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X. APPENDIX II
The use of an atomic absorption spectrophotometer probably provides 
the most economical method for the analysis of tungsten. This method is 
recommended by NIOSH for determining compliance with the recommended 
tungsten standard. The procedure is based on Method No. P & CAM 173 of 
the NIOSH Manual of Analytical Methods [65]. Other modifications of the 
method in extraction [82], dissolution [80], and elimination of 
interferences [81] may be beneficial in improving the sensitivity. Other 
methods of analysis of tungsten may be used, provided their precision and 
sensitivity are determined to be at least equivalent to this method.
Principle of the Method
The sample, collected on a cellulose membrane filter, is washed using 
a mixture of nitric acid and hydrofluoric acid [80] to destroy the organic 
matter and to bring tungsten into solution. Samples, blanks, and standards 
are aspirated into the nitrous oxide-acetylene flame of the atomic 
absorption spectrophotometer. A hollow cathode lamp for tungsten provides 
the characteristic lines at 255 [80,81,107] or 401 nm [82-84,108]. The 
former of these two wavelengths is preferred because of its greater 
sensitivity. However, the 255 nm line is more susceptible to 
interferences, especially from molybdenum, manganese, and chromium [81]. 
The absorption of these lines by the ground-state atoms in the flame is
ANALYTICAL METHOD FOR TUNGSTEN
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proportional to the tungsten concentration in the aspirated sample.
Range and Sensitivity
For tungsten, the optimum working concentration is 500 jug/ml [83], 
and the lowest detectable concentration is 3 Mg/ml [84]. The method can be 
extended to higher concentrations by dilution of the sample. The 
sensitivity is 35 /ug of tungsten/ml/1% absorbance [84]. This value will 
vary somewhat with the instrument used.
Interferences
Edgar [81] reported enhancement of tungsten absorption caused by the 
presence of contaminant metals, particularly by vanadium, molybdenum, 
manganese, chromium, and nickel. He recommended a 2% addition of sodium 
sulfate to eliminate interference by these other metals.
Precision and Accuracy
In general, this analytical method will provide a coefficient of 
variation of approximately 2%, depending to an extent upon the instrument 
used. Keller and Parsons [108] estimated a standard deviation of 0.06% 
based on their analyses of tungsten in silicate ores. Data on the accuracy 
and precision of the method are not yet available.
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Advantages and Disadvantages
The method is rapid because there is little sample preparation 
involved. It can be performed with generally available laboratory 
equipment and by general laboratory personnel. Although interferences by 
other metals were recognized [81], these interferences were not reported 
[10,29] in the determination of environmental concentrations of tungsten. 
However, since the method measures total tungsten, it is not capable of 
distinguishing insoluble from soluble tungsten compounds. Furthermore, the 
proposed method will not determine tungstic oxide, an acid-insoluble 
compound.
Apparatus and Equipment
(a) Hollow cathode lamp for tungsten.
(b) Atomic absorption spectrophotometer having a monochromator 
with a reciprocal linear dispersion of about 6.5 Angstroms/mm in the 
ultraviolet region and equipped with a burner head for nitrous oxide- 
acetylene flame.
(c) Oxidant: Nitrous oxide is required as an oxidant since higher 
temperatures are needed in the analysis of tungsten.
(d) Fuel: Acetylene, commercially available for atomic absorption
use.
(e) Pressure-reducing valves: A 2-gauge, 2-stage pressure-
reducing valve and appropriate hose connections are needed for each 
compressed gas tank used.
(f) Glassware:
15-ml graduated tubes
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10-ml and 100-ral volumetric flasks
(g) Plastic Laboratory Ware:
125-ml polytetrafluoroethylene (PTFE) beakers with 
PTFE lids
125-ml polyethylene bottles
(h) Hotplates capable of reaching 250 C
Reagents
(a) Doubly distilled or deionized water
(b) Redistilled concentrated nitric acid
(c) Concentrated hydrofluoric acid
(d) 10% aqueous sodium sulfate
(e) Aqueous stock standards of tungsten or cobalt of 2,000 Mg/ml
Procedure
(a) Cleaning of Equipment:
Before use, plastic and glassware should be washed with a laboratory 
glassware detergent, rinsed with tap water, then soaked for 30 minutes with 
10% nitric acid. Several rinses with distilled or deionized water should 
follow.
(b) Analysis of Samples:
Samples are transferred to clean 125-ml PTFE beakers (glassware 
should not be used at this stage) and several milliliters of concentrated 
nitric acid and hydrofluoric acid are added to each. Each beaker is 
covered loosely with a PTFE lid and heated on a hotplate (140 C) in a fume
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hood until the sample chars or until a slightly yellow solution remains. 
Several additions of nitric acid and hydrofluoric acid may be needed to 
completely ash and destroy the organic material.
Once the ashing is complete, as indicated by a whitish residue in the 
beaker and following several minutes on the high temperature hotplate (200- 
250 C), the ash is then dissolved with deionized water and quantitatively 
transferred to a 15-ml graduated tube. If the sample is expected to be 
heavily contaminated with such metals as vanadium, molybdenum, manganese, 
chromium, and nickel, it may be useful to add 2% of sodium sulfate as 
recommended by Edgar [81] to reduce interferences. Aliquots of this can be 
diluted if necessary, or the volume can be reduced by evaporation to get 
the tungsten concentration within the working range of the method.
The sample is then aspirated into a reducing nitrous oxide-acetylene 
flame and measured at 255 nm (alternatively 401 nm). The other operating 
parameters are set according to the instrument instructions from the 
manufacturer. When very low tungsten concentrations are found in the 
sample, scale expansion can be used to increase instrument response.
Calibration and Standards
From 2,000 Mg of tungsten/ml of stock standard solutions, prepare 
working standards to cover the range between 3 and 1,000 n g / m l . The 
standard solutions are made in deionized water, with 2% sodium sulfate 
added if the samples were similarly treated, and are stored in polyethylene 
bottles. The low concentration standards may deteriorate and should be 
made on the day they are to be used.
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Aspirate the series of standards and record the percentage of 
absorption.
Prepare calibration curves by plotting on linear graph paper the 
absorbance versus the concentration of each standard in jug/ml. It is 
advisable to run a set of standards both before and after a sample run to 
ensure that conditions have not changed.
Calculations
From the calibration curve, read the concentration in /ug/ml in the 
analysis sample.
Blank values, if any, are subtracted from each sample. The 
concentration of tungsten in air can be expressed as milligrams of 
tungsten/cubic meter of air, which is numerically equal to micrograms of 
tungsten/liter of air:
mg tungsten/cu m = jug tungsten/V x D
where:
jug tungsten = micrograms of tungsten from the 
calibration curve
V = volume of air sampled (in liters) at 25 C 
and 7 60 mmHg 
D = dilution, if any
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XI. APPENDIX III 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material shall be provided in the appropriate block of the 
Material Safety Data Sheet (MSDS).
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read 
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the rules in Chapter V, 
Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (Including area code) are inserted in the appropriate blocks of 
Section I. The company listed should be a source of detailed backup 
information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially 
formal chemical nomenclature. Every known chemical designation or
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competitor's trade name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another
component because of its flammability, while a third component could be
included both for its toxicity and its reactivity. Note that a MSDS for a 
single component product must have the name of the material repeated in 
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is
known.
The "%" may be the approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50- 
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.1000," or, if not available, from other sources of publications such 
as the American Conference of Governmental Industrial Hygienists or the 
American National Standards Institute Inc. Flashpoint, shock sensitivity
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or similar descriptive data may be used to indicate flatnmability, 
reactivity, or similar hazardous properties of the material.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury
(mmHg); vapor density of gas or vapor (air = 1); solubility in water, in
parts/hundred parts of water by weight; specific gravity (water = 1);
percent volatiles (indicated if by weight or volume) at 70 degrees
Fahrenheit (21.1 degrees Celsius); evaporation rate for liquids or 
sublimable solids, relative to butyl acetate; and appearance and odor. 
These data are useful for the control of toxic substances. Boiling point, 
vapor density, percent volatiles, vapor pressure, and evaporation are 
useful for designing proper ventilation equipment. This information is
also useful for design and deployment of adequate fire and spill
containment equipment. The appearance and odor may facilitate
identification of substances stored in improperly marked containers, or 
when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the
product, including flashpoint and autoignition temperature in degrees
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable 
standard. Other data are acceptable, such as lowest LD50 if multiple 
components are involved.
Under "Routes of Exposure," comments in each category should reflect
the potential hazard from absorption by the route in question. Comments
should indicate the severity of the effect and the basis for the statement
if possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, possibly mild irritation.
Eye Contact— some pain and mild transient irritation; no corneal
scarring.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed employees.
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(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances, such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect employees assigned to 
cleanup detail. Specific neutralizing chemicals or procedures should be 
described in detail. Disposal methods should be explicit including proper 
labeling of containers holding residues and ultimate disposal methods such 
as "sanitary landfill," or "incineration." Warnings such as "comply with 
local, state, and federal antipollution ordinances" are proper but not 
sufficient. Specific procedures shall be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. 
Respirators shall be specified as to type and NIOSH or US Bureau of Mines 
approval class, ie, "Supplied air," "Organic vapor canister," etc. 
Protective equipment must be specified as to type and materials of 
construction.
160
(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on
any aspect of safety or health not covered in other sections should be
inserted in Section IX. The lower block can contain references to 
published guides or in-house procedures for handling and storage. 
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to employees 
exposed to the hazardous substance. The MSDS can be used as a training aid 
and basis for discussion during safety meetings and training of new 
employees. It should assist management by directing attention to the need 
for specific control engineering, work practices, and protective measures 
to ensure safe handling and use of the material. It will aid the safety 
and health staff in planning a safe and healthful work environment and in 
suggesting appropriate emergency procedures and sources of help in the 
event of harmful exposure of employees.
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TABLE XII-1
CHEMICAL AND PHYSICAL PROPERTIES OF
TUNGSTEN AND SELECTED TUNGSTEN COMPOUNDS
Molecular
Formula
Formula
Weight
Melting
Point
(c)
Solubility
g/IOOcc
Compound Density h 2 o * Other
Ammonium metatungstate <NH4 >6H 2W 1 2 °4 0 - Decomposes 200 4.0 Very soluble -
Ammonium paratungstate <N H 4*10*H 10W 1 2 ° 4 6 ) - - - Insoluble Decomposes in acid or 
alkali
Ammonium phosphotungstate <NlW < W3°1 0> 4 2,931.27 - - Slightly
soluble
Soluble in alkali, insol­
uble in acid
Cadmium tungstate C dW 0 4 360.25 - - 0.05 Soluble in N H 4 OH
Calcium tungstate CaW 0 4 287.93 - 6.062 0 .0 0 0 6 4 (1 5 0 -
tt
tt - - 0 .0 0 3 2 3 (2 5 0 Insoluble in alcohol, 
acid; soluble in N H 4 CI
Calcium tungstate (Scheelite) it tt - - 0 .0 0 1 3 (2 0 C ) -
§t ft it
- - 0.0002 (90 C) -
Calcium metatungstate Ca3 H 4 [H 2 (W 2 0 7 )6 ] 27H 20 3,500.96 -7 H 20  105 - - Decomposes in acid
Cerium ( I I I )  tungstate Ce2 (W 0 4 ) 3 1,023.78 1,089 6.77 - -
Cesium tungstate Cs2 W 0 4 380.76 - - 85.6 (17 C)
Cobalt tungstate C oW 0 4 306.78 - 8.42 Insoluble Soluble in hot concen­
trated acid
Copper ( II)  tungstate C uW 0 4 2H 20 347.42 Red heat — 0.1 (15 0 Soluble in N H 4 O H ; insol­
uble in alcohol; decom­
poses in mineral acid
Cyclopentadienylbitungsten
hexacarbonyl
(c 5 h 5 ) 2 w 2 ( c o ) 6 665.95 2 4 0 -2  decomposes - - Soluble in chloroform,
cci4, cs2
Iron ( II)  tungstate FeW 0 4 303.69 - 6.64 -
Lead tungstate PbW 0 4 455.04 - - 0.00159 (25 C) -
Lithium tungstate L i2 W 0 4 261.73 742 3.71 Very soluble Decomposes in acid; 
insoluble in alcohol
Magnesium tungstate M gW 0 4 272.73 5.66 Insoluble tt
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TABLE X I1-1 (Continued)
CHEMICAL AND PHYSICAL PROPERTIES OF
TUNGSTEN AND SELECTED TUNGSTEN COMPOUNDS
Molecular
Formula
Formula
Weight
Melting
Point
(c)
Solubility
g /1 0 0 cc
Compound Density h 2 o * Other
Mercury (I) tungstate Hg2 W 0 4 649.03 Decomposes — Insoluble Decomposes in acid; 
insoluble in alcohol
Mercury ( II)  tungstate HgW 0 4 448.44 tt - tt tt
Mesitylene-tungsten tricarbonyl <CH 3)3C6 H 3W (C 0 )3 388.08 160-165  decom­
poses
- -
Metatungstic acid H 2W4 ° 1 3 -9H 2 ° 1,107.4 2.5239
3.6503
88.57 (22 C)
111.87 (43.5 C)
Phospho-tungstic acid H 3 ^ W 3 ° 1 cM  ’ 14H 2 °  
Tungstophosphoric acid
3,132 39 160-165  decom­
poses
Soluble Soluble in alcohol and 
ether
Phospho-tungstic acid H 3 ^ W3 °1 0 *4 l ' 24H 2 °  
Dodectungstophosphoric acid
3,312.54 89
Potassium tungstate K 2 W 0 4 ■2H 20 362.08 921 3.113 51.5 Decomposes in acid; 
insoluble in alcohol
Potassium metatungstate K6 [H 2W 1 2 ° 4 0 ] ' 1 8 H 2 ° 3,407.08 930 - Soluble Decomposes in acid
Silicotungstic acid H8SiW 1 2 °4 2 2,914.2 - 961 .5  (18 C) -
Silver tungstate Ag2 W 0 4 463.59 - 0 .05  (15 C) -
Sodium tungstate Na 2 W 0 4 293.83 698 4.179 57.5  (0 C )  
73.2 (21 C)
—
Sodium tungstate, dihydrate Na 2 W 0 4 - 2H 20 329.86 698 Anhydrous 3 .2 3 -3 .2 5 41 .0  (0 C ) Slightly soluble in NH^; 
insoluble in alcohol, acid
Sodium metatungstate Na20  W 0 2 -10H 20 1,169.53 706.6 - Soluble Insoluble in acid
Sodium paratungstate Na6W 7 ° 2 4 '16H2 ° 2,097.12 -1 2 H 20  -1 6 H 20 3.987 8
Strontium tungstate SrW 0 4 335.47 Decomposes 6.187 0.14 (15 C) Insoluble in dilute acid, 
alcohol
Tungsten (Wolfram) W 183.85 3 ,4 1 0 + 2 0 19.35 Insoluble Slightly soluble in HNOg, 
^ 2 ®®4 ' a<*ua re9 'a- soluble 
in H N O 3 + H F , fused in 
NaOH+NaNOg; insoluble 
in H F , KOH
TABLE X I1-1 (Continued)
C H E M IC A L  A N D  P H Y S IC A L PRO PERTIES OF  
T U N G S T E N  A N D  SELECTED T U N G S T E N  CO M PO UNDS
Molecular
Formula
Formula
Weight
Melting
Point
(c)
Solubility
g /1 0 0 cc
Compound Density h 2o Other
Tungsten arsenide WAs2 333.69 Decomposes in red 
heat
6.9 Insoluble Decomposes in hot 
H N 0 3 , hot H 2 S 0 4
Tungsten diboride w b 2 205.47 2,900 10.77 I I Soluble in aqua regia
Tungsten dibromide WBr2 343.67 Decomposes 4,400 - Decomposes
Tungsten pentabromide W Br5 583.40 276
'
Soluble, in absolute alco­
hol, chloroform, ether, 
alkali
Tungsten hexabromide WBr6 663.30 232 6.9 Insoluble Soluble in absolute alco­
hol, ether CS2 , N H 4 OH
Tungsten carbide WC 195.86 2870+50 15.63 n Soluble in HN O g+HF, 
aqua regia
Tungsten dicarbide w c 2 379.71 2860 17.15 I I Soluble in H N O 3 +HCI
Tungsten carbonyl W (CO ) 6 351.91 Decomposes N 150 2.65 Soluble in fuming H N 0 3 -, 
slightly soluble in alcohol, 
ether
Tungsten dichloride W CI2 254.76 - 5.436 - -
Tungsten tetrachloride W CI4 325.66 Decomposes 4.624 -
Tungsten pentachloride W CI5 361.12 248 3.875 Slightly soluble in CS2
Tungsten-hexachloride W CI6 396.57 275 3.52 Decomposes 
<60 C)
Soluble in alcohol, ether, 
benzene, C C I4 , very sol­
uble in CS2 , POCI 
Impure WCIg decomposes 
at even lower tempera­
tures
Tungsten hexafluoride W F 6 297.84 2.5 3.44  
(Liquid) 
12.9 g/l (Gas)
Decomposes Soluble in alkali
TABLE X II—1 (Continued)
C H E M IC A L  A N D  P H Y S IC A L PRO PERTIES OF  
T U N G S TE N  A N D  SELEC TED  T U N G S T E N  COM PO UNDS
Molecular
Formula
Formula
Weight
Melting
Point
(c)
Solubility
g/IOOcc
Compound Density h 2 o * Other
Tungsten diiodide w i 2 437.66 Decomposes 6.799 Insoluble Soluble in alkali; insoluble 
in alcohol, CS2
Tungsten tetraiodide w i 4 691.47 5.2 Soluble in absolute alcohol 
insoluble in ether, chloro­
form, turpentine
Tungsten dinitride w n 2 2 1 1 . 8 6 Above 400(vacuum) - Decomposes -
Tungsten dioxide w o 2 215.85 1.500 (in N2) 1 2 . 1 Insoluble Soluble in acid, KOH
Tungsten trioxide (Wolframite) W 0 3 231.85 1.473 7.16 " Soluble in hot alkali; 
insoluble in acid
Tungsten pentoxide Mineral blue W 2 O go rW 4O ii 447 .70  or 911.39 8 0 0 -9 0 0  Sublimes - Insoluble Insoluble in acid
Tungsten dioxydibromide W 0 2 Br2 375.67 Decomposes - - -
Tungsten oxytetrabromide W 0B r4 519.49 277 - Decomposes -
Tungsten oxytetrachloride w o c i4 341.66 2 1 1 - " Soluble in CS2 , S2 CI2  and 
benzene
Tungsten dioxydichloride w o 2c i2 286.75 266 - Soluble Insoluble in alcohol; sol­
uble in N H 4 OH, alkali
Tungsten oxytetrafluoride w o f 4 275.84 1 1 0 - Decomposes Slightly soluble in CS2 ; 
insoluble in CCI4
Tungsten phosphide WP 214.82 - 8.5 Insoluble Soluble in H N O 3 +H F; in­
soluble in alkali, HCI
Tungsten phosphide w p 2 245.80 Decomposes 5.8 Soluble in H N O ^+H F; in­
soluble in alkali, HCI; 
soluble in aqua regia
Tungsten phosphide w 2p 398.67 5.21 Soluble in fused Na 2 COg; 
insoluble in acid, aqua 
regia
TABLE X I1-1 (Continued)
CHEMICAL AND PHYSICAL PROPERTIES OF
TUNGSTEN AND SELECTED TUNGSTEN COMPOUNDS
Molecular
Formula
Formula
Weight
Melting
Point
(c)
Solubility
g /1 0 0 cc
Compound Density h 2 o * Other
Tungsten silicide WSi2 240.02 Above 900 9.4 Insoluble Soluble in HN O g+HF; 
insoluble in aqua regia
Tungsten disulfide (Tungstenite) ws2 247.98 Decomposes 7.5 it Soluble in HN O g+H F, 
fused alkali; insoluble in 
alcohol
12-Tungstophosphoric acid P2 ° 5 24W 03 -45H 20 6,516.35 86 .75 (92 C)
For the purpose o f compliance w ith the recommended standards, insoluble tungsten compounds include all those for which water solubility is listed as insoluble 
or less than 0.01 g /100 cc. Soluble tungsten compounds are those listed as very soluble, soluble, slightly soluble, equal to or greater than 0.01 g/100 cc, or 
decomposes. Those compounds for which no solubility information is listed should be considered soluble unless it can be demonstrated that they are insoluble 
in water.
Adapted from references 2 - 6
TABLE XI1-2
OCCUPATIONS WITH POTENTIAL TUNGSTEN EXPOSURE
Alloy makers 
Carbonyl workers 
Ceramic workers
Cemented tungsten carbide workers 
Cement makers
Dyemakers
Dyers
Flameproofers
High-speed tool steelworkers 
Incandescent-lamp makers 
Industrial chemical synthesizers 
Inkmakers
Lamp-filament makers 
Lubricant makers
Adapted from reference 12
Melting, pouring, casting workers 
Metal sprayers
Ore-refining and foundry workers
Paint and pigment makers
Papermakers
Penpoint makers
Petroleum refinery workers
Photographic developers
Spark-plug makers
Textile dryers
Tool grinders
Tungsten and molybdenum miners 
Waterproofing makers 
Welders
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SCHÈELITE WOLFRAMITE
TUNGSTIC ACID
^ -A M M O N IU M  H Y D R O X ID E
AM M O N IU M —P—TUNGSTATE  
6(NH 4 )20 -12 W 0 3 n H 20  
or
6(NH 4 )20 -12 W 0 3 -6H20
t  A 400°
A M M O N IA  I
TUNGSTIC O XIDE less than 5-micrometer size 
W 0 3
P HYDROGEN  REDUCTIONTUNGSTEN PENTOXIDE (BLUE OXIDE)
less than 5-micrometer size 
HYDROGEN  
REDUCTION
W2 ° 5 ,
TUNGSTEN D IO X ID E  (BROWN OXIDE)
D UC TILE  TUNGSTEN
FERROTUNGSTEN
TUNGSTEN
W
less than S-micrometer size
less than 5-micrometer size
'CA R BO N  BLACK (6 .05 -6 .2% )
TUNGSTEN CARBIDE  
WC
OTHER METALS (OR) TH E IR  CARBIDES: 
DOPING (V.Cr.M o.Ti.Ta.Nb.Hf, Zr)
BINDERS: G EN ER ALLY 4-10% COBALT,
LESS FR EQ U EN TLY N ICKEL OR IRON
CEM ENTED TUNGSTEN CARBIDE  
(HARD M ETA LI
FIGURE XII-1
PRODUCTION OF COMMERCIAL TUNGSTEN COMPOUNDS AND 
CEMENTED TUNGSTEN CARBIDE
From references 10 and 11
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To Atmosphere
grinder 
FIGURE X I1-2
TYPICAL LOW VOLUME HIGH VELOCITY VEN TILATION SYSTEM*
'B ell and socket, sm ooth-flow type tubing and fittings should be used throughout the system. 
When system will be used for vacuum cleaning of abrasive materials. Schedule No. 40  and C .l. 
drainage fittings, or heavier, should be used in place of tubing.
Adapted from reference 61
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FIGURE XII-3 
CALIBRATION SETUP FOR PERSONAL SAMPLING PUMP 
WITH FILTER CASSETTE
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